Section 55

EurekaMag PDF full texts Chapter 54,531


Hongkan, W.; Soongswang, J.; Veerakul, G.; Sanpakit, K.; Punlee, K.; Rochanasiri, W.; Udompunturak, S. 2009: N-terminal pro brain natriuretic peptide and cardiac function in doxorubicin administered pediatric patients. Journal of the Medical Association of Thailand 92(11): 1450-1457
Luchner, A.; Möckel, M.; Spanuth, E.; Möcks, J.; Peetz, D.; Baum, Hörg.; Spes, C.; Wrede, C.E.; Vollert, Jörn.; Müller, R.; Katus, H.; Giannitsis, E. 2012: N-terminal pro brain natriuretic peptide in the management of patients in the medical emergency department (PROMPT): correlation with disease severity, utilization of hospital resources, and prognosis in a large, prospective, randomized multicentre trial. European Journal of Heart Failure 14(3): 259-267
Naito, T.; Masaki, T.; Shimizu, Y.; Ogawa, T.; Ochiai, M.; Hamaguchi, N.; Hirashio, S.; Doi, T.; Yokoyama, Y.; Yorioka, N. 2011: N-terminal pro brain natriuretic peptide predicts hospitalization of hemodialysis patients for cardiovascular disease. Nihon Jinzo Gakkai Shi 53(4): 633-641
Grauslund, J.; Nybo, M.; Green, A.; Sjølie, A.K. 2010: N-terminal pro brain natriuretic peptide reflects long-term complications in type 1 diabetes. Scandinavian Journal of Clinical and Laboratory Investigation 70(6): 392-398
Tigen, K.; Karaahmet, T.; Kahveci, G.; Tanalp, A.C.; Bitigen, A.; Fotbolcu, H.; Bayrak, F.; Mutlu, B.; Basaran, Y. 2007: N-terminal pro brain natriuretic peptide to predict prognosis in dilated cardiomyopathy with sinus rhythm. Heart Lung and Circulation 16(4): 290-294
Maeder, M.T.; Rickenbacher, P.; Rickli, H.; Abbühl, H.; Gutmann, M.; Erne, P.; Vuilliomenet, A.é; Peter, M.; Pfisterer, M.; Brunner-La Rocca, H.-P. 2013: N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF). European Journal of Heart Failure 15(10): 1148-1156
Allanore, Y.; Meune, C. 2009: N-terminal pro brain natriuretic peptide: the new cornerstone of cardiovascular assessment in systemic sclerosis. Clinical and Experimental Rheumatology 27(3 Suppl 54: 59-63
Park, S.J.; Cho, K.I.; Jung, S.J.; Choi, S.W.; Choi, J.W.; Lee, D.W.; Lee, H.G.; Kim, T.I. 2009: N-terminal pro-B-type natriuretic Peptide in overweight and obese patients with and without diabetes: an analysis based on body mass index and left ventricular geometry. Korean Circulation Journal 39(12): 538-544
Slubowska, K.; Sadowska, A.; Kwiatkowski, A.; Durlik, M. 2014: N-terminal pro-B-type natriuretic peptide (NT-proBNP) assessment in the first year after renal transplantation and its relationship with graft function and left ventricular hypertrophy. Transplantation Proceedings 46(8): 2729-2732
Berg, T.; Zdunek, D.; Stalke, J.; Dupke, S.; Baumgarten, A.; Carganico, A.; Hess, G. 2007: N-terminal pro-B-type natriuretic peptide (NT-proBNP) in HIV-1 infected individuals on HAART. European Journal of Medical Research 12(4): 152-160
Zheng, P.; Wang, H.; Tian, Y.-q.; Guo, Y.-l.; He, Z.-x.; Lu, Y.; Zheng, X.; Ma, W.-j.; Xu, N.; Sun, X.; Zhang, L. 2011: N-terminal pro-B-type natriuretic peptide and diastolic function measurements by adenosine stress echocardiography in prediction of coronary stenosis in patients. Chinese Medical Journal 124(14): 2089-2095
Maeder, M.T.; Ammann, P.; Rickli, H.; Schoch, O.D.; Korte, W.; Hürny, C.; Myers, J.; Münzer, T. 2008: N-terminal pro-B-type natriuretic peptide and functional capacity in patients with obstructive sleep apnea. Sleep and Breathing 12(1): 7-16
Singh, H.S.; Bibbins-Domingo, K.; Ali, S.; Wu, A.H.B.; Schiller, N.B.; Whooley, M.A. 2009: N-terminal pro-B-type natriuretic peptide and inducible ischemia in the Heart and Soul Study. Clinical Cardiology 32(8): 447-453
Eindhoven, J.A.; van den Bosch, A.E.; Ruys, T.P.E.; Opić, P.; Cuypers, J.A.A.E.; McGhie, J.S.; Witsenburg, M.; Boersma, E.; Roos-Hesselink, J.W. 2013: N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease. Journal of the American College of Cardiology 62(13): 1203-1212
Krackhardt, F.; Düngen, H.-D.; Trippel, T.D.; Inkrot, S.; Tscholl, V.; Schlattmann, P.; Kehrt, K.; Haverkamp, W. 2011: N-terminal pro-B-type natriuretic peptide and long-term mortality in non-ischaemic cardiomyopathy. Wiener Klinische Wochenschrift 123(23-24): 738-742
Oterdoom, L.H.; de Vries, A.P.J.; van Ree, R.M.; Gansevoort, R.T.; van Son, W.J.; van der Heide, J.J.H.; Navis, G.; de Jong, P.E.; Gans, R.O.B.; Bakker, S.J.L. 2009: N-terminal pro-B-type natriuretic peptide and mortality in renal transplant recipients versus the general population. Transplantation 87(10): 1562-1570
Cushman, M.; Judd, S.E.; Howard, V.J.; Kissela, B.; Gutiérrez, O.M.; Jenny, N.S.; Ahmed, A.; Thacker, E.L.; Zakai, N.A. 2014: N-terminal pro-B-type natriuretic peptide and stroke risk: the reasons for geographic and racial differences in stroke cohort. Stroke 45(6): 1646-1650
Albert, C.M. 2011: N-terminal pro-B-type natriuretic peptide and sudden cardiac death risk: implications for primary prevention of sudden cardiac death. Heart Rhythm 8(2): 234-235
Kocharian, A.; Shabanian, R.; Rahimzadeh, M.; Kiani, A.; Hosseini, A.; Zanjani, K.S.; Heidari-Bateni, G.; Hosseini-Navid, N. 2009: N-terminal pro-B-type natriuretic peptide and ventricular dysfunction in children and adolescents. Cardiology in the Young 19(6): 580-588
El-Khuffash, A.F.; Amoruso, M.; Culliton, M.; Molloy, E.J. 2007: N-terminal pro-B-type natriuretic peptide as a marker of ductal haemodynamic significance in preterm infants: a prospective observational study. Archives of Disease in Childhood. Fetal and Neonatal Edition 92(5): F421-F422
Patton, K.K.; Heckbert, S.R.; Alonso, A.; Bahrami, H.; Lima, J.A.C.; Burke, G.; Kronmal, R.A. 2013: N-terminal pro-B-type natriuretic peptide as a predictor of incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis: the effects of age, sex and ethnicity. Heart 99(24): 1832-1836
Khan, S.Q.; Narayan, H.; Ng, K.H.; Dhillon, O.S.; Kelly, D.; Quinn, P.; Squire, I.B.; Davies, J.E.; Ng, L.L. 2009: N-terminal pro-B-type natriuretic peptide complements the GRACE risk score in predicting early and late mortality following acute coronary syndrome. Clinical Science 117(1): 31-39
Pitt, B. 2008: N-terminal pro-B-type natriuretic peptide concentrations > or = 100 ng/l increased risk of all-cause mortality. Evidence-Based Medicine 13(1): 26
Hijazi, Z.; Wallentin, L.; Siegbahn, A.; Andersson, U.; Christersson, C.; Ezekowitz, J.; Gersh, B.J.; Hanna, M.; Hohnloser, S.; Horowitz, J.; Huber, K.; Hylek, E.M.; Lopes, R.D.; McMurray, J.J.V.; Granger, C.B. 2013: N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation). Journal of the American College of Cardiology 61(22): 2274-2284
Mangge, H.; Almer, G.; Zelzer, S.; Vasan, R.; Kraigher-Krainer, E.; Gasser, R.; Schnedl, W.; Ille, R.; Wallner, S.; Möller, R.; Horejsi, R.; Weghuber, D. 2011: N-terminal pro-B-type natriuretic peptide in early and advanced phases of obesity. Clinical Chemistry and Laboratory Medicine 49(9): 1539-1545
Andreassen, M.; Faber, J.; Vestergaard, H.; Kistorp, C.; Kristensen, L.Øs. 2007: N-terminal pro-B-type natriuretic peptide in patients with growth hormone disturbances. Clinical Endocrinology 66(5): 619-625
Wu, X.; Sha, H.; Sun, Y.; Gao, L.; Liu, H.; Yuan, Q.; Zhang, T.; Zhu, J.; Zhou, L.; Hu, J. 2011: N-terminal pro-B-type natriuretic peptide in patients with isolated traumatic brain injury: a prospective cohort study. Journal of Trauma 71(4): 820
Patton, K.K.; Ellinor, P.T.; Heckbert, S.R.; Christenson, R.H.; DeFilippi, C.; Gottdiener, J.S.; Kronmal, R.A. 2009: N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study. Circulation 120(18): 1768-1774
Rajagopalan, S.; Croal, B.L.; Reeve, J.; Bachoo, P.; Brittenden, J. 2011: N-terminal pro-B-type natriuretic peptide is an independent predictor of all-cause mortality and MACE after major vascular surgery in medium-term follow-up. European Journal of Vascular and Endovascular Surgery: the Official Journal of the European Society for Vascular Surgery 41(5): 657-662
Linssen, G.C.M.; Bakker, S.J.L.; Voors, A.A.; Gansevoort, R.T.; Hillege, H.L.; de Jong, P.E.; van Veldhuisen, D.J.; Gans, R.O.B.; de Zeeuw, D. 2010: N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population. European Heart Journal 31(1): 120-127
Meyer, B.; Huelsmann, M.; Wexberg, P.; Delle Karth, G.; Berger, R.; Moertl, D.; Szekeres, T.; Pacher, R.; Heinz, G. 2007: N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients. Critical Care Medicine 35(10): 2268-2273
Kwon, T.G.; Bae, J.H.; Jeong, M.H.; Kim, Y.J.; Hur, S.H.; Seong, I.W.; Cho, M.C.; Seung, K.B.; Jang, Y.S.; Park, S.J.; Jeong, M.H.; Kim, Y.J.; Kim, C.J.; Cho, M.C.; Ahn, Y.K.; Kim, J.H.; Chae, S.C.; Hur, S.H.; Seong, I.W.; Hong, T.J.; Choi, D.H.; Chae, J.K.; Rhew, J.Y.; Kim, D.I.; Chae, I.H.; Yoon, J.; Koo, B.K.; Kim, B.O.; Lee, M.Y.; Kim, K.S.; Hwang, J.Y.; Oh, S.K.; Lee, N.H.; Jeong, K.T.; Tahk, S.J.; Bae, J.H.; Rha, S.W.; Park, K.S.; Han, K.R.; Ahn, T.H.; Kim, M.H.; Yang, J.Y.; Rhim, C.Y.; Gwon, H.C.; Park, S.W.; Koh, Y.Y.; Joo, S.J.; Kim, S.J.; Jin, D.K.; Cho, J.M.; Chung, W.S.; Jang, Y.S.; Cho, J.G.; Seung, K.B.; Park, S.J. 2009: N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention. International Journal of Cardiology 133(2): 173-178
Chen, Y.-C.; Lee, M.-C.; Lee, C.-J.; Ho, G.-J.; Yin, W.-Y.; Chang, Y.-J.; Hsu, B.-G. 2013: N-terminal pro-B-type natriuretic peptide is associated with arterial stiffness measured using the cardio-ankle vascular index in renal transplant recipients. Journal of Atherosclerosis and Thrombosis 20(7): 646-653
Wei, G.; Ningfu, W.; Xianhua, Y.; Liang, Z.; Jianmin, Y.; Guoxin, T.; Peng, X. 2012: N-terminal pro-B-type natriuretic peptide is associated with severity of the coronary lesions in unstable angina patients with preserved left ventricular function. Journal of Interventional Cardiology 25(2): 126-131
Patton, K.K.; Sotoodehnia, N.; DeFilippi, C.; Siscovick, D.S.; Gottdiener, J.S.; Kronmal, R.A. 2011: N-terminal pro-B-type natriuretic peptide is associated with sudden cardiac death risk: the Cardiovascular Health Study. Heart Rhythm 8(2): 228-233
Chang, H.-R.; Hsieh, J.-C.; Hsu, B.-G.; Wang, L.-Y.; Yu-Chih Chen, M.; Wang, J.-H. 2014: N-terminal pro-B-type natriuretic peptide is inversely associated with metabolic syndrome in hypertensive patients. American Journal of the Medical Sciences 348(3): 210-214
Wang, J.-H.; Lee, C.-J.; Hsieh, J.-C.; Chen, Y.-C.; Hsu, B.-G. 2014: N-terminal pro-B-type natriuretic peptide level inversely associates with metabolic syndrome in elderly persons. Diabetology and Metabolic Syndrome 6(1): 15
Hong, S.N.; Ahn, Y.; Yoon, N.S.; Moon, J.Y.; Kim, K.H.; Hong, Y.J.; Park, H.W.; Kim, J.H.; Jeong, M.H.; Cho, J.G.; Park, J.C.; Kang, J.C. 2008: N-terminal pro-B-type natriuretic peptide level is depressed in patients with significant coronary artery disease who have high body mass index. International Heart Journal 49(4): 403-412
Cuthbertson, B.H.; Croal, B.L.; Rae, D.; Gibson, P.H.; McNeilly, J.D.; Jeffrey, R.R.; Smith, W.C.; Prescott, G.J.; Buchan, K.G.; El-Shafei, H.; Gibson, G.A.; Hillis, G.S. 2009: N-terminal pro-B-type natriuretic peptide levels and early outcome after cardiac surgery: a prospective cohort study. British Journal of Anaesthesia 103(5): 647-653
Yildiz, S.; Uzun, G.; Uz, O.; Ipcioglu, O.M.; Kardesoglu, E.; Ozcan, O. 2008: N-terminal pro-B-type natriuretic peptide levels increases after hyperbaric oxygen therapy in diabetic patients. Clinical and Investigative Medicine. Medecine Clinique et Experimentale 31(5): E231-E235
D'Errico, M.P.; Grimaldi, L.; Petruzzelli, M.F.; Gianicolo, E.A.L.; Tramacere, F.; Monetti, A.; Placella, R.; Pili, G.; Andreassi, M.G.; Sicari, R.; Picano, E.; Portaluri, M. 2012: N-terminal pro-B-type natriuretic peptide plasma levels as a potential biomarker for cardiac damage after radiotherapy in patients with left-sided breast cancer. International Journal of Radiation Oncology Biology Physics 82(2): E239-E246
Kampman, M.A.M.; Balci, A.; van Veldhuisen, D.J.; van Dijk, A.P.J.; Roos-Hesselink, J.W.; Sollie-Szarynska, K.M.; Ludwig-Ruitenberg, M.; van Melle, J.P.; Mulder, B.J.M.; Pieper, P.G. 2014: N-terminal pro-B-type natriuretic peptide predicts cardiovascular complications in pregnant women with congenital heart disease. European Heart Journal 35(11): 708-715
Alonso-Martínez, J.é L.; Urbieta-Echezarreta, M.; Anniccherico-Sánchez, F.J.; Abínzano-Guillén, M.L.; Garcia-Sanchotena, J.L. 2009: N-terminal pro-B-type natriuretic peptide predicts the burden of pulmonary embolism. American Journal of the Medical Sciences 337(2): 88-92
Sarlak, H.; Akhan, M.; Cakar, M.; Kurt, O.; Arslan, E.; Balta, S. 2013: N-terminal pro-B-type natriuretic peptide should be used in all dyspneic patients in the ED. American Journal of Emergency Medicine 31(12): 1711
Moe, G.W.; Howlett, J.; Januzzi, J.L.; Zowall, H. 2007: N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study. Circulation 115(24): 3103-3110
Li, H.; Wang, H.; Lou, Y.; Miao, W.; Sha, N. 2014: N-terminal pro-B-type natriuretic peptide value for prediction of mortality among critically ill patients in different age groups in intensive care unit. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 26(7): 508-512
Spatenkova, V.; Bradac, O.; Kazda, A.; Suchomel, P. 2011: N-terminal pro-B-type natriuretic peptide with fractional excretion and clearance of sodium in relation to cardiovascular events after elective cervical spine surgery. Neuro Endocrinology Letters 32(6): 874-878
Lainchbury, J.G.; Troughton, R.W.; Strangman, K.M.; Frampton, C.M.; Pilbrow, A.; Yandle, T.G.; Hamid, A.K.; Nicholls, M.Gary.; Richards, A.Mark. 2009: N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial. Journal of the American College of Cardiology 55(1): 53-60
Berger, R.; Moertl, D.; Peter, S.; Ahmadi, R.; Huelsmann, M.; Yamuti, S.; Wagner, B.; Pacher, R. 2010: N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study. Journal of the American College of Cardiology 55(7): 645-653
Farombi-Oghuvbu, I.; Matthews, T.; Mayne, P.D.; Guerin, H.; Corcoran, J.D. 2008: N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus. Archives of Disease in Childhood. Fetal and Neonatal Edition 93(4): F257-F260
Luterek, K.; Szymusik, I.; Bartkowiak, R.; Koltowski, L.; Filipiak, K.J.; Wielgos, M. 2011: N-terminal pro-B-type natriuretic peptide: a potential marker of fetal heart failure in hemolytic disease. Neuro Endocrinology Letters 32(5): 657-662
Cosson, E.; Nguyen, M.T.; Pham, I.; Pontet, M.; Nitenberg, A.; Valensi, P. 2009: N-terminal pro-B-type natriuretic peptide: an independent marker for coronary artery disease in asymptomatic diabetic patients. Diabetic Medicine: a Journal of the British Diabetic Association 26(9): 872-879
Cherniack, N.S. 2008: N-terminal pro-B-type naturetic peptide (NTBNP): so much promise and such a disappointment. Sleep and Breathing 12(1): 3-5
Salama, R.; El-Moniem, A.; El-Hefney, N.; Samor, T. 2011: N-terminal pro-BNP in acute coronary syndrome patients with ST elevation (STE-ACS) versus non ST elevation (NSTE-ACS). International Journal of Health Sciences 5(2 Suppl 1: 27-29
Yamashita, T.; Seino, Y.; Ogawa, A.; Ogata, K.-i.; Fukushima, M.; Tanaka, K.; Mizuno, K. 2010: N-terminal pro-BNP is a novel biomarker for integrated cardio-renal burden and early risk stratification in patients admitted for cardiac emergency. Journal of Cardiology 55(3): 377-383
Chadha, D.S.; Karthikeyan, G.; Goel, K.; Malani, S.K.; Seth, S.; Singh, S.; Dhall, A.; Bhargava, B. 2010: N-terminal pro-BNP plasma levels before and after percutaneous transvenous mitral commissurotomy for mitral stenosis. International Journal of Cardiology 144(2): 238-240
Cai, B.; Wang, L.; Liu, J.; Shi, Y.; Guo, Y. 2011: N-terminal pro-Brain natriuretic peptide as a useful biomarker for monitoring prognosis in patients with cardiac valve replacement. Journal of Clinical Laboratory Analysis 25(3): 149-155
Floras, A.N.K.; Holowaychuk, M.K.; Bienzle, D.; Bersenas, A.M.E.; Sharif, S.; Harvey, T.; Nordone, S.K.; Wood, G.A. 2014: N-terminal pro-C-natriuretic peptide and cytokine kinetics in dogs with endotoxemia. Journal of Veterinary Internal Medicine 28(5): 1447-1453
Krogh, J.; Ströhle, A.; Westrin, A.; Klausen, T.; Jørgensen, M.B.; Nordentoft, M. 2011: N-terminal pro-atrial natriuretic peptide response to acute exercise in depressed patients and healthy controls. Psychoneuroendocrinology 36(5): 656-663
Shiraishi, M.; Fuse, S.; Mori, T.; Doyama, A.; Honjyo, S.; Hoshino, Y.; Hoshino, E.; Kawaguchi, A.; Kuroiwa, Y.; Hotsubo, T. 2013: N-terminal pro-brain natriuretic Peptide as a useful diagnostic marker of acute Kawasaki disease in children. Circulation Journal: Official Journal of the Japanese Circulation Society 77(8): 2097-2101
Wannamethee, S.G.; Welsh, P.; Lowe, G.D.; Gudnason, V.; Di Angelantonio, E.; Lennon, L.; Rumley, A.; Whincup, P.H.; Sattar, N. 2011: N-terminal pro-brain natriuretic Peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular disease. Journal of the American College of Cardiology 58(1): 56-64
Hadzović-Dzuvo, A.; Kucukalić-Selimović, E.; Nakas-Ićindić, E.; Zaćiragić, A.; Drazeta, Z. 2007: N-terminal pro-brain natriuretic peptide (NT-proBNP) serum concentrations in apparently healthy Bosnian women. Bosnian Journal of Basic Medical Sciences 7(4): 307-310
Thejus, J.; Francis, J. 2009: N-terminal pro-brain natriuretic peptide and atrial fibrillation. Indian Pacing and Electrophysiology Journal 9(1): 1-4
Kostoeva, A.U.; Mazur, N.A.; Masenko, V.P.; Sbrodova, L.V.; Babaev, F.Z.; Volkov, V.E.; Pshenitsin, A.I.; Khezheva, F.M.; Shestakova, N.V. 2009: N-terminal pro-brain natriuretic peptide and cardiac involvement in patients with hypertensive disease. Kardiologiia 49(12): 33-38
Wijsman, L.W.; Sabayan, B.; van Vliet, P.; Trompet, S.; de Ruijter, W.; Poortvliet, R.K.E.; van Peet, P.G.; Gussekloo, J.; Jukema, J.W.; Stott, D.J.; Sattar, N.; Ford, I.; Westendorp, R.G.J.; de Craen, A.J.M.; Mooijaart, S.P. 2014: N-terminal pro-brain natriuretic peptide and cognitive decline in older adults at high cardiovascular risk. Annals of Neurology 76(2): 213-222
Yildiz, A.; Gur, M.; Yilmaz, R.; Demirbag, R. 2007: N-terminal pro-brain natriuretic peptide and coronary artery stenosis. European Journal of Clinical Investigation 37(7): 596; Author Reply 597
Geyik, B.; Ozdemir, O.; Osmonov, D.; Soylu, M.O. 2012: N-terminal pro-brain natriuretic peptide and electrocardiographic variables associated with increased risk of complete atrioventricular block and mortality in patients with acute inferior myocardial infarction. Cardiology Journal 19(5): 479-486
Felker, G.M.; Whellan, D.; Kraus, W.E.; Clare, R.; Zannad, F.; Donahue, M.; Adams, K.; McKelvie, R.; Piña, I.L.; O'Connor, C.M.; O'Connor, C.M.; Lee, K.L.; Ellis, S.J.; Rendall, D.S.; Whellan, D.J.; Piña, I.L.; Keteyian, S.J.; Cooper, L.S.; Boineau, R.; Fine, L.J.; Fleg, J.L.; Leifer, E.S.; Erickson, V.; Howlett, J.G.; Miller, N.H.; Isaac, D.; McKelvie, R.; Zannad, F.; Boozer, S.; Connolly, P.; Doll, A.; Ellis, S.J.; Frazier, C.; Mark, D.; McClanahan-Crowder, M.; Meyer, M.; Mickley, B.S.; Rendall, D.S.; Rich, M.; Rostami, H.; Settles, S.; Spinella, K.; Staib, J.; Thompson, O.; Abraham, W.; Biniakiewicz, D.; Homan, J.; Bittner, V.; Fitz-Gerald, M.; Ewald, G.; Craddock, H.; Flanagan, J.; Fonarow, G.; Erickson, V.; Colucci, W.; Lim 2009: N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study. American Heart Journal 158(4 Suppl): S37-S44
Ballotta, A.; Ranucci, M.; Kunkl, A.; El Baghdady, H.; Bossone, E.; Castelvecchio, S.; Frigiola, A.; Menicanti, L.; Di Donato, M.; Mehta, R.H. 2010: N-terminal pro-brain natriuretic peptide and outcomes in patients undergoing surgical ventricular restoration. American Journal of Cardiology 105(5): 640-644
Price, A.H.; Welsh, P.; Weir, C.J.; Feinkohl, I.; Robertson, C.M.; Morling, J.R.; McLachlan, S.; Strachan, M.W.J.; Sattar, N.; Price, J.F. 2014: N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetologia 57(12): 2505-2512
Antonelli, A.; Ferri, C.; Ferrari, S.M.; Marchi, S.; De Bortoli, N.; Sansonno, D.; Chiavacci, C.; Ferrannini, E.; Fallahi, P. 2010: N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha both are increased in patients with Hepatitis C. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 30(5): 359-363
Wongpraparut, N.; Chulaluk, K.; Chirakamjanakorn, S.; Phankingthongkum, R.; Limtangturakulm, S.; Pongakasira, R. 2013: N-terminal pro-brain natriuretic peptide as a biomarker for a significant renal artery stenosis in medically refractory hypertensive patients. Journal of the Medical Association of Thailand 96(Suppl 2): S164-S170
Park, B.H.; Kim, Y.S.; Chang, J.; Kim, S.K.; Kang, Y.A.; Jung, J.Y.; Lee, K.J.; Son, J.Y.; Kim, E.Y.; Lim, J.E.; Park, M.S. 2011: N-terminal pro-brain natriuretic peptide as a marker of right ventricular dysfunction after open-lung approach in patients with acute lung injury/acute respiratory distress syndrome. Journal of Critical Care 26(3): 241-248
Avello, N.; Molina, B.D.; Llorente, E.; Bernardo, M.J.; Prieto, B.; Alvarez, F.V. 2007: N-terminal pro-brain natriuretic peptide as a potential non-invasive marker of cardiac transplantation rejection. Annals of Clinical Biochemistry 44(Part 2): 182-188
Hirono, K.; Sekine, M.; Shiba, N.; Hayashi, S.; Nakaoka, H.; Ibuki, K.; Saito, K.; Watanabe, K.; Ozawa, S.; Higuma, T.; Yoshimura, N.; Kitajima, I.; Ichida, F. 2014: N-terminal pro-brain natriuretic peptide as a predictor of reoperation in children with surgically corrected tetralogy of fallot. Circulation Journal: Official Journal of the Japanese Circulation Society 78(3): 693-700
Mokart, D.; Sannini, A.; Brun, J.-P.; Faucher, M.; Blaise, D.; Blache, J.-L.; Faucher, C. 2007: N-terminal pro-brain natriuretic peptide as an early prognostic factor in cancer patients developing septic shock. Critical Care 11(2): R37
Iorio, L.; Rigolini, R.; Costa, E.; Cotta, O.; Cannavò, S.; Ambrosi, B. 2010: N-terminal pro-brain natriuretic peptide determination as a possible marker of cardiac dysfunction in patients with adrenal disorders. Journal of Endocrinological Investigation 33(7): 509-510
Jungbauer, C.G.; Buchner, S.; Birner, C.; Resch, M.; Heinicke, N.; Debl, K.; Buesing, M.; Biermeier, D.; Schmitz, G.; Riegger, G.ün.; Luchner, A. 2010: N-terminal pro-brain natriuretic peptide from fresh urine for the biochemical detection of heart failure and left ventricular dysfunction. European Journal of Heart Failure 12(4): 331-337
Samy, K.; Anouar, J.; Mnif, E.; Imed, F.; Fatma, A.; Abdelhamid, K. 2012: N-terminal pro-brain natriuretic peptide identifies patients at risk for occurence of postoperative atrial fibrillation in cardiac surgery with cardiopulmonary bypass. Annals of Cardiac Anaesthesia 15(3): 199-205
Thakkar, V.; Stevens, W.M.; Prior, D.; Moore, O.A.; Byron, J.; Liew, D.; Patterson, K.; Hissaria, P.; Roddy, J.; Zochling, J.; Sahhar, J.; Nash, P.; Tymms, K.; Celermajer, D.; Gabbay, E.; Youssef, P.; Proudman, S.M.; Nikpour, M. 2012: N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study. Arthritis Research and Therapy 14(3): R143
Sezen, Y.; Baş, M.; Demirbag, R.; Yildiz, A.; Celik, H.; Aksoy, S. 2009: N-terminal pro-brain natriuretic peptide in cases with metabolic syndrome and its relationship with components of metabolic syndrome and left ventricular mass index. Clinical Biochemistry 42(15): 1500-1503
Arikan, S.; Bahceci, M.; Tuzcu, A.; Gokalp, D. 2010: N-terminal pro-brain natriuretic peptide in newly diagnosed acromegaly. Journal of Endocrinological Investigation 33(8): 571-575
Adachi, Y.; Nishio, A. 2008: N-terminal pro-brain natriuretic peptide in prevalent peritoneal dialysis patients. Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 24: 75-78
Dimitroulas, T.; Giannakoulas, G.; Karvounis, H.; Dimitroula, H.; Settas, L. 2009: N-terminal pro-brain natriuretic peptide in systemic sclerosis related pulmonary arterial hypertension under bosentan treatment. Rheumatology International 29(3): 347-348
Allanore, Y.; Wahbi, K.; Borderie, D.; Weber, S.; Kahan, A.; Meune, C. 2009: N-terminal pro-brain natriuretic peptide in systemic sclerosis: a new cornerstone of cardiovascular assessment?. Annals of the Rheumatic Diseases 68(12): 1885-1889
Elshamy, H.A.; Ibrahim, S.E.; Farouk, H.M.; Moustafa, A.A.; Aly, I.M.; Osman, W.M. 2011: N-terminal pro-brain natriuretic peptide in systemic sclerosis: new insights. European Journal of Dermatology: Ejd 21(5): 686-690
Markovic-Sovtic, G.; Kosutic, J.; Jankovic, B.; Bojanin, D.; Sovtic, A.; Radojicic, Z.; Rakonjac, M.Z. 2014: N-terminal pro-brain natriuretic peptide in the assessment of respiratory distress in term neonates. Pediatrics International: Official Journal of the Japan Pediatric Society 56(3): 373-377
Szadkowska, I.; Goch, J.H.; Kawiński, J.; Chizyński, K. 2008: N-terminal pro-brain natriuretic peptide in the elderly with myocardial infarction. Clinical Cardiology 31(9): 443-447
Guo, Q.; Bárány, P.; Qureshi, A.R.; Snaedal, S.; Heimburger, O.; Stenvinkel, P.; Lindholm, B.; Axelsson, J. 2009: N-terminal pro-brain natriuretic peptide independently predicts protein energy wasting and is associated with all-cause mortality in prevalent HD patients. American Journal of Nephrology 29(6): 516-523
Harbaum, L.; Hennigs, J.K.; Baumann, H.J.; Lüneburg, N.; Griesch, E.; Bokemeyer, C.; Grünig, E.; Klose, H. 2014: N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pre-capillary pulmonary hypertension and renal insufficiency. Plos one 9(4): E94263
Purroy, F.; Suárez-Luis, I.; Mauri-Capdevila, G.; Cambray, S.; Farré, J.; Sanahuja, J.; Piñol-Ripoll, G.; Quílez, A.; González-Mingot, C.; Begué, R.; Gil, M.I.; Fernández, E.; Benabdelhak, I. 2014: N-terminal pro-brain natriuretic peptide level determined at different times identifies transient ischaemic attack patients with atrial fibrillation. European Journal of Neurology 21(4): 679-683
Zmudka, K.; Zalewski, J.; El-Massri, N.; Stepien, E.; Zajdel, W.; Durak, M.; Dudek, D.; Przewlocki, T. 2006: N-terminal pro-brain natriuretic peptide level in relation to epicardial and myocardial reperfusion in ST-segment elevation myocardial infarction treated with facilitated angioplasty. Eurointervention: Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2(2): 203-210
Elbasan, Z.; Gür, M.; Sahin, D.ş Y.ıl.ır.; Kırım, S.; Akyol, S.; Kuloğlu, O.; Koyunsever, N.Y.ıl.ız.; Seker, T.; Kıvrak, A.; Caylı, M. 2014: N-terminal pro-brain natriuretic peptide levels and abnormal geometric patterns of left ventricle in untreated hypertensive patients. Clinical and Experimental Hypertension 36(3): 153-158
Fujioka, K.; Sakai, H.; Tanaka, S.; Iwatani, S.; Wada, K.; Mizobuchi, M.; Yoshimoto, S.; Nakao, H. 2013: N-terminal pro-brain natriuretic peptide levels in monochorionic diamniotic twins with twin-to-twin transfusion syndrome treated by fetoscopic laser photocoagulation. Kobe Journal of Medical Sciences 59(1): E28-E35
Lee, J.E.; Choi, S.Y.; Huh, W.; Park, S.W.; Kim, D.J.; Oh, H.Y.; Kim, Y.-G. 2009: N-terminal pro-brain natriuretic peptide levels predict left ventricular systolic function in patients with chronic kidney disease. Journal of Korean Medical Science 24 Suppl: S63-S68
Vanzetto, G.; Jacon, P.; Calizzano, A.; Neuder, Y.; Faure, P.; Fagret, D.; Machecourt, J. 2007: N-terminal pro-brain natriuretic peptide predicts myocardial ischemia and is related to postischemic left-ventricular dysfunction in patients with stable coronary artery disease. Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology 14(6): 835-842
Fonseca, A.C.; Brito, D.; Pinho e Melo, T.; Geraldes, R.; Canhão, P.íc.; Caplan, L.R.; Ferro, J.é M. 2014: N-terminal pro-brain natriuretic peptide shows diagnostic accuracy for detecting atrial fibrillation in cryptogenic stroke patients. International Journal of Stroke: Official Journal of the International Stroke Society 9(4): 419-425
Mouly-Bertin, C.; Bissery, A.; Milon, H.; Dzudie, A.; Rabilloud, M.; Bricca, G.; Vincent, M.; Lantelme, P. 2008: N-terminal pro-brain natriuretic peptide--a promising biomarker for the diagnosis of left ventricular hypertrophy in hypertensive women. Archives of Cardiovascular Diseases 101(5): 307-315
Paget, V.; Legedz, L.; Gaudebout, N.; Girerd, N.; Bricca, G.; Milon, H.; Vincent, M.; Lantelme, P. 2011: N-terminal pro-brain natriuretic peptide: a powerful predictor of mortality in hypertension. Hypertension 57(4): 702-709
Mirjafari, H.; Welsh, P.; Verstappen, S.M.M.; Wilson, P.; Marshall, T.; Edlin, H.; Bunn, D.; Chipping, J.; Lunt, M.; Symmons, D.P.M.; Sattar, N.; Bruce, I.N. 2014: N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis: results from the Norfolk Arthritis Registry (NOAR). Annals of the Rheumatic Diseases 73(4): 684-690
Dronavalli, V.B.; Ranasinghe, A.M.; Venkateswaran, R.J.; James, S.R.; McCabe, C.J.; Wilson, I.C.; Mascaro, J.G.; Bonser, R.S. 2010: N-terminal pro-brain-type natriuretic peptide: a biochemical surrogate of cardiac function in the potential heart donor. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 38(2): 181-186
Fagnani, F.; Spaccamiglio, A.; Grasso, L.; Termine, A.; Angeli, A.; Pigozzi, F.; Borrione, P. 2009: N-terminal proB-type natriuretic peptide and homocysteine concentrations in athletes. Journal of Sports Medicine and Physical Fitness 49(4): 440-447
Rumenjak, V.; Brajković-Bralić, M.; Varlaj-Knobloch, V.; Orsanić-Brcić, D.; Brajković, I.; Marinković, D.; Knobloch, M. 2011: N-terminal proBNP and high sensivity cardiac troponin i concentrations in haemodialysis patients. Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 65(Suppl 3): 36-40
Booth, J.; Pinney, J.; Davenport, A. 2010: N-terminal proBNP--marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients?. Clinical Journal of the American Society of Nephrology: Cjasn 5(6): 1036-1040
Sharma, J.C.; Ananda, K.; Ross, I.; Hill, R.; Vassallo, M. 2006: N-terminal pro Brain natriuretic peptide levels predict short-term poststroke survival. Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association 15(3): 121-127
Dimitroulas, T.; Giannakoulas, G.; Karvounis, H.; Koliakos, G.; Sfetsios, T.; Dimitroula, H.; Settas, L. 2008: N-terminal probrain natriuretic peptide as a biochemical marker in the evaluation of bosentan treatment in systemic-sclerosis-related pulmonary arterial hypertension. Clinical Rheumatology 27(5): 655-658
Fonseca, A.C.; Matias, J.S.; Pinho e Melo, T.; Falcão, F.; Canhão, P.íc.; Ferro, J.é M. 2011: N-terminal probrain natriuretic peptide as a biomarker of cardioembolic stroke. International Journal of Stroke: Official Journal of the International Stroke Society 6(5): 398-403
Bruno, G.; Landi, A.; Barutta, F.; Ghezzo, G.; Baldin, C.; Spadafora, L.; Schimmenti, A.; Prinzis, T.; Cavallo Perin, P.; Gruden, G. 2013: N-terminal probrain natriuretic peptide is a stronger predictor of cardiovascular mortality than C-reactive protein and albumin excretion rate in elderly patients with type 2 diabetes: the Casale Monferrato population-based study. Diabetes Care 36(9): 2677-2682
Breuer, T.ás.; Sápi, E.éb.; Skoumal, R.ék.; Tóth, M.ós.; Ala-Kopsala, M.; Vuolteenaho, O.; Leppäluoto, J.; Ruskoaho, H.; Szatmári, A.ás.; Székely, A. 2007: N-terminal probrain natriuretic peptide level inversely correlates with cardiac index after arterial switch operation in neonates. Paediatric Anaesthesia 17(8): 782-788
Chang, L.; Yan, H.; Li, H.; Song, Z.; Gui, Y.; Yan, Z.; Li, T.; Duan, D. 2014: N-terminal probrain natriuretic peptide levels as a predictor of functional outcomes in patients with ischemic stroke. Neuroreport 25(13): 985-990
Idris, I.; Hill, R.; Ross, I.; Sharma, J.C. 2010: N-terminal probrain natriuretic peptide predicts 1-year mortality following acute stroke: possible evidence of occult cardiac dysfunction among patients with acute stroke. Age and Ageing 39(6): 752-755
Puri, A.; Narain, V.S.; Mehrotra, S.; Dwivedi, S.K.; Saran, R.K.; Puri, V.K. 2006: N-terminal probrain natriuretic peptide predicts adverse outcomes in acute-myocardial infarction even with preserved left ventricular ejection fraction. Indian Heart Journal 58(2): 138-143
Raghavan, P.S.; Rajaram, H.; Apte, S.K. 2013: N-terminal processing of membrane-targeted MnSOD and formation of multiple active superoxide dismutase dimers in the nitrogen-fixing cyanobacterium Anabaena sp. strain PCC7120. Febs Journal 280(19): 4827-4838
Tachibana, M.; Wu, Y.; Iriko, H.; Muratova, O.; MacDonald, N.J.; Sattabongkot, J.; Takeo, S.; Otsuki, H.; Torii, M.; Tsuboi, T. 2011: N-terminal prodomain of Pfs230 synthesized using a cell-free system is sufficient to induce complement-dependent malaria transmission-blocking activity. Clinical and Vaccine Immunology: Cvi 18(8): 1343-1350
Wei, G.; Yaqi, R.; Ningfu, W.; Xuwei, H. 2013: N-terminal prohormone B-type natriuretic peptide and cardiovascular risk in stable coronary artery disease: a meta-analysis of nine prospective studies. Reviews in Cardiovascular Medicine 14(2-4): E92-E98
Mady, C.; Fernandes, F.; Ramires, F.J.A.; Nastari, L.; Buck, P.C.; Arteaga, E.; Ianni, B.M.; Salemi, V.M.C. 2008: N-terminal prohormone brain natriuretic peptide (NT-proBNP) as a noninvasive marker for restrictive syndromes. Brazilian Journal of Medical and Biological Research 41(8): 664-667
Mazurek, B.ła.; Szydłowski, L.ła.; Giec-Fuglewicz, G.; Markiewicz-Łoskot, G. 2009: N-terminal prohormone brain natriuretic peptide-proBNP levels in ventricular arrhythmias in children. Clinical Cardiology 32(12): 690-694
Häupl, T.; Burmester, G.R.; Giannitsis, E.; Rohrlach, T.; Spanuth, E.; Parsch, H.; Brune, K. 2007: N-terminal prohormone brain natriuretic peptide: a biomarker for detecting cardiovascular risks in patients with rheumatoid arthritis or osteoarthritis?. Annals of the Rheumatic Diseases 66(6): 838-839
Jamshed, N.; Ozair, F.F.; Ekka, M.; Aggarwal, P. 2014: N-terminal prohormone of brain natriuretic peptide--how far can we extrapolate?. American Journal of Emergency Medicine 32(4): 389
Winkler, B.E.; Schuetz, W.; Froeba, G.; Muth, C.-M. 2012: N-terminal prohormone of brain natriuretic peptide: a useful tool for the detection of acute pulmonary artery embolism in post-surgical patients. British Journal of Anaesthesia 109(6): 907-910
Ferraris, J.; Radl, D.B.; Zárate, S.; Jaita, G.; Eijo, G.; Zaldivar, V.ón.; Clapp, C.; Seilicovich, A.; Pisera, D. 2011: N-terminal prolactin-derived fragments, vasoinhibins, are proapoptoptic and antiproliferative in the anterior pituitary. Plos one 6(7): E21806
Rayala, S.; Francis, V.G.; Sivagnanam, U.; Gummadi, S.N. 2014: N-terminal proline-rich domain is required for scrambling activity of human phospholipid scramblases. Journal of Biological Chemistry 289(19): 13206-13218
Bhasin, S.; He, E.J.; Kawakubo, M.; Schroeder, E.T.; Yarasheski, K.; Opiteck, G.J.; Reicin, A.; Chen, F.; Lam, R.; Tsou, J.A.; Castaneda-Sceppa, C.; Binder, E.F.; Azen, S.P.; Sattler, F.R. 2009: N-terminal propeptide of type IIi procollagen as a biomarker of anabolic response to recombinant human GH and testosterone. Journal of Clinical Endocrinology and Metabolism 94(11): 4224-4233
Martins, J.; Leão, P.N.; Ramos, V.; Vasconcelos, V. 2013: N-terminal protease gene phylogeny reveals the potential for novel cyanobactin diversity in cyanobacteria. Marine Drugs 11(12): 4902-4916
Nika, H.; Hawke, D.H.; Angeletti, R.H. 2014: N-terminal protein characterization by mass spectrometry after cyanogen bromide cleavage using combined microscale liquid- and solid-phase derivatization. Journal of Biomolecular Techniques: Jbt 25(1): 19-30
Nika, H.; Angeletti, R.H.; Hawke, D.H. 2014: N-terminal protein characterization by mass spectrometry using combined microscale liquid and solid-phase derivatization. Journal of Biomolecular Techniques: Jbt 25(3): 77-86
Liebscher, S.; Schöpfel, M.; Aumüller, T.; Sharkhuukhen, A.; Pech, A.; Höss, E.; Parthier, C.; Jahreis, G.ün.; Stubbs, M.T.; Bordusa, F. 2014: N-terminal protein modification by substrate-activated reverse proteolysis. Angewandte Chemie 53(11): 3024-3028
Wagner, A.M.; Fegley, M.W.; Warner, J.B.; Grindley, C.L.J.; Marotta, N.P.; Petersson, E.J. 2011: N-terminal protein modification using simple aminoacyl transferase substrates. Journal of the American Chemical Society 133(38): 15139-15147
Graña-Montes, R.; Marinelli, P.; Reverter, D.; Ventura, S. 2014: N-terminal protein tails act as aggregation protective entropic bristles: the SUMO case. Biomacromolecules 15(4): 1194-1203
Van Damme, P.; Gawron, D.; Van Criekinge, W.; Menschaert, G. 2014: N-terminal proteomics and ribosome profiling provide a comprehensive view of the alternative translation initiation landscape in mice and men. Molecular and Cellular Proteomics: Mcp 13(5): 1245-1261
Dini, F.L.; Fontanive, P.; Buralli, S.; Panicucci, E.; Andreini, D.; Conti, U.; De Tommasi, S.M. 2009: N-terminal protype-B natriuretic peptide and Doppler diastolic variables are incremental for risk stratification of patients with NYHA class I-Ii systolic heart failure. International Journal of Cardiology 136(2): 144-150
Mealman, T.D.; Zhou, M.; Affandi, T.; Chacón, K.N.; Aranguren, M.E.; Blackburn, N.J.; Wysocki, V.H.; McEvoy, M.M. 2012: N-terminal region of CusB is sufficient for metal binding and metal transfer with the metallochaperone CusF. Biochemistry 51(34): 6767-6775
Kisiela, D.I.; Aulik, N.A.; Atapattu, D.N.; Czuprynski, C.J. 2010: N-terminal region of Mannheimia haemolytica leukotoxin serves as a mitochondrial targeting signal in mammalian cells. Cellular Microbiology 12(7): 976-987
Inoue, M.; Arasaki, K.; Ueda, A.; Aoki, T.; Tagaya, M. 2008: N-terminal region of ZW10 serves not only as a determinant for localization but also as a link with dynein function. Genes to Cells: Devoted to Molecular and Cellular Mechanisms 13(8): 905-914
Yano, S.; Suyotha, W.; Honda, A.; Takagi, K.; Rattanakit-Chandet, N.; Wakayama, M.; Tachiki, T. 2011: N-terminal region of chitinase i of Bacillus circulans KA-304 contained new chitin-biding domain. Bioscience Biotechnology and Biochemistry 75(2): 299-304
Mazumdar, B.; Meyer, K.; Ray, R. 2012: N-terminal region of gelsolin induces apoptosis of activated hepatic stellate cells by a caspase-dependent mechanism. Plos one 7(8): E44461
Raucci, R.; Colonna, G.; Giovane, A.; Castello, G.; Costantini, S. 2014: N-terminal region of human chemokine receptor CXCR3: Structural analysis of CXCR3(1-48) by experimental and computational studies. Biochimica et Biophysica Acta 1844(10): 1868-1880
Košík, I.; Krejnusová, I.; Bystrická, M.; Poláková, K.; Russ, G. 2011: N-terminal region of the PB1-F2 protein is responsible for increased expression of influenza a viral protein PB1. Acta Virologica 55(1): 45-53
Araki, Y.; Gombos, L.; Migueleti, S.P.S.; Sivashanmugam, L.; Antony, C.; Schiebel, E. 2010: N-terminal regions of Mps1 kinase determine functional bifurcation. Journal of Cell Biology 189(1): 41-56
Childers, B.M.; Cao, X.; Weber, G.G.; Demeler, B.; Hart, P.J.; Klose, K.E. 2011: N-terminal residues of the Vibrio cholerae virulence regulatory protein ToxT involved in dimerization and modulation by fatty acids. Journal of Biological Chemistry 286(32): 28644-28655
Shi, C.; Kendall, S.C.; Grote, E.; Kaminskyj, S.; Loewen, Mèle.C. 2009: N-terminal residues of the yeast pheromone receptor, Ste2p, mediate mating events independently of G1-arrest signaling. Journal of Cellular Biochemistry 107(4): 630-638
Huang, Z.; Liu, T.; Borjigin, J. 2010: N-terminal residues regulate proteasomal degradation of AANAT. Journal of Pineal Research 48(3): 290-296
Nerelius, C.; Alvelius, G.; Jörnvall, H. 2010: N-terminal segment of proinsulin C-peptide active in insulin interaction/desaggregation. Biochemical and Biophysical Research Communications 403(3-4): 462-467
Das, R.K.; Crick, S.L.; Pappu, R.V. 2012: N-terminal segments modulate the α-helical propensities of the intrinsically disordered basic regions of bZIP proteins. Journal of Molecular Biology 416(2): 287-299
Speicher, K.D.; Gorman, N.; Speicher, D.W. 2009: N-terminal sequence analysis of proteins and peptides. Current Protocols in Protein Science Chapter 11: Unit 11.10
Kryuchkov, F.; Verano-Braga, T.; Kjeldsen, F. 2014: N-terminal sequence tagging using reliably determined b2 ions: a useful approach to deconvolute tandem mass spectra of co-fragmented peptides in proteomics. Journal of Proteomics 103: 254-260
Melo, Z.; de los Heros, P.; Cruz-Rangel, S.; Vázquez, N.; Bobadilla, N.A.; Pasantes-Morales, H.; Alessi, D.R.; Mercado, A.; Gamba, G. 2013: N-terminal serine dephosphorylation is required for KCC3 cotransporter full activation by cell swelling. Journal of Biological Chemistry 288(44): 31468-31476
Watanabe, T.; Miyata, Y.; Abe, R.; Muranaka, N.; Hohsaka, T. 2007: N-terminal specific fluorescence labeling of proteins through fourbase codon-mediated incorporation of fluorescent hydroxy acid. Nucleic Acids Symposium Series 51: 363-364
Ebisu, K.; Tateno, H.; Kuroiwa, H.; Kawakami, K.; Ikeuchi, M.; Hirabayashi, J.; Sisido, M.; Taki, M. 2009: N-terminal specific point-immobilization of active proteins by the one-pot NEXT-A method. Chembiochem: a European Journal of Chemical Biology 10(15): 2460-2464
Kesner, B.A.; Ding, F.; Temple, B.R.; Dokholyan, N.V. 2010: N-terminal strands of filamin Ig domains act as a conformational switch under biological forces. Proteins 78(1): 12-24
Vecchio, L.M.; Bermejo, M.K.; Beerepoot, P.; Ramsey, A.J.; Salahpour, A. 2014: N-terminal tagging of the dopamine transporter impairs protein expression and trafficking in vivo. Molecular and Cellular Neurosciences 61: 123-132
Guse, A.H. 2013: N-terminal tagging of two-pore channels interferes with NAADP action. Biochemical Journal 453(1): E1-E2
Samgina, T.Y.; Kovalev, S.V.; Gorshkov, V.A.; Artemenko, K.A.; Poljakov, N.B.; Lebedev, A.T. 2010: N-terminal tagging strategy for de novo sequencing of short peptides by ESI-MS/MS and MALDI-MS/MS. Journal of the American Society for Mass Spectrometry 21(1): 104-111
Gad, W.; Kim, Y. 2009: N-terminal tail of a viral histone H4 encoded in Cotesia plutellae bracovirus is essential to suppress gene expression of host histone H4. Insect Molecular Biology 18(1): 111-118
Pratt, E.B.; Tewson, P.; Bruederle, C.E.; Skach, W.R.; Shyng, S.-L. 2011: N-terminal transmembrane domain of SUR1 controls gating of Kir6.2 by modulating channel sensitivity to PIP2. Journal of General Physiology 137(3): 299-314
Zha, D.; Zhang, H.; Zhang, H.; Xu, L.; Yan, Y. 2014: N-terminal transmembrane domain of lipase LipA from Pseudomonas protegens Pf-5: a must for its efficient folding into an active conformation. Biochimie 105: 165-171
Kim, H-Jung.; Kim, H.Jung.; Jeong, J-Eun.; Baek, J.Yeob.; Jeong, J.; Kim, S.; Kim, Y-Mee.; Kim, Y.; Nam, J.Han.; Huh, S.Hee.; Seo, J.; Jin, B.Kwan.; Lee, K-Joo. 2014: N-terminal truncated UCH-L1 prevents Parkinson's disease associated damage. Plos one 9(6): E99654
Lovett, D.H.; Mahimkar, R.; Raffai, R.L.; Cape, L.; Zhu, B.-Q.; Jin, Z.-Q.; Baker, A.J.; Karliner, J.S. 2013: N-terminal truncated intracellular matrix metalloproteinase-2 induces cardiomyocyte hypertrophy, inflammation and systolic heart failure. Plos one 8(7): E68154
D'Arrigo, C.; Tabaton, M.; Perico, A. 2009: N-terminal truncated pyroglutamyl beta amyloid peptide Abetapy3-42 shows a faster aggregation kinetics than the full-length Abeta1-42. Biopolymers 91(10): 861-873
Unno, M.; Tsukiji, Y.; Kubota, K.; Masuda, S. 2012: N-terminal truncation does not affect the location of a conserved tryptophan in the BLUF domain of AppA from Rhodobacter sphaeroides. Journal of Physical Chemistry. B 116(30): 8974-8980
Song, L.; Jia, Y.; Zhu, W.; Newton, I.P.; Li, Z.; Li, W. 2014: N-terminal truncation mutations of adenomatous polyposis coli are associated with primary cilia defects. International Journal of Biochemistry and Cell Biology 55: 79-86
Dagvadorj, A.; Tan, S.-H.; Liao, Z.; Xie, J.; Nurmi, M.; Alanen, K.; Rui, H.; Mirtti, T.; Nevalainen, M.T. 2010: N-terminal truncation of Stat5a/b circumvents PIAS3-mediated transcriptional inhibition of Stat5 in prostate cancer cells. International Journal of Biochemistry and Cell Biology 42(12): 2037-2046
Paholikova, K.; Salingova, B.; Opattova, A.; Skrabana, R.; Majerova, P.; Zilka, N.; Kovacech, B.; Zilkova, M.; Barath, P.; Novak, M. 2015: N-terminal truncation of microtubule associated protein tau dysregulates its cellular localization. Journal of Alzheimer's Disease: Jad 43(3): 915-926
Carlsson-Jonsson, A.; Gao, T.; Hao, J.-X.; Fransson, R.; Sandström, A.; Nyberg, F.; Wiesenfeld-Hallin, Z.; Xu, X.-J. 2014: N-terminal truncations of substance P 1-7 amide affect its action on spinal cord injury-induced mechanical allodynia in rats. European Journal of Pharmacology 738: 319-325
Munera, D.; Crepin, V.F.; Marches, O.; Frankel, G. 2010: N-terminal type IIi secretion signal of enteropathogenic Escherichia coli translocator proteins. Journal of Bacteriology 192(13): 3534-3539
Misaki, R.; Sakai, Y.; Omasa, T.; Fujiyama, K.; Seki, T. 2011: N-terminal vacuolar sorting signal at the mouse antibody alters the N-linked glycosylation pattern in suspension-cultured tobacco BY2 cells. Journal of Bioscience and Bioengineering 112(5): 476-484
Charneira, C.; Grilo, N.M.; Pereira, S.A.; Godinho, A.L.A.; Monteiro, E.C.; Marques, M.M.; Antunes, A.M.M. 2012: N-terminal valine adduct from the anti-HIV drug abacavir in rat haemoglobin as evidence for abacavir metabolism to a reactive aldehyde in vivo. British Journal of Pharmacology 167(6): 1353-1361
Maier, O.; Wiethoff, C.M. 2010: N-terminal α-helix-independent membrane interactions facilitate adenovirus protein Vi induction of membrane tubule formation. Virology 408(1): 31-38
Lee, S.H.; Kyung, H.; Yokota, R.; Goto, T.; Oe, T. 2014: N-terminal α-ketoamide peptides: formation and transamination. Chemical Research in Toxicology 27(4): 637-648
Yashiroda, H.; Toda, Y.; Otsu, S.; Takagi, K.; Mizushima, T.; Murata, S. 2015: N-terminal α7 deletion of the proteasome 20S core particle substitutes for yeast PI31 function. Molecular and Cellular Biology 35(1): 141-152
Luo, J.; Teplyakov, A.; Obmolova, G.; Malia, T.J.; Chan, W.; Jacobs, S.A.; O'Neil, K.T.; Gilliland, G.L. 2014: N-terminal β-strand swapping in a consensus-derived alternative scaffold driven by stabilizing hydrophobic interactions. Proteins 82(7): 1527-1533
Schultz, M.; Kistorp, C.; Langdahl, B.; Raymond, I.; Hildebrandt, P.; Faber, J. 2007: N-terminal-pro-B-type natriuretic peptide in acute hyperthyroidism. Thyroid: Official Journal of the American Thyroid Association 17(3): 237-241
Dzavík, V.ír. 2009: N-terminal-pro-B-type natriuretic peptide in cardiogenic shock: a marker ready for prime time or a therapeutic target?. Critical Care Medicine 37(6): 2091-2092
Hammerman, C.; Shchors, I.; Schimmel, M.S.; Bromiker, R.; Kaplan, M.; Nir, A. 2010: N-terminal-pro-B-type natriuretic peptide in premature patent ductus arteriosus: a physiologic biomarker, but is it a clinical tool?. Pediatric Cardiology 31(1): 62-65
Murray, H. 2007: N-terminal-pro-B-type natriuretic peptide testing reduced duration of ED visits in patients presenting with dyspnea. Acp Journal Club 147(3): 62
Okkonen, M.; Varpula, M.; Linko, R.; Perttilä, J.; Varpula, T.; Pettilä, V.; Laru-Sompa, R.; Kirkhope, T.; Nykänen, S.; Suvela, M.; Kauppinen, S.; Turkulainen, A.-M.; Varpula, T.; Rahkonen, M.; Kuitunen, A.; Korhonen, A.-M.; Linko, R.; Okkonen, M.; Myller, J.; Pekkola, J.; Pettilä, L.; Sutinen, S.; Suojaranta-Ylinen, R.; Kukkonen, S.; Nurmi-Toivonen, E.; Bäcklund, T.; Rossinen, J.; Mäkelä, R.; Reitala, J.; Vuola, J.; Niemi, R.; Pihlajamaa, M.-L.; Uusipaavalniemi, A.; Koivusalo, A.-M.; Kyllönen, P.; Puolakka, R.; Heikkilä, T.; Laitinen, P.; Forsström, S.; Kaminski, T.; Kuusela, T.; Ruokonen, E.; Parviainen, I.; Halonen, E.; Rahikainen, S.; Pentti, J.; Alila, S.; Koskinen, R.; Kiviniemi, O.; Laurila, T.; Pikkuhookana, T.; Reinikaine 2011: N-terminal-pro-BNP in critically ill patients with acute respiratory failure: a prospective cohort study. Acta Anaesthesiologica Scandinavica 55(6): 749-757
Bunnag, S.; Pattanasombatsakul, K. 2012: N-terminal-pro-brain natriuretic peptide for the differential diagnosis of hypovolemia vs. euvolemia in hyponatremic patients. Journal of the Medical Association of Thailand 95(Suppl 3): S69-S74
Andreas, M.; Zeisler, H.; Handisurya, A.; Franz, M.B.; Gottsauner-Wolf, M.; Wolzt, M.; Kautzky-Willer, A. 2011: N-terminal-pro-brain natriuretic peptide is decreased in insulin dependent gestational diabetes mellitus: a prospective cohort trial. Cardiovascular Diabetology 10: 28
Nuntnarumit, P.; Chongkongkiat, P.; Khositseth, A. 2011: N-terminal-pro-brain natriuretic peptide: a guide for early targeted indomethacin therapy for patent ductus arteriosus in preterm Infants. Acta Paediatrica 100(9): 1217-1221
Majstorov, V.; Pop, G.D.; Vavlukis, M.; Peovska, I.; Maksimovik, J.; Vaskova, O.; Kuzmanovska, S.; Zdraveska-Kochovska, M. 2008: N-terminal-proB natriuretic peptide in patients with stable coronary artery disease evaluated for ischemia with myocardial perfusion imaging. Bratislavske Lekarske Listy 109(7): 293-297
Ekstein, S.; Nir, A.; Rein, A.J.J.T.; Perles, Z.; Bar-Oz, B.; Salpeter, L.; Algur, N.; Weintraub, M. 2007: N-terminal-proB-type natriuretic peptide as a marker for acute anthracycline cardiotoxicity in children. Journal of Pediatric Hematology/Oncology 29(7): 440-444
Duprez, D.A.; Neuhaus, J.; Tracy, R.; Kuller, L.H.; Deeks, S.G.; Orkin, C.; Stoehr, A.; Woolley, I.J.; Neaton, J.D. 2011: N-terminal-proB-type natriuretic peptide predicts cardiovascular disease events in HIV-infected patients. Aids 25(5): 651-657
Baldisserotto, A.; Destro, F.; Vertuani, G.; Marastoni, M.; Gavioli, R.; Tomatis, R. 2009: N-terminal-prolonged vinyl ester-based peptides as selective proteasome beta1 subunit inhibitors. Bioorganic and Medicinal Chemistry 17(15): 5535-5540
Yap, W.B.; Tey, B.T.; Ng, M.Y.T.; Ong, S.T.; Tan, W.S. 2009: N-terminally His-tagged hepatitis B core antigens: construction, expression, purification and antigenicity. Journal of Virological Methods 160(1-2): 125-131
Matsueda, S.; Gao, H.; Efferson, C.L.; Tsuda, N.; Ishiyama, S.; Li, Y.; Ioannides, M.G.; Fisk, B.; Peoples, G.E.; Ioannides, C.G. 2009: N-terminally LRMK-linked HER-2 peptides, AE-37 [p776(774-788)] and AE-47 [Ava-F7(776-788)], aid differentiation of E75-TCR+CD8+ cells to perforin-positive cells. Anticancer Research 29(7): 2427-2435
Pakravan, N.; Soudi, S.; Hassan, Z.M. 2010: N-terminally fusion of Her2/neu to HSP70 decreases efficiency of Her2/neu DNA vaccine. Cell Stress and Chaperones 15(5): 631-638
Sorochkina, A.I.; Plotnikov, E.Y.; Rokitskaya, T.I.; Kovalchuk, S.I.; Kotova, E.A.; Sychev, S.V.; Zorov, D.B.; Antonenko, Y.N. 2012: N-terminally glutamate-substituted analogue of gramicidin a as protonophore and selective mitochondrial uncoupler. Plos one 7(7): E41919
Dewangan, R.P.; Joshi, S.; Kumari, S.; Gautam, H.; Yar, M.S.; Pasha, S. 2014: N-terminally modified linear and branched spermine backbone dipeptidomimetics against planktonic and sessile methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and ChemoTherapy 58(9): 5435-5447
Liu, Y.; Kim, Y-Boum.; Löchelt, M. 2011: N-terminally myristoylated feline foamy virus Gag allows Env-independent budding of sub-viral particles. Viruses 3(11): 2223-2237
Mao, H.; Chattopadhyay, S.; Banerjee, A.K. 2009: N-terminally truncated C protein, CNDelta25, of human parainfluenza virus type 3 is a potent inhibitor of viral replication. Virology 394(1): 143-148
Mikami, S.; Kobayashi, T.; Machida, K.; Masutani, M.; Yokoyama, S.; Imataka, H. 2010: N-terminally truncated GADD34 proteins are convenient translation enhancers in a human cell-derived in vitro protein synthesis system. Biotechnology Letters 32(7): 897-902
Lopotová, T.; Nádvorníková, S.; Záčková, M.ét.; Polák, J.; Schwarz, J.ří; Klamová, H.; Moravcová, J. 2012: N-terminally truncated WT1 variant (sWT1) is expressed at very low levels in acute myeloid leukemia and advanced phases of chronic myeloid leukemia. Leukemia Research 36(4): E81-E83
Převorovský, M.; Atkinson, S.R.; Ptáčková, M.; McLean, J.R.; Gould, K.; Folk, P.; Půta, F.še.; Bähler, J.ür. 2011: N-termini of fungal CSL transcription factors are disordered, enriched in regulatory motifs and inhibit DNA binding in fission yeast. Plos one 6(8): E23650
Hartmann, E.M.; Armengaud, J. 2014: N-terminomics and proteogenomics, getting off to a good start. Proteomics 14(23-24): 2637-2646
Timmer, J.C.; Salvesen, G.S. 2011: N-terminomics: a high-content screen for protease substrates and their cleavage sites. Methods in Molecular Biology 753: 243-255
Nefzi, A.; Fenwick, J.E. 2011: N-terminus 4-Chloromethyl Thiazole Peptide as a Macrocyclization Tool in the Synthesis of Cyclic Peptides: Application to the Synthesis of Conformationally Constrained RGD-Containing Integrin Ligands. Tetrahedron Letters 52(7): 817-819
Dickenson, N.E.; Arizmendi, O.; Patil, M.K.; Toth, R.T.; Middaugh, C.R.; Picking, W.D.; Picking, W.L. 2013: N-terminus of IpaB provides a potential anchor to the Shigella type IIi secretion system tip complex protein IpaD. Biochemistry 52(49): 8790-8799
Mizota, K.; Ueda, H. 2008: N-terminus of MAP2C as a neurosteroid-binding site. Neuroreport 19(15): 1529-1533
Aubol, B.E.; Plocinik, R.M.; Keshwani, M.M.; McGlone, M.L.; Hagopian, J.C.; Ghosh, G.; Fu, X.-D.; Adams, J.A. 2014: N-terminus of the protein kinase CLK1 induces SR protein hyperphosphorylation. Biochemical Journal 462(1): 143-152
Zissimopoulos, S.; Marsh, J.; Stannard, L.; Seidel, M.; Lai, F.A. 2014: N-terminus oligomerization is conserved in intracellular calcium release channels. Biochemical Journal 459(2): 265-273
Zissimopoulos, S.; Viero, C.; Seidel, M.; Cumbes, B.; White, J.; Cheung, I.; Stewart, R.; Jeyakumar, L.H.; Fleischer, S.; Mukherjee, S.; Thomas, N.L.; Williams, A.J.; Lai, F.A. 2013: N-terminus oligomerization regulates the function of cardiac ryanodine receptors. Journal of Cell Science 126(Part 21): 5042-5051
Torres, B.; Ruoho, A.E. 2014: N-terminus regulation of VMAT2 mediates methamphetamine-stimulated efflux. Neuroscience 259: 194-202
Garg, R.; Riento, K.; Keep, N.; Morris, J.D.H.; Ridley, A.J. 2008: N-terminus-mediated dimerization of ROCK-i is required for RhoE binding and actin reorganization. Biochemical Journal 411(2): 407-414
Rajalakshmi, P.; Srinivasan, N.; Krishnakumar, R.V.; Razak, I.A.; Rosli, M.M. 2013: N-tert-But-oxy-carbonyl-α-(2-fluoro-benzyl)-l-proline. Acta Crystallographica. Section e Structure Reports Online 69(Part 8): O1297
Cheraiet, Z.; Ouarna, S.; Hessainia, S.; Berredjem, M.; Aouf, N.-E. 2012: N-tert-Butoxycarbonylation of Structurally Diverse Amines and Sulfamides under Water-Mediated Catalyst-Free Conditions. Isrn Organic Chemistry 2012: 404235
Liu, L.-J.; Meng, F.-J.; Xu, H.; Wang, D.; Zhao, C.-Q. 2011: N-tert-Butyl O-2-isopropyl-5-methyl-cyclo-hexyl phenyl-phospho-namidate. Acta Crystallographica. Section e Structure Reports Online 67(Part 5): O1244
Fatima, Z.; Srinivasan, T.; Koorathota, S.; Thennarasu, S.; Velmurugan, D. 2013: N-tert-Butyl-2-(2,6-di-chloro-phen-yl)imidazo[1,2-a]pyrazin-3-amine. Acta Crystallographica. Section E Structure Reports Online 69(Part 6): O949-O950
Fatima, Z.; Srinivasan, T.; Koorathota, S.; Thennarasu, S.; Velmurugan, D. 2013: N-tert-Butyl-2-[4-(dimethyl-amino)-phen-yl]imidazo[1,2-a]pyrazin-3-amine. Acta Crystallographica. Section E Structure Reports Online 69(Part 4): O612-O613
Kluge, K.A.; Fridyland, D.; Macbeth, C.E.; Hardcastle, K.I. 2011: N-tert-Butyl-2-methyl-propanamide. Acta Crystallographica. Section E Structure Reports Online 67(Part 8): O2143
Li, J.-S.; Simpson, J.; Li, X.-J.; Li, X.; Huang, P.-M. 2009: N-tert-Butyl-3-hydr-oxy-5-androstene-17-carboxamide monohydrate. Acta Crystallographica. Section e Structure Reports Online 65(Part 7): O1507-O1508
Maharramov, A.M.; Khalilov, A.N.; Gurbanov, A.V.; Brito, I.án. 2011: N-tert-Butyl-3-mesitylpropanamide. Acta Crystallographica. Section e Structure Reports Online 67(Part 6): O1307
Yan, X.; Xu, S.; Wang, J.; Chen, Y.; Xia, P. 2009: N-tert-Butyl-5α-androstane-17β-carboxamide. Acta Crystallographica. Section E Structure Reports Online 65(Part 3): O587
Candish, L.; Forsyth, C.M.; Lupton, D.W. 2013: N-tert-butyl triazolylidenes: catalysts for the enantioselective (3+2) annulation of α,β-unsaturated acyl azoliums. Angewandte Chemie 52(35): 9149-9152
Bambi-Nyanguile, S.M.; Mangwala Kimpende, P.; Pirotte, B.; Van Meervelt, L. 2013: N-tert-butyl-N'-[5-cyano-2-(4-methylphenoxy)phenylsulfonyl]urea, a new TXA₂ receptor antagonist. Acta Crystallographica. Section C Crystal Structure Communications 69(Part 8): 901-903
Willems, M.M.J.H.P.; Zom, G.G.; Khan, S.; Meeuwenoord, N.; Melief, C.J.M.; van der Stelt, M.; Overkleeft, H.S.; Codée, J.D.C.; van der Marel, G.A.; Ossendorp, F.; Filippov, D.V. 2014: N-tetradecylcarbamyl lipopeptides as novel agonists for Toll-like receptor 2. Journal of Medicinal Chemistry 57(15): 6873-6878
Kwon, Y.J.; Saubern, S.; Macdonald, J.M.; Huang, X.-P.; Setola, V.; Roth, B.L. 2010: N-tetrahydrothiochromenoisoxazole-1-carboxamides as selective antagonists of cloned human 5-HT2B. Bioorganic and Medicinal Chemistry Letters 20(18): 5488-5490
Yang, R.; Hou, W.; Zhang, X.; Liu, C.-F. 2012: N-to-C sequential ligation using peptidyl N,N-bis(2-mercaptoethyl)amide building blocks. Organic Letters 14(1): 374-377
Alexandrou, C.; Leontiou, T.; Negele, J.W.; Tsapalis, A. 2007: N-to-Delta axial transition form factors from lattice QCD. Physical Review Letters 98(5): 052003
Tlais, S.F.; Danheiser, R.L. 2014: N-tosyl-3-azacyclohexyne. Synthesis and chemistry of a strained cyclic ynamide. Journal of the American Chemical Society 136(44): 15489-15492
Ha, K.-H.; Byun, M.-S.; Choi, J.; Jeong, J.; Lee, K.-J.; Jue, D.-M. 2009: N-tosyl-L-phenylalanine chloromethyl ketone inhibits NF-kappaB activation by blocking specific cysteine residues of IkappaB kinase beta and p65/RelA. Biochemistry 48(30): 7271-7278
Péron, F.; Fossey, C.; Cailly, T.; Fabis, F.éd.ér. 2012: N-tosylcarboxamide as a transformable directing group for Pd-catalyzed C-H ortho-arylation. Organic Letters 14(7): 1827-1829
Barluenga, J.é; Moriel, P.; Valdés, C.; Aznar, F. 2007: N-tosylhydrazones as reagents for cross-coupling reactions: a route to polysubstituted olefins. Angewandte Chemie 46(29): 5587-5590
Shao, Z.; Zhang, H. 2012: N-tosylhydrazones: versatile reagents for metal-catalyzed and metal-free cross-coupling reactions. Chemical Society Reviews 41(2): 560-572
Huard, K.; Lebel, H.él.èn. 2008: N-tosyloxycarbamates as reagents in rhodium-catalyzed C-H amination reactions. Chemistry 14(20): 6222-6230
Přichystalová, H.; Almonasy, N.; Nepraš, M.š; Bureš, F.; Dvořák, M.; Michl, M.; Cermák, J.ři.; Burgert, L. 2013: N-triazinyl derivatives of 1- and 9-aminoanthracene: synthesis and photo-physical properties. Journal of Fluorescence 23(3): 425-437
Bootwicha, T.; Liu, X.; Pluta, R.; Atodiresei, I.; Rueping, M. 2013: N-trifluoromethylthiophthalimide: a stable electrophilic SCF3 -reagent and its application in the catalytic asymmetric trifluoromethylsulfenylation. Angewandte Chemie 52(49): 12856-12859
Xu, C.; Ma, B.; Shen, Q. 2014: N-trifluoromethylthiosaccharin: an easily accessible, shelf-stable, broadly applicable trifluoromethylthiolating reagent. Angewandte Chemie 53(35): 9316-9320
Cheon, C.H.; Yamamoto, H. 2010: N-triflylthiophosphoramide catalyzed enantioselective Mukaiyama aldol reaction of aldehydes with silyl enol ethers of ketones. Organic Letters 12(11): 2476-2479
Liao, D.; Liu, X.; Dai, W.; Tang, T.; Ou, G.; Zhang, K.; Han, M.; Kang, R.; Yang, S.; Xiang, D. 2015: N-trimethyl chitosan (TMC)-modified microemulsions for improved oral bioavailability of puerarin: preparation and evaluation. Drug Delivery 22(4): 516-521
Chen, H.; Wu, J.; Sun, M.; Guo, C.; Yu, A.; Cao, F.; Zhao, L.; Tan, Q.; Zhai, G. 2012: N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin. Journal of Liposome Research 22(2): 100-109
Guan, M.; Zhou, Y.; Zhu, Q-Ling.; Liu, Y.; Bei, Y-Yan.; Zhang, X-Nong.; Zhang, Q. 2012: N-trimethyl chitosan nanoparticle-encapsulated lactosyl-norcantharidin for liver cancer therapy with high targeting efficacy. Nanomedicine: Nanotechnology Biology and Medicine 8(7): 1172-1181
Cao, J.; Sun, J.; Wang, X.; Li, X.; Deng, Y. 2009: N-trimethyl chitosan-coated multivesicular liposomes for oxymatrine oral delivery. Drug Development and Industrial Pharmacy 35(11): 1339-1347
Huang, A.; Makhlof, A.; Ping, Q.; Tozuka, Y.; Takeuchi, H. 2011: N-trimethyl chitosan-modified liposomes as carriers for oral delivery of salmon calcitonin. Drug Delivery 18(8): 562-569
Jiang, F.; Yeh, C-Ko.; Wen, J.; Sun, Y. 2015: N-trimethylchitosan/alginate layer-by-layer self assembly coatings act as "fungal repellents" to prevent biofilm formation on healthcare materials. Advanced Healthcare Materials 4(3): 469-475
Sonawane, M.R.; Císarová, I.; Lyapkalo, I.M. 2010: N-trimethylsilyloxyenamines as new aldehyde enolate synthons: general, efficient and diastereoselective aldol reaction with ketals and acetals. Chemical Communications 46(15): 2656-2658
Cozzolino, A.F.; Bain, A.D.; Hanhan, S.; Vargas-Baca, I. 2009: N-triphenylboryl- and N,N'-bis(triphenylboryl)benzo-2,1,3-telluradiazole. Chemical Communications 27: 4043-4045
Antonios, G.; Saiepour, N.; Bouter, Y.; Richard, B.C.; Paetau, A.; Verkkoniemi-Ahola, A.; Lannfelt, L.; Ingelsson, M.; Kovacs, G.G.; Pillot, T.; Wirths, O.; Bayer, T.A. 2013: N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody. Acta Neuropathologica Communications 1: 56
Youssef, I.; Florent-Béchard, S.; Malaplate-Armand, C.; Koziel, V.; Bihain, B.; Olivier, J.-L.; Leininger-Muller, B.; Kriem, B.; Oster, T.; Pillot, T. 2008: N-truncated amyloid-beta oligomers induce learning impairment and neuronal apoptosis. Neurobiology of Aging 29(9): 1319-1333
Condic, M.; Oberstein, T.J.; Herrmann, M.; Reimann, M.C.; Kornhuber, J.; Maler, J.M.; Spitzer, P. 2014: N-truncation and pyroglutaminylation enhances the opsonizing capacity of Aβ-peptides and facilitates phagocytosis by macrophages and microglia. Brain Behavior and Immunity 41: 116-125
Smith, P.A. 2009: N-type Ca(2+) -channels in murine pancreatic beta-cells are inhibited by an exclusive coupling with somatostatin receptor subtype 1. Endocrinology 150(2): 741-748
Kamiya-Matsuoka, C.; Blas-Boria, D.; Williams, M.D.; Garciarena, P.; Tummala, S.; Tremont-Lukats, I.W. 2014: N-type calcium channel antibody-mediated paraneoplastic limbic encephalitis: a diagnostic challenge. Journal of the Neurological Sciences 338(1-2): 188-190
Nattel, S. 2014: N-type calcium channel blockade: a new approach to preventing sudden cardiac death?. Cardiovascular Research 104(1): 1-2
Mao, J. 2010: N-type calcium channel blocker for pain treatment. Pain Medicine 11(2): 153
Tokuhara, N.; Namiki, K.; Uesugi, M.; Miyamoto, C.; Ohgoh, M.; Ido, K.; Yoshinaga, T.; Yamauchi, T.; Kuromitsu, J.; Kimura, S.; Miyamoto, N.; Kasuya, Y. 2010: N-type calcium channel in the pathogenesis of experimental autoimmune encephalomyelitis. Journal of Biological Chemistry 285(43): 33294-33306
Lei, B.; Nakano, D.; Fujisawa, Y.; Liu, Y.; Hitomi, H.; Kobori, H.; Mori, H.; Masaki, T.; Asanuma, K.; Tomino, Y.; Nishiyama, A. 2012: N-type calcium channel inhibition with cilnidipine elicits glomerular podocyte protection independent of sympathetic nerve inhibition. Journal of Pharmacological Sciences 119(4): 359-367
Sánchez-Mejorada, E.; Sánchez-Mondragon, G.; Pineda, J.C.; González, M.ón.; Barral, J. 2009: N-type calcium channels mediate a GABA(B) presynaptic modulation in the corticostriatal synapse in turtle's paleostriatum augmentatum. Synapse 63(10): 855-862
Duan, J.-H.; Hodgdon, K.E.; Hingtgen, C.M.; Nicol, G.D. 2014: N-type calcium current, Cav2.2, is enhanced in small-diameter sensory neurons isolated from Nf1+/- mice. Neuroscience 270: 192-202
Wu, Y.; Li, Y.; Li, H.; Shi, Q.; Fu, H.; Yao, J. 2009: N-type cascade electron transfer along an oxidative gradient. Chemical Communications 45: 6955-6957
Zhitomirsky, D.; Furukawa, M.; Tang, J.; Stadler, P.; Hoogland, S.; Voznyy, O.; Liu, H.; Sargent, E.H. 2012: N-type colloidal-quantum-dot solids for photovoltaics. Advanced Materials 24(46): 6181-6185
Chung, Y.-B.; Park, H.-K.; Lee, S.-H.; Song, J.-H.; Hwang, N.-M. 2011: N-type crystalline silicon films free of amorphous silicon deposited on glass by HCl addition using hot wire chemical vapour deposition. Journal of Nanoscience and Nanotechnology 11(9): 8242-8245
Sargsyan, A.; Mirzoyan, R.; Papoyan, A.; Sarkisyan, D. 2012: N-type resonances in a buffered micrometric Rb cell: splitting in a strong magnetic field. Optics Letters 37(23): 4871-4873
Freeman, D.D.; Choi, K.; Yu, C. 2012: N-type thermoelectric performance of functionalized carbon nanotube-filled polymer composites. Plos one 7(11): E47822
Kang, S.J.; Liu, M.-G.; Shi, T.-Y.; Zhao, M.-G.; Kaang, B.-K.; Zhuo, M. 2013: N-type voltage gated calcium channels mediate excitatory synaptic transmission in the anterior cingulate cortex of adult mice. Molecular Pain 9: 58
Saegusa, H.; Tanabe, T. 2014: N-type voltage-dependent Ca2+ channel in non-excitable microglial cells in mice is involved in the pathophysiology of neuropathic pain. Biochemical and Biophysical Research Communications 450(1): 142-147
Sureshbabu, V.V.; Naik, S.A.; Hemantha, H.P.; Narendra, N.; Das, U.; Guru Row, T.N. 2009: N-urethane-protected amino alkyl isothiocyanates: synthesis, isolation, characterization, and application to the synthesis of thioureidopeptides. Journal of Organic Chemistry 74(15): 5260-5266
De Caro, V.; Scaturro, A.L.; Sutera, F.M.; Avellone, G.; Schiera, G.; Ferrantelli, E.; Carafa, M.; Rizzo, V.; Carletti, F.; Sardo, P.; Giannola, L.I. 2014: N-valproyl-L-phenylalanine as new potential antiepileptic drug: synthesis, characterization and in vitro studies on stability, toxicity and anticonvulsant efficacy. Medicinal Chemistry 11(1): 30-40
De Caro, V.; Giandalia, G.; Siragusa, M.G.; Lamartina, L.; Friscia, S.; Sardo, P.; Carletti, F.; Rizzo, V.; Ferraro, G.; Giannola, L.I. 2011: N-valproyl-L-tryptophan for CNS-targeting: synthesis, characterization and efficacy in vitro studies of a new potential antiepileptic drug. Medicinal Chemistry 7(1): 9-17
Villa, F.; Giacomucci, L.; Polo, A.; Principi, P.; Toniolo, L.; Levi, M.; Turri, S.; Cappitelli, F. 2009: N-vanillylnonanamide tested as a non-toxic antifoulant, applied to surfaces in a polyurethane coating. Biotechnology Letters 31(9): 1407-1413
Solà, J.; Helliwell, M.; Clayden, J. 2010: N-versus C-terminal control over the screw-sense preference of the configurationally achiral, conformationally helical peptide motif Aib(8)GlyAib(8). Journal of the American Chemical Society 132(13): 4548-4549
Weber, S.; Halm, S.; Du Vall, M.; Whitney, K.; Blaich, G.; Bury, D. 2012: N-vinylpyrrolidone dimer (VPD), a novel excipient for oral drugs: repeat-dose oral toxicity in Sprague-Dawley rats. Toxicology Letters 210(3): 324-331
Guo, J-Chao.; Li, J.; Zhao, Y-Pei.; Zhou, L.; Cui, Q-Cai.; Zhou, W-Xun.; Zhang, T-Ping.; You, L.; Shu, H. 2014: N-wasp in pancreatic ductal adenocarcinoma: associations with perineural invasion and poor prognosis. World Journal of Surgery 38(8): 2126-2131
Liu, C.; Bai, X.; Wu, J.; Sharma, S.; Upadhyaya, A.; Dahlberg, C.I.M.; Westerberg, L.S.; Snapper, S.B.; Zhao, X.; Song, W. 2013: N-wasp is essential for the negative regulation of B cell receptor signaling. Plos Biology 11(11): E1001704
Xiao, X.; Mruk, D.D.; Tang, E.I.; Massarwa, R.'a.; Mok, K.W.; Li, N.; Wong, C.K.C.; Lee, W.M.; Snapper, S.B.; Shilo, B.-Z.; Schejter, E.D.; Cheng, C.Y. 2014: N-wasp is required for structural integrity of the blood-testis barrier. Plos Genetics 10(6): E1004447
Hoppe, A.D.; Scott, B.L.; Welliver, T.P.; Straight, S.W.; Swanson, J.A. 2013: N-way FRET microscopy of multiple protein-protein interactions in live cells. Plos one 8(6): E64760
Tsakovski, S.; Kudłak, B.ła.; Simeonov, V.; Wolska, L.; Garcia, G.; Dassenakis, M.; Namieśnik, J. 2009: N-way modelling of sediment monitoring data from Mar Menor lagoon, Spain. Talanta 80(2): 935-941
Mostafapour, S.; Parastar, H. 2015: N-way partial least squares with variable importance in projection combined to GC × GC-TOFMS as a reliable tool for toxicity identification of fresh and weathered crude oils. Analytical and Bioanalytical Chemistry 407(1): 285-295
Sun, C-Wen.; Wu, Y.; Wang, J. 2012: N-{(1Z)-1-[(6-Chloro-pyridin-3-ylmeth-yl)(eth-yl)amino]-3-(3-chloro-phen-yl)-2-nitro-5-oxohex-1-en-yl}-N-methyl-acetamide. Acta Crystallographica. Section E Structure Reports Online 68(Pt 11): O3229
Gomes, C.R.B.; Vasconcelos, T.R.A.; Junior, W.T.Vellasco.; Cunico, W.; Wardell, J.L.; Wardell, S.M.S.V.; Tiekink, E.R.T. 2011: N-{(2S)-3-Hy-droxy-4-[(5-methyl-1,3,4-thia-diazol-2-yl)sulfan-yl]-1-phenyl-2-but-yl}-4-methyl-benzene-sulfonamide. Acta Crystallographica. Section E Structure Reports Online 67(Pt 9): O2447-O2448
Wang, B.; Wan, R.; Yin, L-He.; Han, F.; Wang, J-Tang. 2008: N-{(E)-4-[(E)-(Dodecyl-imino)meth-yl]benzyl-idene}dodecan-1-imine. Acta Crystallographica. Section E Structure Reports Online 64(Pt 3): O565
Sarfraz, M.; Tariq, M.Ilyas.; Tahir, M.Nawaz. 2010: N-{(E)-[4-(Dimethyl-amino)-phen-yl]methyl-idene}-2,3-dimethyl-aniline. Acta Crystallographica. Section E Structure Reports Online 66(Pt 8): O2055
Quiroa-Montalván, C.M.; Chávez, D.; Reyes-Martínez, R.; Morales-Morales, D.; Parra-Hake, M. 2013: N-{1,2-Bis(pyridin-3-yl)-2-[(E)-(pyridin-3-yl)methyl-idene-amino]-eth-yl}nicotinamide. Acta Crystallographica. Section E Structure Reports Online 69(Pt 5): O691-O692
Thirupathi, R.; Reddy, D.N.; Brinda, S.; Prabhakaran, E.N. 2009: N-{1-[(3-Bromo-prop-yl)amino-carbon-yl]eth-yl}-2-(2-nitro-benzene-sulfonamido)propionamide. Acta Crystallographica. Section E Structure Reports Online 65(Pt 10): O2308-O2309
Dorn, A.; Schollmeyer, D.; Laufer, S.A. 2010: N-{2-Methyl-5-[(5-oxo-10,11-dihydro-5H-dibenzo[a,d]cyclo-hepten-2-yl)amino]-phen-yl}benzamide. Acta Crystallographica. Section E Structure Reports Online 66(Pt 7): O1867
Karczmarzyk, Z.; Wolińska, E.; Fruziński, A. 2011: N-{2-[(4S)-4-tert-Butyl-4,5-dihydro-1,3-oxazol-2-yl]phen-yl}-5,6-diphenyl-1,2,4-triazin-3-amine. Acta Crystallographica. Section E Structure Reports Online 67(Pt 3): O651
Ahmad, K.; Awang, K.; Thomas, N.F.; Weber, J-Frederic.Faizal.; Ng, S.Weng. 2009: N-{2-[2-(2,6-Dichloro-3,5-dimethoxy-phen-yl)ethen-yl]phen-yl}acetamide. Acta Crystallographica. Section E Structure Reports Online 65(Pt 2): O438
Lu, L. 2012: N-{2-[2-(2-Cyano-4,6-di-nitro-phen-yl)diazen-yl]-5-(diethyl-amino)phen-yl}acetamide. Acta Crystallographica. Section E Structure Reports Online 68(Pt 10): O3005
Shao, Y.; An, D.; Zhou, M.; Liu, L.; Sun, X-Qiang. 2012: N-{2-[4-(2-Hy-droxy-eth-yl)piperazin-1-yl]eth-yl}phthalimide. Acta Crystallographica. Section E Structure Reports Online 68(Pt 1): O173
Lu, C.; Jiang, Q. 2010: N-{2-[4-(2-Meth-oxy-phen-yl)piperazin-1-yl]eth-yl}-4-nitro-N-(2-pyrid-yl)benzamide. Acta Crystallographica. Section E Structure Reports Online 66(Pt 10): O2697
Jiang, Q-Fu.; Lu, C-Xiong. 2010: N-{2-[4-(2-Meth-oxy-phen-yl)piperazin-1-yl]eth-yl}pyridin-2-amine monohydrate. Acta Crystallographica. Section E Structure Reports Online 66(Pt 7): O1727
Pervez, H.; Ahmad, M.; Yaqub, M.; Tahir, M.Nawaz.; Saira, N. 2010: N-{2-[N-(4-Methyl-phen-yl)oxamo-yl]phen-yl}propanamide. Acta Crystallographica. Section E Structure Reports Online 66(Pt 7): O1729
Haffner, C.D.; Thomson, S.A.; Guo, Y.; Schaller, L.T.; Boggs, S.; Dickerson, S.; Gobel, J.; Gillie, D.; Condreay, J.Patrick. 2010: N-{3-[(1,1-dioxido-1,2-benzothiazol-3-yl)(phenyl)amino]propyl}benzamide analogs as potent Kv1.3 inhibitors. Part 1. Bioorganic and Medicinal Chemistry Letters 20(23): 6983-6988
Patroniak, V.; Radecka-Paryzek, W.; Kubicki, M. 2008: N-{3-[(2-Ammonioethyl)amino]propyl}ethane-1,2-diaminium tris(trifluoromethanesulfonate): a salt of a folded triply protonated tetramine. Acta Crystallographica. Section C Crystal Structure Communications 64(Pt 9): O511-O513
Vinduvahini, M.; Jeyaseelan, S.; Shylajakumari, J.; Revanasiddappa, H.D.; Devaru, V.B. 2012: N-{3-[2-(4-Fluoro-phen-oxy)eth-yl]-2,4-dioxo-1,3-diaza-spiro-[4.5]decan-7-yl}-4-meth-oxy-benzene-sulfonamide. Acta Crystallographica. Section E Structure Reports Online 68(Pt 1): O194-O195
Vinduvahini, M.; Saha, B.Krishna.; Mahalakhmi; Revanasiddappa, H.D.; Devarajegowda, H.C. 2011: N-{3-[2-(4-Fluoro-phen-oxy)eth-yl]-2,4-dioxo-1,3-diaza-spiro-[4.5]decan-7-yl}-4-methyl-benzamide. Acta Crystallographica. Section E Structure Reports Online 67(Pt 6): O1440-O1441
Mai, A.; Khan, G.S.; Clark, G.R.; Barker, D. 2008: N-{3-[Bis(2-hydroxy-ethyl)amino-meth-yl]-5-nitro-phen-yl}benzamide. Acta Crystallographica. Section E Structure Reports Online 64(Pt 6): O978-O979
Song, X-Mei.; Li, Z-Yang.; Wang, Z-Yang.; Fu, J-Hua. 2009: N-{4-Bromo-2-[(S)-menth-yloxy]-5-oxo-2,5-dihydro-3-fur-yl}-l-valine. Acta Crystallographica. Section E Structure Reports Online 65(Pt 8): O1838
Chen, Y.; Goudet, C.; Pin, J-Philippe.; Conn, P.Jeffrey. 2008: N-{4-Chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide (CPPHA) acts through a novel site as a positive allosteric modulator of group 1 metabotropic glutamate receptors. Molecular Pharmacology 73(3): 909-918
Ahmad, S.; Farrukh, M.Akhyar.; Qureshi, F.Ashraf.; Adnan, A.; Akkurt, M. 2011: N-{4-[(2-Meth-oxy-phen-yl)sulfamo-yl]phen-yl}acetamide. Acta Crystallographica. Section E Structure Reports Online 67(Pt 2): O303-O304
John, P.; Khizar, S.; Khan, I.Ullah.; Sharif, S.; Tiekink, E.R.T. 2010: N-{4-[(3,4-Dimethyl-phen-yl)(eth-yl)sulfamo-yl]phen-yl}-N-ethyl-acetamide. Acta Crystallographica. Section E Structure Reports Online 66(Pt 12): O3152
Khan, I.Ullah.; John, P.; Khizar, S.; Sharif, S.; Tiekink, E.R.T. 2010: N-{4-[(3,4-Dimethyl-phen-yl)sulfamo-yl]phen-yl}acetamide. Acta Crystallographica. Section E Structure Reports Online 66(Pt 8): O2134-O2135
Farrukh, M.Akhyar.; Qureshi, F.Ashraf.; Adnan, A.; Türktekin, S.; Akkurt, M. 2012: N-{4-[(3-Methyl-phen-yl)sulfamo-yl]phen-yl}acetamide. Acta Crystallographica. Section E Structure Reports Online 68(Pt 2): O437
Lahtinen, M.; Damodara, J.; Upadhyaya, P.; Nonappa; Kolehmainen, E. 2011: N-{4-[(3-Methyl-phen-yl)sulfamo-yl]phen-yl}benzamide. Acta Crystallographica. Section E Structure Reports Online 67(Pt 11): O2866
John, P.; Khan, I.Ullah.; Sajjad, M.Arif.; Sharif, S.; Tiekink, E.R.T. 2010: N-{4-[(4-Methyl-phen-yl)sulfamo-yl]phen-yl}acetamide. Acta Crystallographica. Section E Structure Reports Online 66(Pt 8): O2031
Yasmeen, S.; Murtaza, S.; Akkurt, M.; Khan, I.Ullah.; Sharif, S. 2010: N-{4-[(5-Methyl-isoxazol-3-yl)sulfamo-yl]phen-yl}benzamide. Acta Crystallographica. Section E Structure Reports Online 66(Pt 9): O2264
Koch, P.; Schollmeyer, D.; Laufer, S. 2009: N-{4-[3-(4-Fluoro-phen-yl)pyrido[2,3-b]pyrazin-2-yl]-2-pyrid-yl}isopropyl-amine. Acta Crystallographica. Section E Structure Reports Online 65(Pt 10): O2557
Ziegler, K.; Schollmeyer, D.; Laufer, S. 2009: N-{4-[4-(4-Fluoro-phen-yl)-1-(2-methoxy-ethyl)-2-methyl-sulfanyl-1H-imidazol-5-yl]-2-pyrid-yl}-2-methyl-3-phenyl-propionamide. Acta Crystallographica. Section E Structure Reports Online 65(Pt 12): O3128
Bühler, S.; Schollmeyer, D.; Hauser, D.; Albrecht, W.; Laufer, S. 2009: N-{4-[4-(4-Fluoro-phen-yl)-1-methyl-2-[(R)-methyl-sulfin-yl]-1H-imidazol-5-yl]-2-pyridyl}acetamide dihydrate. Acta Crystallographica. Section E Structure Reports Online 66(Pt 1): O121
Znovjyak, K.O.; Ovchynnikov, V.A.; Sliva, T.Yu.; Shishkina, S.V.; Amirkhanov, V.M. 2009: N-{Bis[meth-yl(phen-yl)amino]phosphor-yl}-2,2,2-trichloro-acetamide. Acta Crystallographica. Section E Structure Reports Online 65(Pt 11): O2812
Czerwinski, A.; Valenzuela, F.; Afonine, P.; Dauter, M.; Dauter, Z. 2010: N-{N-[2-(3,5-Difluorophenyl)acetyl]-(S)-alanyl}-(S)-phenylglycine tert-butyl ester (DAPT): an inhibitor of γ-secretase, revealing fine electronic and hydrogen-bonding features. Acta Crystallographica. Section C Crystal Structure Communications 66(Pt 12): O585-O588
Wang, P.; Wan, R.; Han, F.; Wang, Y. 2009: N-{N-[5-(2,4-Dichloro-phen-yl)-1,3,4-thia-diazol-2-yl]carbamo-yl}-2,6-difluoro-benzamide. Acta Crystallographica. Section E Structure Reports Online 65(Pt 11): O2946
Xu, W.Jie.; Liao, X.Jian.; Diao, J.Zhong.; Zhou, L.; Xu, S.Hai. 2008: N-{N-[N-(1,1-Dimethyl-ethoxy-carbon-yl)-l-leuc-yl]-N-methyl-l-leuc-yl}-N-methyl-l-leucine benzyl ester. Acta Crystallographica. Section E Structure Reports Online 64(Pt 11): O2178
Liu, Y-Hong.; Li, F-Shi.; Li, Y. 2008: N-{[2,5-Dichloro-4-(1,1,2,3,3,3-hexa-fluoro-prop-oxy)phen-yl]amino-carbon-yl}-2,6-difluoro-benzamide. Acta Crystallographica. Section E Structure Reports Online 64(Pt 9): O1756
Sukalovic, V.; Bogdan, A.Elena.; Tovilovic, G.; Ignjatovic, D.; Andric, D.; Kostic-Rajacic, S.; Soskic, V. 2013: N-{[2-(4-Phenyl-piperazin-1-yl)-ethyl]-phenyl}-arylamides with dopamine D₂ and 5-Hydroxytryptamine 5HT(1A) activity: synthesis, testing, and molecular modeling. Archiv der Pharmazie 346(10): 708-717
Mustafa, G.; Akkurt, M.; Khan, I.Ullah.; Naseem, R.; Sajjad, B. 2010: N-{[4-(4-Meth-oxy-benzene-sulfonamido)-phen-yl]sulfon-yl}acetamide. Acta Crystallographica. Section E Structure Reports Online 66(Pt 7): O1768
Xu, H.; Jiang, B.; Meng, L.; Ren, T.; Zeng, Y.; Wu, J.; Qu, L.; Shou, C. 2012: N-α-acetyltransferase 10 protein inhibits apoptosis through RelA/p65-regulated MCL1 expression. Carcinogenesis 33(6): 1193-1202
Hua, K.-T.; Tan, C.-T.; Johansson, G.; Lee, J.-M.; Yang, P.-W.; Lu, H.-Y.; Chen, C.-K.; Su, J.-L.; Chen, P.B.; Wu, Y.-L.; Chi, C.-C.; Kao, H.-J.; Shih, H.-J.; Chen, M.-W.; Chien, M.-H.; Chen, P.-S.; Lee, W.-J.; Cheng, T.-Y.; Rosenberger, G.; Chai, C.-Y.; Yang, C.-J.; Huang, M.-S.; Lai, T.-C.; Chou, T.-Y.; Hsiao, M.; Kuo, M.-L. 2011: N-α-acetyltransferase 10 protein suppresses cancer cell metastasis by binding PIX proteins and inhibiting Cdc42/Rac1 activity. Cancer Cell 19(2): 218-231
Willis, V.C.; Gizinski, A.M.; Banda, N.K.; Causey, C.P.; Knuckley, B.; Cordova, K.N.; Luo, Y.; Levitt, B.; Glogowska, M.; Chandra, P.; Kulik, L.; Robinson, W.H.; Arend, W.P.; Thompson, P.R.; Holers, V.M. 2011: N-α-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis. Journal of Immunology 186(7): 4396-4404
Rodríguez, O.M.; Maresca, A.; Témpera, C.A.; Bravo, R.D.; Colinas, P.A.; Supuran, C.T. 2011: N-β-glycosyl sulfamides are selective inhibitors of the cancer associated carbonic anhydrase isoforms IX and XIi. Bioorganic and Medicinal Chemistry Letters 21(15): 4447-4450
Hellwig, M.; Matthes, R.é; Peto, A.; Löbner, J.ür.; Henle, T. 2014: N-ε-fructosyllysine and N-ε-carboxymethyllysine, but not lysinoalanine, are available for absorption after simulated gastrointestinal digestion. Amino Acids 46(2): 289-299
Medina-Enríquez, M.M.; Alcántara-Farfán, V.ón.; Aguilar-Faisal, L.; Trujillo-Ferrara, J.é G.; Rodríguez-Páez, L.; Vargas-Ramírez, A.L. 2015: N-ω-chloroacetyl-l-ornithine, a new competitive inhibitor of ornithine decarboxylase, induces selective growth inhibition and cytotoxicity on human cancer cells versus normal cells. Journal of Enzyme Inhibition and Medicinal Chemistry 30(3): 345-353
Anonymous 1917: N. A. M. Communications. Journal of the National Medical Association 9(3): 146
Ermoleva, Z.V.; Gamaleia, N.F. 1945: N. F. Gamaleia. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 1945(3): 3-5
Pedersen, F.S. 1999: N. F. S. Grundtvig and social policy in the Danish Constituent Assembly in the spring of 1849.. Historie 1999(1): 32-58
Sârbu, V.; Unc, O.; Hortolomei, N. 2011: N. Hortolomei (1885-1961). His surgical legacy after half of a century. Chirurgia 106(5): 689-692
Sayed, A.A.; Abbas, O.A.; Saad, M.A.; Marie, M.-A.S. 2018: Cicer arietinum extract ameliorate γ-irradiation disorders via modulation of oxidative/antioxidative pathway. Journal of Photochemistry and Photobiology. B Biology 183: 46-56
Mugnai, D. 2010: N. Leonicenus interpretes of Galen on causa coniuncta. Medicina Nei Secoli 22(1-3): 593-610
Anonymous 1911: N. M. A. Communication. Journal of the National Medical Association 3(3): 250-259
Anonymous 1910: N. M. A. Communications. Journal of the National Medical Association 2(2): 137-139
Anonymous 1917: N. M. A. Cummunications. Journal of the National Medical Association 9(4): 212-223
Anonymous 1931: N. M. A. Executive Board and Cabinet Meetings. Journal of the National Medical Association 23(4): 177-178
Anonymous 1910: N. M. A. Presidency. Journal of the National Medical Association 2(1): 35
Solov'ev, I.N.; Perevodchikova, N.I.; Blokhin, N.N. 2012: N. N. Blohin--the glorious son of Russia. Khirurgiia 2012(5): 93-94
Lepukaln, A.F.; Burdenko, N.NILOVICH. 1947: N. N. Burdenko, scientist, social worker and statesman of the great Stalin epoch. Khirurgiia 1947(5): 7-16
Beliaev, A.M. 2012: N. N. Petrov Research Institute of Oncology: present and future. Voprosy Onkologii 58(2): 140-147
Samoĭlov, V.O.; Pirogov, Nĭ.Ivanovich. 2010: N. O. Pirogov and physiology. Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 96(7): 740-751
Perko, Z.; Kraljević, J. 2007: N. O. T. E. S.--natural orifice transluminal endoscopic surgery. Lijecnicki Vjesnik 129(10-11): 371-372
Helvie, M.A.; Dunnick, N.Reed. 2014: N. Reed Dunnick, MD, President, Radiological Society of North America, 2014. Radiology 270(1): 12-13
Higashi, D.L.; Biais, N.; Weyand, N.J.; Agellon, A.; Sisko, J.L.; Brown, L.M.; So, M. 2011: N. elongata produces type IV pili that mediate interspecies gene transfer with N. gonorrhoeae. Plos one 6(6): E21373
Chaulk, S.; Lu, J.; Tan, K.; Arthur, D.C.; Edwards, R.A.; Frost, L.S.; Joachimiak, A.; Glover, J.N.Mark. 2010: N. meningitidis 1681 is a member of the FinO family of RNA chaperones. Rna Biology 7(6): 812-819
Retnev, V.M.; Grebenkov, S.V.; Tchashin, V.P.; Shilov, V.V.; Vigdortchik, N.A. 2013: N.A. Vigdortchik--outstanding national scientist, teacher and public figure, as founder of scientific occupational medicine school in Leningrad (to the 140th birthday). Meditsina Truda i Promyshlennaia Ekologiia 2013(12): 42-46
Anonymous 1964: N.A.A.C.P. Health Resolutions, 1964. Journal of the National Medical Association 56(6): 542
Anonymous 1963: N.A.A.C.P. Hospital Suits Pending. Journal of the National Medical Association 55(5): 443
Cobb, W.M. 1951: N.A.A.C.P. Resolutions in Health Area. Journal of the National Medical Association 43(5): 342-343
Anonymous 1959: N.A.A.C.P. Resolutions on Health, 1959. Journal of the National Medical Association 51(5): 401
Anonymous 1963: N.A.A.C.P. Resoluton on Hospitals and Health, 1963. Journal of the National Medical Association 55(6): 560-561
Berry, S. 2007: N.A.S.C.A.R. NASCAR ambulance standbys cause acoustic ruin. Jems: a Journal of Emergency Medical Services 32(7): 97
Pavlovskiĭ, L.N.; Strazhesko, N.D. 2008: N.D. Strazhesko and his role in the development of modern clinical medicine. Likars'ka Sprava 2008(1-2): 132-139
Anonymous 1948: N.H.S. British Medical Journal 2(4584): 864-865
Brown, D.M.; Acred, P. 1961: "Penbritin"-A new Broad-spectrum Antibiotic. British Medical Journal 2(5246): 197-198
Anonymous 1957: N.H.S. Drugs for Private Patients. British Medical Journal 1(5032): 1408-1409
Smaill, G.B. 1961: Bilateral Rupture of Achilles Tendons. British Medical Journal 1(5240): 1657-1658
Robeznieks, A. 2007: N.J. ASC ruling dings doctors. Modern Healthcare 37(48): 14
Kotzen, M.S. 2013: N.J. health system saves \$1.2 million. How real-time locating systems improve efficiency and patient care. Health Management Technology 34(8): 18
Mirskiĭ, M.B.; Karpinskiĭ, N.K. 2010: N.K.Karpinsky--first general-headquarter-doctor. Voenno-Meditsinskii Zhurnal 331(10): 91-94
Knopov, M.Sh.; Taranukha, V.K.; Priorov, Nĭ.Nikolaevich. 2011: N.N. Priorov--one of the founders of Russian traumatology and orthopedics. Khirurgiia 2011(4): 78-81
Targarona, E.M. 2012: N.O.T.E.S. what have learned?. Cirugia Espanola 90(1): 1-3
Al-Akash, M.; Boyle, E.; Tanner, W.A. 2009: N.O.T.E.S.: the progression of a novel and emerging technique. Surgical Oncology 18(2): 95-103
Langer, E. 1964: N.S. Savannah: Nine Years after Inception It Is Uncertain if Ship Is a Boon or a Boondoggle. Science 145(3627): 33-35
Perkins, D. 1964: Prehistoric Fauna from Shanidar, Iraq. Science 144(3626): 1565-1566
de Monte, M.; Scruignec, J.; Dubus, J.C.; Chaumuzeau, J.P.; Dautzenberg, B.; Dessanges, J.F.; Becquemin, M.H.; Diot, P. 2007: N.U.A.G.E.S: a survey of nebulisation practice in France with regard to ERS guidelines. Respiratory Medicine 101(12): 2561-2565
Rhea, S. 2008: N.Y. Berger deadline passes ... but debate over success of hospital plan goes on. Modern Healthcare 38(27): 16
Robeznieks, A. 2007: N.Y. IPA gets nod from FTC. Modern Healthcare 37(38): 14
DerGurahian, J. 2008: N.Y. Medicaid ups the ante. By refusing to pay for 14 'never events,' the nation's biggest Medicaid program could propel other states into action. Modern Healthcare 38(24): 6-7 1
Evans, M. 2013: N.Y. hospitals shift focus to preparing facilities for future superstorms. Modern Healthcare 43(43): 14
Anonymous 1974: N.h.s. Doctors' pay: new case for the review body. British Medical Journal 3(5929): 538
Anonymous 1974: N.h.s. Doctors' pay: p.m. Replies. British Medical Journal 3(5924): 210
Anonymous 1974: N.h.s. Private beds: summary of events. British Medical Journal 3(5923): 127-128
Anonymous 1966: N.h.s. Statistics. British Medical Journal 2(5511): 423
Anonymous 1971: N.h.s. Superannuation. British Medical Journal 1(5750): 622-623
Anonymous 1974: N.h.s. Superannuation-purchase of added years. British Medical Journal 4(5935): 59-60
Anonymous 1975: N.u.p.e. Criticizes doctors. British Medical Journal 1(5953): 350
Zhao, Q.-Q.; Chen, J.-L.; Lv, T.-F.; He, C.-X.; Tang, G.-P.; Liang, W.-Q.; Tabata, Y.; Gao, J.-Q. 2009: N/P ratio significantly influences the transfection efficiency and cytotoxicity of a polyethylenimine/chitosan/DNA complex. Biological and Pharmaceutical Bulletin 32(4): 706-710
Van de Voorde, B.; Boulhout, M.; Vermoortele, F.; Horcajada, P.; Cunha, D.; Lee, J.S.; Chang, J.-S.; Gibson, E.; Daturi, M.; Lavalley, J.-C.; Vimont, A.; Beurroies, I.; De Vos, D.E. 2013: N/S-heterocyclic contaminant removal from fuels by the mesoporous metal-organic framework MIL-100: the role of the metal ion. Journal of the American Chemical Society 135(26): 9849-9856
Piatto, G.; Cardin, F.; Lorenzetti, R.; Mazzalai, F.; Terranova, C.; Militello, C. 2012: N0 Stage colon cancer: prognostic role of age in relation to tumor site. Aging Clinical and Experimental Research 24(3 Suppl): 2-5
Wei, Y.-S.; Zhang, H.; Lu, X.-H.; Dong, Y.-S.; Zhao, B.-H. 2007: N01WA-735E, a human leukocyte elastase inhibitor from metabolites of microorganisms. Sheng Wu Gong Cheng Xue Bao 23(6): 1112-1115
Tan, W.W.; Hillman, D.W.; Salim, M.; Northfelt, D.W.; Anderson, D.M.; Stella, P.J.; Niedringhaus, R.; Bernath, A.M.; Gamini, S.S.; Palmieri, F.; Perez, E.A. 2010: N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial. Annals of Oncology: Official Journal of the European Society for Medical Oncology 21(3): 493-497
Folsom, R.C.; Owsley, R.M. 1987: N1 action potentials in humans: influence of simultaneous contralateral stimulation. Acta Oto-Laryngologica 103(5-6): 262-265
Dekio-Hotta, S.; Kojima, T.; Karino, S.; Yamasoba, T.; Dekio, I.; Ito, Y.M.; Satake, H.; Kaga, K. 2009: N1 component reflects difference of terminal chords in three-chord sequences. Neuroreport 20(3): 251-256
Sinke, C.; Neufeld, J.; Wiswede, D.; Emrich, H.M.; Bleich, S.; Münte, T.F.; Szycik, G.R. 2014: N1 enhancement in synesthesia during visual and audio-visual perception in semantic cross-modal conflict situations: an ERP study. Frontiers in Human Neuroscience 8: 21
Casali, C.; Stefani, A.; Morandi, U. 2011: N1 non-small-cell lung cancer. a 20-year surgical experience. Asian Cardiovascular and Thoracic Annals 19(3-4): 217-224
Shishkin, S.L.; Ganin, I.P.; Basyul, I.A.; Zhigalov, A.Y.; Kaplan, A.Y. 2009: N1 wave in the P300 BCi is not sensitive to the physical characteristics of stimuli. Journal of Integrative Neuroscience 8(4): 471-485
Ghonaim, H.M.; Li, S.; Blagbrough, I.S. 2010: N1,N12-Diacyl spermines: SAR studies on non-viral lipopolyamine vectors for plasmid DNA and siRNA formulation. Pharmaceutical Research 27(1): 17-29
Novikov, M.S.; Valuev-Elliston, V.T.; Babkov, D.A.; Paramonova, M.P.; Ivanov, A.V.; Gavryushov, S.A.; Khandazhinskaya, A.L.; Kochetkov, S.N.; Pannecouque, C.; Andrei, G.; Snoeck, R.; Balzarini, J.; Seley-Radtke, K.L. 2013: N1,N3-disubstituted uracils as nonnucleoside inhibitors of HIV-1 reverse transcriptase. Bioorganic and Medicinal Chemistry 21(5): 1150-1158
Gao, Y.; Ji, B.-S. 2014: N1-(Quinolin-2-ylmethyl) butane-1, 4-diamine, a polyamine analog: inhibition of platelet aggregation mediated by an elevated VASP, and decreased MAPK phosphorylation. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 25(5): 476-485
Amundsen, L.H.; Malentacchi, L.A. 1946: N1-(amino-alkyl)-sulfanilamides and N1-(acetamidoalkyl)-sulfanilamides. Journal of the American Chemical Society 68: 584
Amundsen, L.H.; Malentacchi, L.A. 1941: N1-(beta-AMINOETHYL)SULFANILAMIDE AND N1-(beta-DIETHYLAMINOETHYL) SULFANILAMIDE. Science 93(2412): 286
Mitchell, M.L.; Son, J.C.; Guo, H.; Im, Y.-A.; Cho, E.J.; Wang, J.; Hayes, J.; Wang, M.; Paul, A.; Lansdon, E.B.; Chen, J.M.; Graupe, D.; Rhodes, G.; He, G.-X.; Geleziunas, R.; Xu, L.; Kim, C.U. 2010: N1-Alkyl pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorganic and Medicinal Chemistry Letters 20(5): 1589-1592
Singh, K.; Arora, D.; Poremsky, E.; Lowery, J.; Moreland, R.S. 2009: N1-Alkylated 3,4-dihydropyrimidine-2(1H)-ones: Convenient one-pot selective synthesis and evaluation of their calcium channel blocking activity. European Journal of Medicinal Chemistry 44(5): 1997-2001
Mitchell, M.L.; Son, J.C.; Lee, I.Y.; Lee, C.-K.; Kim, H.S.; Guo, H.; Wang, J.; Hayes, J.; Wang, M.; Paul, A.; Lansdon, E.B.; Chen, J.M.; Eisenberg, G.; Geleziunas, R.; Xu, L.; Kim, C.U. 2010: N1-Heterocyclic pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorganic and Medicinal Chemistry Letters 20(5): 1585-1588
Wang, X.-D.; Gao, Z.-H.; Xue, X.; Cheng, Y.-N.; Yue, P.; Fang, X.-W.; Qu, X.-J. 2011: N1-acetyl substituted pyrrolidine derivative CIP-A5: a novel compound that could ameliorate liver cirrhosis through modulation of hepatic stellate cell activity. Toxicology in Vitro: An International Journal Published in Association with Bibra 25(4): 897-904
Ruiz, J.é; Cutillas, N.; Villa, M.ía.D.; López, G.; Espinosa, A.; Bautista, D. 2009: N1-coordination in palladium(II) and platinum(II) complexes with 9-methylhypoxanthine: crystal structures and theoretical calculations. Dalton Transactions 43: 9637-9644
Lou, B.; Fan, J.; Wang, K.; Chen, W.; Zhou, X.; Zhang, J.; Lin, S.; Lv, F.; Chen, Y. 2013: N1-guanyl-1,7-diaminoheptane (GC7) enhances the therapeutic efficacy of doxorubicin by inhibiting activation of eukaryotic translation initiation factor 5A2 (eIF5A2) and preventing the epithelial-mesenchymal transition in hepatocellular carcinoma cells. Experimental Cell Research 319(17): 2708-2717
Yang, J.; Yu, H.; Shen, M.; Wei, W.; Xia, L.; Zhao, P. 2014: N1-guanyl-1,7-diaminoheptane sensitizes bladder cancer cells to doxorubicin by preventing epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2 activation. Cancer Science 105(2): 219-227
Palmer, S.B.; Musiek, F.E. 2013: N1-p2 recordings to gaps in broadband noise. Journal of the American Academy of Audiology 24(1): 37-45
Feriotto, G.; Nastruzzi, C.; Mischiati, C.; Gambari, R. 1992: N1-substituted tetra-benzamidines - inhibition of DNA-protein interactions and invitro tumor-cell growth. International Journal of Oncology 1(3): 277-281
Michalewski, H.J.; Starr, A.; Zeng, F.-G.; Dimitrijevic, A. 2009: N100 cortical potentials accompanying disrupted auditory nerve activity in auditory neuropathy (AN): effects of signal intensity and continuous noise. Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology 120(7): 1352-1363
Sakamoto, M.; Itasaka, Y.; Ishikawa, K. 2007: N100m findings of auditory-evoked fields in patients with psychogenic hearing impairment. Nihon Jibiinkoka Gakkai Kaiho 110(10): 672-679
Lanke, E.; Kristoffersson, A.-C.; Isaksson, C.; Holmberg, L.; Lethagen, S. 2008: N1421K mutation in the glycoprotein Ib binding domain impairs ristocetin- and botrocetin-mediated binding of von Willebrand factor to platelets. European Journal of Haematology 81(5): 384-390
Skalweit, M.J.; Li, M.; Conklin, B.C.; Taracila, M.A.; Hutton, R.A. 2013: N152G, -S, and -T substitutions in CMY-2 β-lactamase increase catalytic efficiency for cefoxitin and inactivation rates for tazobactam. Antimicrobial Agents and ChemoTherapy 57(4): 1596-1602
Ravin, N.V. 2011: N15: the linear phage-plasmid. Plasmid 65(2): 102-109
Simon, G.; Petit, L.; Bernard, C.; Rebaï, M. 2007: N170 ERPs could represent a logographic processing strategy in visual word recognition. Behavioral and Brain Functions: Bbf 3: 21
Lopes, R.; Cabral, P.; Canas, N.; Breia, P.; Foreid, J.P.; Calado, Eália.; Silva, R.; Leal, A. 2011: N170 asymmetry as an index of inferior occipital dysfunction in patients with symptomatic occipital lobe epilepsy. Clinical neurophysiology: official journal of the International Federation of Clinical Neurophysiology 122(1): 9-15
He, W.-q.; Luo, W.-b.; He, H.-m.; Chen, X.; Zhang, D.-j. 2011: N170 effects during exact and approximate calculation tasks: an ERP study. Neuroreport 22(9): 437-441
Hietanen, J.K.; Astikainen, P. 2013: N170 response to facial expressions is modulated by the affective congruency between the emotional expression and preceding affective picture. Biological Psychology 92(2): 114-124
Gratz, M.S.; Suezer, Y.; Kremer, M.; Volz, A.; Majzoub, M.; Hanschmann, K.-M.; Kalinke, U.; Schwantes, A.; Sutter, G. 2011: N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infection. Journal of Virology 85(7): 3557-3569
Forest, V.-I.; Clark, J.J.; Veness, M.J.; Milross, C. 2010: N1S3: a revised staging system for head and neck cutaneous squamous cell carcinoma with lymph node metastases: results of 2 Australian Cancer Centers. Cancer 116(5): 1298-1304
Hoonhorst, I.; Serniclaes, W.; Collet, G.; Colin, C.; Markessis, E.; Radeau, M.; Deltenre, P. 2009: N1b and Na subcomponents of the N100 long latency auditory evoked-potential: neurophysiological correlates of voicing in French-speaking subjects. Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology 120(5): 897-903
Nishimura, T.; Nakagawa, S.; Yamashita, A.; Sakaguchi, T.; Hosoi, H. 2009: N1m amplitude growth function for bone-conducted ultrasound. Acta Oto-Laryngologica. Supplementum 2009(562): 28-33
Casiraghi, M.; Fortier-Gauthier, U.; Sessa, P.; Dell'Acqua, R.; Jolicœur, P. 2013: N1pc reversal following repeated eccentric visual stimulation. Psychophysiology 50(4): 351-364
Cerbai, F.; Giovannini, M.Grazia.; Melani, C.; Enz, A.; Pepeu, G. 2007: N1phenethyl-norcymserine, a selective butyrylcholinesterase inhibitor, increases acetylcholine release in rat cerebral cortex: a comparison with donepezil and rivastigmine. European Journal of Pharmacology 572(2-3): 142-150
Roskoski, J.P. 1980: N2 Fixation (C2H 2 reduction) by epiphylls on coffee,Coffea arabica. Microbial Ecology 6(4): 349-355
Zhou, Y.; Huang, J.; He, W.; Fan, W.; Fang, W.; He, G.; Wu, Q.; Chu, S.; Li, Y. 2014: N2 ameliorates neural injury during experimental ischemic stroke via the regulation of thromboxane A2 production. Pharmacology Biochemistry and Behavior 124: 458-465
Aron, K.; Harris, L.E.; Fendell, J. 1983: N2 and CO vibrational CARS and H2 rotational CARS spectroscopy of CH4/N2O flames. Applied Optics 22(22): 3604-3611
Keskin-Ergen, Y.; Tükel, R.şi.; Aslantaş-Ertekin, B.; Ertekin, E.; Oflaz, S.; Devrim-Üçok, M.üg. 2014: N2 and P3 potentials in early-onset and late-onset patients with obsessive-compulsive disorder. Depression and Anxiety 31(12): 997-1006
Fryzuk, M.D. 2013: N2 coordination. Chemical Communications 49(43): 4866-4868
Defranchi, S.A.; Cassivi, S.D.; Nichols, F.C.; Allen, M.S.; Shen, K.R.; Deschamps, C.; Wigle, D.A. 2009: N2 disease in T1 non-small cell lung cancer. Annals of Thoracic Surgery 88(3): 924-928
Toker, A. 2008: N2 disease in non-small cell lung cancer patients, diagnosis and evaluation: a Turkish chest surgeon's perspective. Zhongguo Fei Ai Za Zhi 11(5): 622-626
Cho, A.H.; Shah, S.; Ampil, F.; Bhartur, S.; Nathan, C-Ann.O. 2009: N2 disease in patients with head and neck squamous cell cancer treated with chemoradiotherapy: is there a role for posttreatment neck dissection?. Archives of Otolaryngology--Head and Neck Surgery 135(11): 1112-1118
Matsushima, T. 2007: N2 emission in NO and N2O reduction on Rh(100) and Rh(110). Physical Chemistry Chemical Physics: Pccp 9(23): 3031-3042
Moret, M.-E.; Peters, J.C. 2011: N2 functionalization at iron metallaboratranes. Journal of the American Chemical Society 133(45): 18118-18121
Pun, D.; Bradley, C.A.; Lobkovsky, E.; Keresztes, I.; Chirik, P.J. 2008: N2 hydrogenation from activated end-on bis(indenyl) zirconium dinitrogen complexes. Journal of the American Chemical Society 130(43): 14046-14047
Riquet, M.; Arame, A.; Fabre, E. 2015: N2 involvement in lung cancer: the Danaïdes' barrel. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 48(1): 176
Cuartero, Mía.Isabel.; Ballesteros, Ián.; Moraga, A.; Nombela, F.; Vivancos, Jé.; Hamilton, J.A.; Corbí, Ángel.L.; Lizasoain, I.; Moro, Mía.A. 2013: N2 neutrophils, novel players in brain inflammation after stroke: modulation by the PPARγ agonist rosiglitazone. Stroke 44(12): 3498-3508
Leuzzi, G.; Cesario, A.; Chiappetta, M.; Margaritora, S.; Porziella, V.; Meacci, E.; Vita, M.L.; Congedo, M.T.; Granone, P. 2013: N2 nodal involvement in multiple primary lung cancer: really an exclusion criterion?. Chest 144(2): 714-715
Chen, J.J.; Cai, X.; Szostak, J.W. 2009: N2'-->p3' phosphoramidate glycerol nucleic acid as a potential alternative genetic system. Journal of the American Chemical Society 131(6): 2119-2121
Andersen, N.K.; Wengel, J.; Hrdlicka, P.J. 2007: N2'-functionalized 2'-amino-alpha-L-LNA adenine derivatives--efficient targeting of single stranded DNA. Nucleosides Nucleotides and Nucleic Acids 26(10-12): 1415-1417
Tasinato, N.; Pietropolli Charmet, A.; Stoppa, P.; Giorgianni, S.; Buffa, G. 2014: N2-, O2- and He-collision-induced broadening of sulfur dioxide ro-vibrational lines in the 9.2 μm atmospheric window. Spectrochimica Acta. Part a Molecular and Biomolecular Spectroscopy 118: 373-379
Corry, J.; Peters, L.; Fisher, R.; Macann, A.; Jackson, M.; McClure, B.; Rischin, D. 2008: N2-N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders-results of Trans Tasman Radiation Oncology Group Study 98.02. Head and Neck 30(6): 737-742
Gangjee, A.; Namjoshi, O.A.; Yu, J.; Ihnat, M.A.; Thorpe, J.E.; Bailey-Downs, L.C. 2013: N2-Trimethylacetyl substituted and unsubstituted-N4-phenylsubstituted-6-(2-pyridin-2-ylethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamines: design, cellular receptor tyrosine kinase inhibitory activities and in vivo evaluation as antiangiogenic, antimetastatic and antitumor agents. Bioorganic and Medicinal Chemistry 21(5): 1312-1323
Adebambo, K.F.; Zanoli, S.; Thomas, M.G.; Cancio, R.; Howarth, N.M.; Maga, G. 2007: N2-benzyloxycarbonylguan-9-yl acetic acid derivatives as HIV-1 reverse transcriptase non-nucleoside inhibitors with decreased loss of potency against common drug-resistance mutations. Chemmedchem 2(10): 1405-1409
Balbo, S.; Hashibe, M.; Gundy, S.; Brennan, P.; Canova, C.; Simonato, L.; Merletti, F.; Richiardi, L.; Agudo, A.; Castellsagué, X.; Znaor, A.; Talamini, R.; Bencko, V.; Holcátová, I.; Wang, M.; Hecht, S.S.; Boffetta, P. 2008: N2-ethyldeoxyguanosine as a potential biomarker for assessing effects of alcohol consumption on DNA. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 17(11): 3026-3032
Martić, S.; Wu, G.; Wang, S. 2008: N2-functionalized blue luminescent guanosines by 2,2'-dipyridylamino and 2-(2'-pyridyl)benzimidazolyl chelate groups and their interactions with Zn(II) ions. Inorganic Chemistry 47(18): 8315-8323
Hu, X.; Pornpattananangkul, N.; Rosenfeld, J.Peter. 2013: N200 and P300 as orthogonal and integrable indicators of distinct awareness and recognition processes in memory detection. Psychophysiology 50(5): 454-464
Reza, M.Faruque.; Ikoma, K.; Ito, T.; Ogawa, T.; Mano, Y. 2007: N200 latency and P300 amplitude in depressed mood post-traumatic brain injury patients. Neuropsychological Rehabilitation 17(6): 723-734
Hong, B.; Guo, F.; Liu, T.; Gao, X.; Gao, S. 2009: N200-speller using motion-onset visual response. Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology 120(9): 1658-1666
Trujillo-Orrego, N. 2011: N200: an electrophysiological signal associated with inhibitory control, as an endophenotype candidate in attention deficit hyperactivity disorder. Revista de Neurologia 53(1): 35-43
Sacks, S.; Finn, J.; Sanna, G.; Khamashta, M.A.; Chowdhury, F.; Hunt, B.J.; Bell, R.; D'Cruz, D.P. 2013: N2010 adult-onset Still's disease complicated by hemophagocytic syndrome and catastrophic antiphospholipid syndrome resulting in four limb amputation. Israel Medical Association Journal: Imaj 15(4): 192-194
Jasper, S.; Hammond, A.; Thomas, J.; Kidd, L.; Strout, D.L. 2011: N22C2 versus N24: role of molecular curvature in determining isomer stability. Journal of Physical Chemistry. a 115(42): 11915-11918
Kaufmann, Jürgen.M.; Schweinberger, S.R.; Burton, A.Mike. 2009: N250 ERP correlates of the acquisition of face representations across different images. Journal of Cognitive Neuroscience 21(4): 625-641
Duñabeitia, J.Andoni.; Molinaro, N.; Laka, I.; Estévez, A.; Carreiras, M. 2009: N250 effects for letter transpositions depend on lexicality: 'casual' or 'causal'?. Neuroreport 20(4): 381-387
Neumann, M.F.; Schweinberger, S.R. 2009: N250r ERP repetition effects from distractor faces when attending to another face under load: Evidence for a face attention resource. Brain Research 1270: 64-77
Neumann, M.F.; Schweinberger, S.R. 2008: N250r and N400 ERP correlates of immediate famous face repetition are independent of perceptual load. Brain Research 1239: 181-190
Hill, J.; Leary, S.; Smither, S.; Best, A.; Pettersson, J.; Forsberg, A.; Lingard, B.; Lipka, A.; Brown, K.A.; Williamson, E.D.; Titball, R.W. 2009: N255 is a key residue for recognition by a monoclonal antibody which protects against Yersinia pestis infection. Vaccine 27(50): 7073-7079
Rothganger, F.; Warrender, C.E.; Trumbo, D.; Aimone, J.B. 2014: N2A: a computational tool for modeling from neurons to algorithms. Frontiers in Neural Circuits 8: 1
Harman, W.H.; Chang, C.J. 2007: N2O activation and oxidation reactivity from a non-heme iron pyrrole platform. Journal of the American Chemical Society 129(49): 15128-15129
Luo, L.-g.; Kondo, M.; Itoh, S. 2010: N2O and CH4 emission from Japan rice fields under different long-term fertilization patterns and its environmental impact. Ying Yong Sheng Tai Xue Bao 21(12): 3200-3206
Zhao, B.; An, Q.; He, Y.Liang.; Guo, J.Song. 2012: N2O and N2 production during heterotrophic nitrification by Alcaligenes faecalis strain NR. Bioresource Technology 116: 379-385
He, P.; Yang, N.; Gu, H.; Zhang, H.; Shao, L. 2011: N2O and NH3 emissions from a bioreactor landfill operated under limited aerobic degradation conditions. Journal of Environmental Sciences 23(6): 1011-1019
Van Hulle, S.W.H.; Callens, J.; Mampaey, K.E.; van Loosdrecht, M.C.M.; Volcke, E.I.P. 2012: N2O and NO emissions during autotrophic nitrogen removal in a granular sludge reactor--a simulation study. Environmental Technology 33(19-21): 2281-2290
Hussain, M.; Fino, D.; Russo, N. 2012: N2O decomposition by mesoporous silica supported Rh catalysts. Journal of Hazardous Materials 211-212: 255-265
Zhang, J.-r.; Wang, S.-y.; Shang, H.-l.; Peng, Y.-z. 2009: N2O emission and control in shortcut nitrification and denitrification and simultaneous nitrification and denitrification biological nitrogen removal systems. Huan Jing Ke Xue= Huanjing Kexue 30(12): 3624-3629
Jia, J.-X.; Zhang, M.; Xiong, Z.-Q.; Li, Y. 2012: N2O emission from an intensively managed greenhouse vegetable field in Nanjing suburb, Jiangsu Province of East China. Ying Yong Sheng Tai Xue Bao 23(3): 739-744
Sun, S.; Cheng, X.; Li, S.; Qi, F.; Liu, Y.; Sun, D. 2013: N2O emission from full-scale urban wastewater treatment plants: a comparison between A(2)O and SBR. Water Science and Technology: a Journal of the International Association on Water Pollution Research 67(9): 1887-1893
Liang, H.; Yang, J.; Gao, D. 2014: N2O emission from nitrogen removal via nitrite in oxic-anoxic granular sludge sequencing batch reactor. Journal of Environmental Sciences 26(3): 537-541
Yan, Y.; Li, P.; Wu, J.; Zhu, N.; Wu, P.; Wang, X. 2014: N2O emission in short-cut simultaneous nitrification and denitrification process: dynamic emission characteristics and succession of ammonia-oxidizing bacteria. Water Science and Technology: a Journal of the International Association on Water Pollution Research 69(12): 2541-2547
Shao, L.-m.; Qiu, W.-j.; Zhang, H.-h.; He, P.-j. 2008: N2O emissions and ammonia volatilization from leachate irrigated soils. Huan Jing Ke Xue= Huanjing Kexue 29(12): 3520-3524
Yang, J.; Trela, J.; Plaza, E.; Tjus, K.år. 2013: N2O emissions from a one stage partial nitrification/anammox process in moving bed biofilm reactors. Water Science and Technology: a Journal of the International Association on Water Pollution Research 68(1): 144-152
Ahn, J.Ho.; Kim, S.; Park, H.; Rahm, B.; Pagilla, K.; Chandran, K. 2010: N2O emissions from activated sludge processes, 2008-2009: results of a national monitoring survey in the United States. Environmental Science and Technology 44(12): 4505-4511
Yang, J.; Han, S.-H.; Li, F.-C.; Zhang, X.; Zhao, X.-L.; Liu, C.-Y.; Fan, M.-H. 2009: N2O emissions from agricultural ecosystem in Sichuan-Chongqing region. Huan Jing Ke Xue= Huanjing Kexue 30(9): 2684-2693
Xie, B.; Yu, J.; Zheng, X.; Qu, F.; Xu, Y.; Lin, H. 2014: N2O emissions from an apple orchard in the coastal area of Bohai Bay, China. Thescientificworldjournal 2014: 164732
Mikola, A.; Heinonen, M.; Kosonen, H.; Leppänen, M.; Rantanen, P.; Vahala, R. 2014: N2O emissions from secondary clarifiers and their contribution to the total emissions of the WWTP. Water Science and Technology: a Journal of the International Association on Water Pollution Research 70(4): 720-728
Houweling, D.; Wunderlin, P.; Dold, P.; Bye, C.; Joss, A.; Siegrist, H. 2011: N2O emissions: modeling the effect of process configuration and diurnal loading patterns. Water Environment Research: a Research Publication of the Water Environment Federation 83(12): 2131-2139
Pei, S.-W.; Zhang, Y.-Y.; Liu, J.-F.; Lun, X.-X.; Mu, Y.-J. 2012: N2O exchange fluxes from wheat-maize crop rotation system in the North China Plain. Huan Jing Ke Xue= Huanjing Kexue 33(10): 3641-3646
Wu, Y.-Z.; Zhang, M.-M.; Qin, H.-L.; Hou, H.-J.; Chen, C.-L.; Wei, W.-X. 2013: N2O flux in winter and its affecting factors under different land use patterns. Huan Jing Ke Xue= Huanjing Kexue 34(8): 2968-2974
Karimi, R.; Bisson, Ér.; Wales, B.; Walles, B.; Beaulieu, S.; Giguère, M.; Long, Z.; Liu, W.-K.; Kieffer, J.-C.; Légaré, F.ço.; Sanderson, J. 2013: N2O ionization and dissociation dynamics in intense femtosecond laser radiation, probed by systematic pulse length variation from 7 to 500 fs. Journal of Chemical Physics 138(20): 204311
Chen, L.-l.; Gao, D.-w. 2013: N2O production in nitrogen removal by micro-expansion of granular sludge. Huan Jing Ke Xue= Huanjing Kexue 34(9): 3532-3537
Law, Y.; Ni, B.-J.; Lant, P.; Yuan, Z. 2012: N2O production rate of an enriched ammonia-oxidising bacteria culture exponentially correlates to its ammonia oxidation rate. Water Research 46(10): 3409-3419
Roberts, J.M.; Osthoff, H.D.; Brown, S.S.; Ravishankara, A.R. 2008: N2O5 oxidizes chloride to Cl2 in acidic atmospheric aerosol. Science 321(5892): 1059
Cosman, L.M.; Knopf, D.A.; Bertram, A.K. 2008: N2O5 reactive uptake on aqueous sulfuric acid solutions coated with branched and straight-chain insoluble organic surfactants. Journal of Physical Chemistry. a 112(11): 2386-2396
Willinger, L. 1946: N2O; death in the dental chair. Oral Hygiene 36(8): 1366-1368
Gamble, M.L.; Luck, S.J. 2011: N2ac: an ERP component associated with the focusing of attention within an auditory scene. Psychophysiology 48(8): 1057-1068
Rodríguez Holguín, S.; Doallo, S.; Vizoso, C.; Cadaveira, F. 2009: N2pc and attentional capture by colour and orientation-singletons in pure and mixed visual search tasks. International Journal of Psychophysiology: Official Journal of the International Organization of Psychophysiology 73(3): 279-286
Cespón, J.; Galdo-Álvarez, S.; Díaz, F. 2013: N2pc is modulated by stimulus-stimulus, but not by stimulus-response incompatibilities. Biological Psychology 93(1): 75-80
Sadek, B.; Ashoor, A.; Al Mansouri, A.; Lorke, D.E.; Nurulain, S.M.; Petroianu, G.; Wainwright, M.; Oz, M. 2012: N3,N7-diaminophenothiazinium derivatives as antagonists of α7-nicotinic acetylcholine receptors expressed in Xenopus oocytes. Pharmacological Research 66(3): 213-218
Nathubhai, A.; Patterson, R.; Woodman, T.J.; Sharp, H.E.C.; Chui, M.T.Y.; Chung, H.H.K.; Lau, S.W.S.; Zheng, J.; Lloyd, M.D.; Thompson, A.S.; Threadgill, M.D. 2011: N3-alkylation during formation of quinazolin-4-ones from condensation of anthranilamides and orthoamides. Organic and Biomolecular Chemistry 9(17): 6089-6099
Saavedra, O.; Claridge, S.; Zhan, L.; Raeppel, F.; Granger, M.-C.; Raeppel, S.ép.; Mannion, M.; Gaudette, F.éd.ér.; Zhou, N.; Isakovic, L.; Bernstein, N.; Déziel, R.; Nguyen, H.; Beaulieu, N.; Beaulieu, C.; Dupont, I.; Wang, J.; Macleod, A.R.; Besterman, J.M.; Vaisburg, A. 2009: N3-arylmalonamides: a new series of thieno[3,2-b]pyridine based inhibitors of c-Met and VEGFR2 tyrosine kinases. Bioorganic and Medicinal Chemistry Letters 19(24): 6836-6839
Parussulo, A.é L.A.; Huila, M.F.G.; Araki, K.; Toma, H.E. 2011: N3-dye-induced visible laser anatase-to-rutile phase transition on mesoporous TiO2 films. Langmuir: the Acs Journal of Surfaces and Colloids 27(15): 9094-9099
Zhang, J.; Hummersone, M.; Matthews, C.S.; Stevens, M.F.G.; Bradshaw, T.D. 2015: N3-substituted temozolomide analogs overcome methylguanine-DNA methyltransferase and mismatch repair precipitating apoptotic and autophagic cancer cell death. Oncology 88(1): 28-48
Khalil, A.; Ishita, K.; Ali, T.; Tjarks, W. 2013: N3-substituted thymidine bioconjugates for cancer therapy and imaging. Future Medicinal Chemistry 5(6): 677-692
Debruille, J.B.; Brodeur, M.B.; Franco Porras, C. 2012: N300 and social affordances: a study with a real person and a dummy as stimuli. Plos one 7(10): E47922
Hasko, S.; Bruder, J.; Bartling, Jürgen.; Schulte-Körne, G. 2012: N300 indexes deficient integration of orthographic and phonological representations in children with dyslexia. Neuropsychologia 50(5): 640-654
Pancera, M.; Yang, Y.; Louder, M.K.; Gorman, J.; Lu, G.; McLellan, J.S.; Stuckey, J.; Zhu, J.; Burton, D.R.; Koff, W.C.; Mascola, J.R.; Kwong, P.D. 2013: N332-Directed broadly neutralizing antibodies use diverse modes of HIV-1 recognition: inferences from heavy-light chain complementation of function. Plos one 8(2): E55701
Biondi, M.J.; Beilhartz, G.L.; McCormick, S.; Götte, M. 2010: N348i in HIV-1 reverse transcriptase can counteract the nevirapine-mediated bias toward RNase H cleavage during plus-strand initiation. Journal of Biological Chemistry 285(35): 26966-26975
Yap, S.H.; Herman, B.D.; Radzio, J.; Sluis-Cremer, N.; Tachedjian, G. 2012: N348i in HIV-1 reverse transcriptase counteracts the synergy between zidovudine and nevirapine. Journal of Acquired Immune Deficiency Syndromes 61(2): 153-157
Sluis-Cremer, N.; Moore, K.; Radzio, J.; Sonza, S.; Tachedjian, G. 2010: N348i in HIV-1 reverse transcriptase decreases susceptibility to tenofovir and etravirine in combination with other resistance mutations. Aids 24(2): 317-319
Radzio, J.; Yap, S.-H.; Tachedjian, G.; Sluis-Cremer, N. 2010: N348i in reverse transcriptase provides a genetic pathway for HIV-1 to select thymidine analogue mutations and mutations antagonistic to thymidine analogue mutations. Aids 24(5): 659-667
Jin, L.; Ding, Y.-h. 2009: N3MN5]q: a type of low-lying sandwich-like isomer on [N8M]q hypersurface with (M, q) = (Ni, 0), (Co, -1), and (Fe, -2). Journal of Physical Chemistry. a 113(49): 13645-13650
Ehlers, C.L.; Phillips, E.; Criado, J.é R.; Gilder, D.A. 2011: N4 component responses to pre-pulse startle stimuli in young adults: relationship to alcohol dependence. Psychiatry Research 188(2): 237-244
Douki, T.; Meador, J.A.; Bérard, I.; Wack, A. 2015: N4-methylation of cytosine drastically favors the formation of (6-4) photoproducts in a TCG context. Photochemistry and Photobiology 91(1): 102-108
Wolter, S.; Dove, S.; Golombek, M.; Schwede, F.; Seifert, R. 2014: N4-monobutyryl-cCMP activates PKA RIα and PKA RIIα more potently and with higher efficacy than PKG Iα in vitro but not in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology 387(12): 1163-1175
Huang, W.; Zheng, W.; Urban, D.J.; Inglese, J.; Sidransky, E.; Austin, C.P.; Thomas, C.J. 2007: N4-phenyl modifications of N2-(2-hydroxyl)ethyl-6-(pyrrolidin-1-yl)-1,3,5-triazine-2,4-diamines enhance glucocerebrosidase inhibition by small molecules with potential as chemical chaperones for Gaucher disease. Bioorganic and Medicinal Chemistry Letters 17(21): 5783-5789
Srinivas, P.; Likhar, P.R.; Maheswaran, H.; Sridhar, B.; Ravikumar, K.; Kantam, M.L. 2009: N4-tetradentate dicarboxyamidate/dipyridyl palladium complexes as robust catalysts for the Heck reaction of deactivated aryl chlorides. Chemistry 15(7): 1578-1581
Amoruso, L.ía.; Gelormini, C.; Aboitiz, F.; Alvarez González, M.; Manes, F.; Cardona, J.F.; Ibanez, A.ín. 2013: N400 ERPs for actions: building meaning in context. Frontiers in Human Neuroscience 7: 57
Kuipers, J.R.; Thierry, G. 2011: N400 amplitude reduction correlates with an increase in pupil size. Frontiers in Human Neuroscience 5: 61
Baetens, K.; der Cruyssen, L.V.; Achtziger, A.; Vandekerckhove, M.; Van Overwalle, F. 2011: N400 and LPP in spontaneous trait inferences. Brain Research 1418: 83-92
Laurent, J.-P.; Kostova, M.; Passerieux, C. 2010: N400 and P300 modulation as functions of processing level in schizophrenia patients exhibiting formal thought disorder. International Journal of Psychophysiology: Official Journal of the International Organization of Psychophysiology 75(2): 177-182
Wang, L.; Ma, Q.; Song, Z.; Shi, Y.; Wang, Y.; Pfotenhauer, L. 2011: N400 and the activation of prejudice against rural migrant workers in China. Brain research 1375: 103-110
Wang, X.; Ma, Q.; Wang, C. 2012: N400 as an index of uncontrolled categorization processing in brand extension. Neuroscience Letters 525(1): 76-81
Chen, X-shi.; Tang, Y-xiang.; Xu, Y-feng.; Xiao, Z-ping.; Wang, J-jun.; Zhang, M-dao.; Lou, F-ying.; Chen, C. 2010: N400 changes elicited by Chinese sentences in first episode schizophrenia. Zhonghua Yi Xue Za Zhi 90(29): 2026-2029
Toivonen, M.; Rämä, P. 2009: N400 during recognition of voice identity and vocal affect. Neuroreport 20(14): 1245-1249
Balconi, M.; Vitaloni, S. 2014: N400 effect when a semantic anomaly is detected in action representation. A source localization analysis. Journal of Clinical Neurophysiology: Official Publication of the American Electroencephalographic Society 31(1): 58-64
Chen, X.-s.; Tang, Y.-x.; Xiao, Z.-p.; Wang, J.-j.; Zhang, M.-d.; Zhang, Z.-f.; Hu, Z.-y.; Lou, F.-y.; Chen, C.; Zhang, T.-h. 2010: N400 elicited by incongruent ending words of Chinese idioms in healthy adults. Chinese Medical Journal 123(6): 686-689
Mohammad, O.M.; DeLisi, L.E. 2013: N400 in schizophrenia patients. Current Opinion in Psychiatry 26(2): 196-207
Masuda, T.; Russell, M.J.; Chen, Y.Y.; Hioki, K.; Caplan, J.B. 2014: N400 incongruity effect in an episodic memory task reveals different strategies for handling irrelevant contextual information for Japanese than European Canadians. Cognitive neuroscience 5(1): 17-25
Germain-Mondon, V.ér.; Silvert, L.; Izaute, M. 2011: N400 modulation by categorical or associative interference in a famous face naming task. Neuroscience Letters 501(3): 188-192
Wang, Q.; Huang, H.; Mao, L. 2009: N400 repetition effect in unidentifiable Chinese characters: evidence for automatic process. Neuroreport 20(7): 723-728
Popescu, M.; Fey, M.E.; Lewine, J.D.; Finestack, L.H.; Popescu, E.-A. 2009: N400 responses of children with primary language disorder: intervention effects. Neuroreport 20(12): 1104-1108
Wang, Q.; Zhang, J. 2011: N400 solution effect of Chinese character fragments: an orthographic neighborhood size effect. Brain Research Bulletin 86(3-4): 179-188
Salisbury, D. 2010: N400 to lexical ambiguity and semantic incongruity in schizophrenia. International Journal of Psychophysiology: Official Journal of the International Organization of Psychophysiology 75(2): 127-132
Nigam, A.; Hoffman, J.E.; Simons, R.F. 1992: N400 to semantically anomalous pictures and words. Journal of Cognitive Neuroscience 4(1): 15-22
Bach, P.; Gunter, T.C.; Knoblich, G.; Prinz, W.; Friederici, A.D. 2009: N400-like negativities in action perception reflect the activation of two components of an action representation. Social Neuroscience 4(3): 212-232
Renoult, L.; Debruille, J.B. 2011: N400-like potentials and reaction times index semantic relations between highly repeated individual words. Journal of Cognitive Neuroscience 23(4): 905-922
Liu, C.; Yao, R.; Wang, Z.; Zhou, R. 2014: N450 as a candidate neural marker for interference control deficits in children with learning disabilities. International Journal of Psychophysiology: Official Journal of the International Organization of Psychophysiology 93(1): 70-77
Askary, A.; Masoudi-Nejad, A.; Sharafi, R.; Mizbani, A.; Parizi, S.N.; Purmasjedi, M. 2009: N4: a precise and highly sensitive promoter predictor using neural network fed by nearest neighbors. Genes and Genetic Systems 84(6): 425-430
Sharma, P.; Murillas, R.; Zhang, H.; Kuehn, M.R. 2010: N4BP1 is a newly identified nucleolar protein that undergoes SUMO-regulated polyubiquitylation and proteasomal turnover at promyelocytic leukemia nuclear bodies. Journal of Cell Science 123(Part 8): 1227-1234
Tustison, N.J.; Avants, B.B.; Cook, P.A.; Zheng, Y.; Egan, A.; Yushkevich, P.A.; Gee, J.C. 2010: N4ITK: improved N3 bias correction. IEEE Transactions on Medical Imaging 29(6): 1310-1320
Creason, G.L.; Gonzales, R.A. 1988: N5-Formyltetrahydrofolate counteracts methotrexate toxicity in tobacco cell culture. Plant Cell Reports 7(3): 182-185
Johnson, B.; Steadman, R.; Patefield, K.D.; Bunker, J.J.; Atkin, A.L.; Dussault, P. 2011: N5-phosphonoacetyl-L-ornithine (PALO): a convenient synthesis and investigation of influence on regulation of amino acid biosynthetic genes in Saccharomyces cerevisiae. Bioorganic and Medicinal Chemistry Letters 21(8): 2351-2353
Xiang, W.F.; Qiu, X.L.; Zhi, D.X.; Min, Z.X.; Yuan, L.; Quan, Y.Z. 2009: N546 in beta18-beta19 loop is important for binding and toxicity of the Bacillus thuringiensis Cry1Ac toxin. Journal of Invertebrate Pathology 101(2): 119-123
Li, X.; Fekner, T.; Chan, M.K. 2010: N6-(2-(R)-propargylglycyl)lysine as a clickable pyrrolysine mimic. Chemistry An Asian Journal 5(8): 1765-1769
Giorgi, I.; Biagi, G.; Bianucci, A.M.; Borghini, A.; Livi, O.; Leonardi, M.; Pietra, D.; Calderone, V.; Martelli, A. 2008: N6-1,3-diphenylurea derivatives of 2-phenyl-9-benzyladenines and 8-azaadenines: synthesis and biological evaluation as allosteric modulators of A2A adenosine receptors. European Journal of Medicinal Chemistry 43(8): 1639-1647
Franchetti, P.; Cappellacci, L.; Vita, P.; Petrelli, R.; Lavecchia, A.; Kachler, S.; Klotz, K.-N.; Marabese, I.; Luongo, L.; Maione, S.; Grifantini, M. 2009: N6-Cycloalkyl- and N6-bicycloalkyl-C5'(C2')-modified adenosine derivatives as high-affinity and selective agonists at the human A1 adenosine receptor with antinociceptive effects in mice. Journal of Medicinal Chemistry 52(8): 2393-2406
Starha, P.; Popa, I.; Trávníček, Z.ěk.; Vančo, J.án. 2013: N6-benzyladenosine derivatives as novel N-donor ligands of platinum(II) dichlorido complexes. Molecules 18(6): 6990-7003
Ciaglia, E.; Pisanti, S.; Picardi, P.; Laezza, C.; Sosa, S.; Tubaro, A.; Vitale, M.; Gazzerro, P.; Malfitano, A.M.; Bifulco, M. 2014: N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in mice. Pharmacological Research 89: 1-10
Castiglioni, S.; Casati, S.; Ottria, R.; Ciuffreda, P.; Maier, J.A.M. 2013: N6-isopentenyladenosine and its analogue N6-benzyladenosine induce cell cycle arrest and apoptosis in bladder carcinoma T24 cells. Anti-Cancer Agents in Medicinal Chemistry 13(4): 672-678
Bifulco, M.; D'Alessandro, A.; Paladino, S.; Malfitano, A.M.; Notarnicola, M.; Caruso, M.G.; Laezza, C. 2013: N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin a. Febs Journal 280(23): 6223-6232
Laezza, C.; Caruso, M.G.; Gentile, T.; Notarnicola, M.; Malfitano, A.M.; Di Matola, T.; Messa, C.; Gazzerro, P.; Bifulco, M. 2009: N6-isopentenyladenosine inhibits cell proliferation and induces apoptosis in a human colon cancer cell line DLD1. International Journal of Cancer 124(6): 1322-1329
Ciaglia, E.; Pisanti, S.; Picardi, P.; Laezza, C.; Malfitano, A.M.; D'Alessandro, A.; Gazzerro, P.; Vitale, M.; Carbone, E.; Bifulco, M. 2013: N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulation. Journal of Leukocyte Biology 94(6): 1207-1219
Cobo, J.; Trilleras, J.; Quiroga, J.; Marchal, A.; Nogueras, M.; Low, J.N.; Glidewell, C. 2008: N6-substituted 2-amino-4-chloro-5-formylpyrimidines: puckered versus planar pyrimidine rings, and hydrogen-bonded aggregation in zero, one, two and three dimensions. Acta Crystallographica. Section B Structural Science 64(Part 5): 596-609
Ashton, T.D.; Baker, S.P.; Hutchinson, S.A.; Scammells, P.J. 2008: N6-substituted C5'-modified adenosines as A1 adenosine receptor agonists. Bioorganic and Medicinal Chemistry 16(4): 1861-1873
Liu, P.; Zhao, L.; Xu, X.; Liu, F.; Zhang, W.; Zhou, C.; Chen, J.; Pan, Y.; Du, Y.; Yang, J.; Wang, Q. 2014: N6-substituted adenosine analogues, a novel class of JAK2 inhibitors, potently block STAT3 signaling in human cancer cells. Cancer Letters 354(1): 43-57
Liu, H.; Enyeart, J.A.; Enyeart, J.J. 2009: N6-substituted cAMP analogs inhibit bTREK-1 K+ channels and stimulate cortisol secretion by a protein kinase A-independent mechanism. Molecular Pharmacology 76(6): 1290-1301
Van Delft, J.H.; Luiten-Schuite, A.; Souliotis, V.L.; Kyrtopoulos, S.A.; Ouwerkerk, J.; Keizer, H.J.; Baan, R.A. 1996: N7-Methylguanine and O(6)-methylguanine levels in DNA of white blood cells from cancer patients treated with dacarbazine. Biomarkers: Biochemical Indicators of Exposure Response and Susceptibility to Chemicals 1(2): 94-98
Tomikawa, C.; Yokogawa, T.; Kanai, T.; Hori, H. 2010: N7-Methylguanine at position 46 (m7G46) in tRNA from Thermus thermophilus is required for cell viability at high temperatures through a tRNA modification network. Nucleic Acids Research 38(3): 942-957
Watzek, N.; Böhm, N.; Feld, J.; Scherbl, D.; Berger, F.; Merz, K.H.; Lampen, A.; Reemtsma, T.; Tannenbaum, S.R.; Skipper, P.L.; Baum, M.; Richling, E.; Eisenbrand, G. 2012: N7-glycidamide-guanine DNA adduct formation by orally ingested acrylamide in rats: a dose-response study encompassing human diet-related exposure levels. Chemical Research in Toxicology 25(2): 381-390
Yoon, H.-S.; Ho, X.-H.; Jang, J.; Lee, H.-J.; Kim, S.-J.; Jang, H.-Y. 2012: N719 dye-sensitized organophotocatalysis: enantioselective tandem Michael addition/oxyamination of aldehydes. Organic Letters 14(13): 3272-3275
Wu, Z.; Benchafia, E.M.; Iqbal, Z.; Wang, X. 2014: N8 (-) polynitrogen stabilized on multi-wall carbon nanotubes for oxygen-reduction reactions at ambient conditions. Angewandte Chemie 53(46): 12555-12559
Baek, J.O.; Kang, H.K.; Na, S.Y.; Lee, J.R.; Roh, J.Y.; Lee, J.H.; Kim, H.J.; Park, S. 2012: N822K c-kit mutation in CD30-positive cutaneous pleomorphic mastocytosis after germ cell tumour of the ovary. British Journal of Dermatology 166(6): 1370-1373
Rakocević-Stojanović, V.; Milić-Rasić, V.; Perić, S.; Baets, J.; Timmerman, V.; Dierick, I.; Pavlović, S.; De Jonghe, P. 2010: N88S mutation in the BSCL2 gene in a Serbian family with distal hereditary motor neuropathy type V or Silver syndrome. Journal of the Neurological Sciences 296(1-2): 107-109
Liu, H.-C.; Zheng, M.-H.; Du, Y.-L.; Wang, L.; Kuang, F.; Qin, H.-Y.; Zhang, B.-F.; Han, H. 2012: N9 microglial cells polarized by LPS and IL4 show differential responses to secondary environmental stimuli. Cellular Immunology 278(1-2): 84-90
Mik, V.ác.; Szüčová, L.; Spíchal, L.áš; Plíhal, O.ře.; Nisler, J.; Zahajská, L.; Doležal, K.; Strnad, M. 2011: N9-Substituted N⁶-[(3-methylbut-2-en-1-yl)amino]purine derivatives and their biological activity in selected cytokinin bioassays. Bioorganic and Medicinal Chemistry 19(23): 7244-7251
Drabczyńska, A.; Müller, C.E.; Karolak-Wojciechowska, J.; Schumacher, B.; Schiedel, A.; Yuzlenko, O.; Kieć-Kononowicz, K. 2007: N9-benzyl-substituted 1,3-dimethyl- and 1,3-dipropyl-pyrimido[2,1-f]purinediones: synthesis and structure-activity relationships at adenosine A1 and A2A receptors. Bioorganic and Medicinal Chemistry 15(14): 5003-5017
Plíhal, O.ře.; Szüčová, L.; Galuszka, P. 2013: N9-substituted aromatic cytokinins with negligible side effects on root development are an emerging tool for in vitro culturing. Plant Signaling and Behavior 8(6): E24392
Mik, V.ác.; Szüčová, L.; Smehilová, M.ár.; Zatloukal, M.; Doležal, K.; Nisler, J.; Grúz, J.ří; Galuszka, P.; Strnad, M.; Spíchal, L.áš 2011: N9-substituted derivatives of kinetin: effective anti-senescence agents. Phytochemistry 72(8): 821-831
Roberge, R.J.; Kim, J-Hyun.; Benson, S. 2012: N95 filtering facepiece respirator deadspace temperature and humidity. Journal of Occupational and Environmental Hygiene 9(3): 166-171
Roberge, R.J.; Kim, J.-H.; Powell, J.B. 2014: N95 respirator use during advanced pregnancy. American Journal of Infection Control 42(10): 1097-1100
Bessesen, M.T.; Savor-Price, C.; Simberkoff, M.; Reich, N.G.; Pavia, A.T.; Radonovich, L.J. 2013: N95 respirators or surgical masks to protect healthcare workers against respiratory infections: are we there yet?. American Journal of Respiratory and Critical Care Medicine 187(9): 904-905
Rengasamy, S.; Eimer, B.C. 2013: N95-companion measurement of cout/cin ratios for two n95 filtering facepiece respirators and one surgical mask. Journal of Occupational and Environmental Hygiene 10(10): 527-532
Kay, N.E.; Shanafelt, T.D.; Call, T.G.; Wu, W.; Laplant, B.R. 2009: N9986: a phase II trial of thalidomide in patients with relapsed chronic lymphocytic leukemia. Leukemia and Lymphoma 50(4): 588-592
García, Jús.; Madrid, C.; Cendra, M.; Juárez, A.; Pons, M. 2009: N9L and L9N mutations toggle Hha binding and hemolysin regulation by Escherichia coli and Vibrio cholerae H-NS. Febs Letters 583(17): 2911-2916
Matzek, V.; Vitousek, P.M. 2009: N:P stoichiometry and protein:RNA ratios in vascular plants: an evaluation of the growth-rate hypothesis. Ecology Letters 12(8): 765-771
Lossani, A.; Savi, L.; Manikowski, A.; Maioli, A.; Gambino, J.; Focher, F.; Spadari, S.; Wright, G.E. 2012: N2-Phenyl-9-(hydroxyalkyl)guanines and related compounds are substrates for Herpes simplex virus thymidine kinases. Journal of Molecular Biochemistry 1(1): 21-25
McAllister, M.; Oprescu, F.; Jones, C. 2013: N 2 E: Envisioning a process to support transition from nurse to educator. Contemporary Nurse 2013
Beem, C.; Rastelli, L.; van Rees, B.C. 2013: N=4 superconformal bootstrap. Physical Review Letters 111(7): 071601
Liu, G.; Khlobystov, A.N.; Charalambidis, G.; Coutsolelos, A.G.; Briggs, G.Andrew.D.; Porfyrakis, K. 2012: N@C60-porphyrin: a dyad of two radical centers. Journal of the American Chemical Society 134(4): 1938-1941
Bozhok, Y.; Greenebaum, E.; Bogdanova, T.I.; McConnell, R.J.; Zelinskaya, A.; Brenner, A.V.; Zurnadzhy, L.Y.; Zablotska, L.; Tronko, M.D.; Hatch, M. 2009: NA cohort study of thyroid cancer and other thyroid diseases after the Chernobyl accident: cytohistopathologic correlation and accuracy of fine-needle aspiration biopsy in nodules detected during the first screening in Ukraine (1998-2000). Cancer 117(2): 73-81
Chen, Q.; Huang, S.; Chen, J.; Zhang, S.; Chen, Z. 2013: NA proteins of influenza a viruses H1N1/2009, H5N1, and H9N2 show differential effects on infection initiation, virus release, and cell-cell fusion. Plos one 8(1): E54334
Vitezić, D.; Pelcić, J.M.ć; Zupan, G.; Vitezić, M.; Ljubicić, D.; Simonić, A. 2008: NA+, K+-ATPase activity in the brain of the rats with kainic acid-induced seizures: influence of lamotrigine. Psychiatria Danubina 20(3): 269-276
Madonna, R.; Montebello, E.; Lazzerini, G.; Zurro, M.; De Caterina, R. 2010: NA+/H+ exchanger 1- and aquaporin-1-dependent hyperosmolarity changes decrease nitric oxide production and induce VCAM-1 expression in endothelial cells exposed to high glucose. International Journal of Immunopathology and Pharmacology 23(3): 755-765
Xu, G.; He, Q.; Shou, Z.; Wang, H.; Zhang, X.; Wang, Y.; Chen, Y.; Chen, J. 2007: NA1/NA2 heterozygote of Fcgr3b is a risk factor for progression of IgA nephropathy in Chinese. Journal of Clinical Laboratory Analysis 21(5): 298-302
Castellano, G.; Dias, C.S.B.; Foerster, B.; Li, L.M.; Covolan, R.J.M. 2012: NAA and NAAG variation in neuronal activation during visual stimulation. Brazilian Journal of Medical and Biological Research 45(11): 1031-1036
Zaichick, V.; Zaichick, S. 2013: NAA-SLR and ICP-AES application in the assessment of mass fraction of 19 chemical elements in pediatric and young adult prostate glands. Biological Trace Element Research 156(1-3): 357-366
Anonymous 1961: NAACP 1961 Health Resolutions. Journal of the National Medical Association 53(6): 648-649
Anonymous 1953: NAACP's Resolutions on Health, 1953. Journal of the National Medical Association 45(6): 438-439
Davis, L.C.; Morgan, A.J.; Chen, J.-L.; Snead, C.M.; Bloor-Young, D.; Shenderov, E.; Stanton-Humphreys, M.N.; Conway, S.J.; Churchill, G.C.; Parrington, J.; Cerundolo, V.; Galione, A. 2012: NAADP activates two-pore channels on T cell cytolytic granules to stimulate exocytosis and killing. Current Biology: Cb 22(24): 2331-2337
Arndt, L.; Castonguay, J.; Arlt, E.; Meyer, D.; Hassan, S.; Borth, H.; Zierler, S.; Wennemuth, G.; Breit, A.; Biel, M.; Wahl-Schott, C.; Gudermann, T.; Klugbauer, N.; Boekhoff, I. 2014: NAADP and the two-pore channel protein 1 participate in the acrosome reaction in mammalian spermatozoa. Molecular Biology of the Cell 25(6): 948-964
Galione, A.; Morgan, A.J.; Arredouani, A.; Davis, L.C.; Rietdorf, K.; Ruas, M.; Parrington, J. 2010: NAADP as an intracellular messenger regulating lysosomal calcium-release channels. Biochemical Society Transactions 38(6): 1424-1431
Collins, T.P.; Bayliss, R.; Churchill, G.C.; Galione, A.; Terrar, D.A. 2011: NAADP influences excitation-contraction coupling by releasing calcium from lysosomes in atrial myocytes. Cell Calcium 50(5): 449-458
Esposito, B.; Gambara, G.; Lewis, A.M.; Palombi, F.; D'Alessio, A.; Taylor, L.X.; Genazzani, A.A.; Ziparo, E.; Galione, A.; Churchill, G.C.; Filippini, A. 2011: NAADP links histamine H1 receptors to secretion of von Willebrand factor in human endothelial cells. Blood 117(18): 4968-4977
Barceló-Torns, M.; Lewis, A.M.; Gubern, A.; Barneda, D.; Bloor-Young, D.; Picatoste, F.; Churchill, G.C.; Claro, E.; Masgrau, R. 2011: NAADP mediates ATP-induced Ca2+ signals in astrocytes. Febs Letters 585(14): 2300-2306
Song, E-Kyung.; Lee, Y-Rae.; Kim, Y-Ri.; Yeom, J-Hyun.; Yoo, C-Hwa.; Kim, H-Kag.; Park, H-Min.; Kang, H-Sub.; Kim, J-Suk.; Kim, U-Hyun.; Han, M-Kwan. 2012: NAADP mediates insulin-stimulated glucose uptake and insulin sensitization by PPARγ in adipocytes. Cell reports 2(6): 1607-1619
Hooper, R.; Patel, S. 2012: NAADP on target. Advances in Experimental Medicine and Biology 740: 325-347
Galione, A. 2011: NAADP receptors. Cold Spring Harbor Perspectives in Biology 3(1): A004036
Thai, T.L.; Churchill, G.C.; Arendshorst, W.J. 2009: NAADP receptors mediate calcium signaling stimulated by endothelin-1 and norepinephrine in renal afferent arterioles. American Journal of Physiology. Renal Physiology 297(2): F510-F516
Coxon, C.H.; Lewis, A.M.; Sadler, A.J.; Vasudevan, S.R.; Thomas, A.; Dundas, K.A.; Taylor, L.; Campbell, R.D.; Gibbins, J.M.; Churchill, G.C.; Tucker, K.L. 2012: NAADP regulates human platelet function. Biochemical Journal 441(1): 435-442
Guse, A.H.; Ernst, I.M.A.; Fliegert, R. 2013: NAADP signaling revisited. Current Topics in Medicinal Chemistry 13(23): 2978-2990
Gambara, G.; Billington, R.A.; Debidda, M.; D'Alessio, A.; Palombi, F.; Ziparo, E.; Genazzani, A.A.; Filippini, A. 2008: NAADP-induced Ca(2+ signaling in response to endothelin is via the receptor subtype B and requires the integrity of lipid rafts/caveolae. Journal of Cellular Physiology 216(2): 396-404
Dammermann, W.; Zhang, B.; Nebel, M.; Cordiglieri, C.; Odoardi, F.; Kirchberger, T.; Kawakami, N.; Dowden, J.; Schmid, F.; Dornmair, K.; Hohenegger, M.; Flügel, A.; Guse, A.H.; Potter, B.V.L. 2009: NAADP-mediated Ca2+ signaling via type 1 ryanodine receptor in T cells revealed by a synthetic NAADP antagonist. Proceedings of the National Academy of Sciences of the United States of America 106(26): 10678-10683
Brailoiu, G.C.; Brailoiu, E.; Parkesh, R.; Galione, A.; Churchill, G.C.; Patel, S.; Dun, N.J. 2009: NAADP-mediated channel 'chatter' in neurons of the rat medulla oblongata. Biochemical Journal 419(1): 91
Pereira, G.J.S.; Hirata, H.; do Carmo, L.úc.G.; Stilhano, R.S.; Ureshino, R.P.; Medaglia, N.C.; Han, S.W.; Churchill, G.; Bincoletto, C.; Patel, S.; Smaili, S.S. 2014: NAADP-sensitive two-pore channels are present and functional in gastric smooth muscle cells. Cell Calcium 56(2): 51-58
Lu, Y.; Hao, B.; Graeff, R.; Yue, J. 2013: NAADP/TPC2/Ca(2+) Signaling Inhibits Autophagy. Communicative and Integrative Biology 6(6): E27595
Guse, A.H.; Lee, H.C. 2008: NAADP: a universal Ca2+ trigger. Science Signaling 1(44): Re10
Yamada, T.; Zuo, D.; Yamamoto, T.; Olszewski, R.T.; Bzdega, T.; Moffett, J.R.; Neale, J.H. 2013: NAAG peptidase inhibition in the periaqueductal gray and rostral ventromedial medulla reduces flinching in the formalin model of inflammation. Molecular Pain 8: 67
Bergeron, R.; Coyle, J.T. 2012: NAAG, NMDA receptor and psychosis. Current Medicinal Chemistry 19(9): 1360-1364
McKinzie, D.L.; Li, T.K.; McBride, W.J.; Slusher, B.S. 2000: NAALADase inhibition reduces alcohol consumption in the alcohol-preferring (P) line of rats. Addiction Biology 5(4): 411-416
Anonymous 2013: NAB2-STAT6 fusions are a hallmark of solitary fibrous tumors. Cancer Discovery 3(3): OF18
Kim, C.-K.; Seol, Y.-J.; Lee, D.-J.; Jeong, I.-S.; Yoon, U.-H.; Lee, G.-S.; Hahn, J.-H.; Park, D.-S. 2013: NABIC marker database: a molecular markers information network of agricultural crops. Bioinformation 9(17): 887-888
Traynor, K. 2013: NABP to inspect compounding pharmacies. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 70(2): 88-90
Anonymous 2007: NABP/ASCP joint report: model rules for long-term care pharmacy practice. Consultant pharmacist: the journal of the American Society of Consultant Pharmacists 22(7): 604-609
Budevsky, O.; Zikolova, T.; Tencheva, J. 1988: NABTIT-a computer program for non-aqueous acid-base titration. Talanta 35(11): 899-905
Sergie, Z.; Mehran, R. 2012: NAC and CIN prevention: mounting evidence of inefficacy. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 79(6): 927-928
Raza, H.; John, A.; Shafarin, J. 2014: NAC attenuates LPS-induced toxicity in aspirin-sensitized mouse macrophages via suppression of oxidative stress and mitochondrial dysfunction. Plos one 9(7): E103379
Zhang, Y.; Berndt, U.; Gölz, H.; Tais, A.; Oellerer, S.; Wölfle, T.; Fitzke, E.; Rospert, S. 2012: NAC functions as a modulator of SRP during the early steps of protein targeting to the endoplasmic reticulum. Molecular Biology of the Cell 23(16): 3027-3040
Jensen, M.K.; Kjaersgaard, T.; Petersen, K.; Skriver, K. 2010: NAC genes: time-specific regulators of hormonal signaling in Arabidopsis. Plant Signaling and Behavior 5(7): 907-910
Puranik, S.; Sahu, P.P.; Srivastava, P.S.; Prasad, M. 2012: NAC proteins: regulation and role in stress tolerance. Trends in Plant Science 17(6): 369-381
Jensen, M.K.; Skriver, K. 2014: NAC transcription factor gene regulatory and protein-protein interaction networks in plant stress responses and senescence. Iubmb Life 66(3): 156-166
Satheesh, V.; Jagannadham, P.T.K.; Chidambaranathan, P.; Jain, P.K.; Srinivasan, R. 2014: NAC transcription factor genes: genome-wide identification, phylogenetic, motif and cis-regulatory element analysis in pigeonpea (Cajanus cajan (L.) Millsp.). Molecular Biology Reports 41(12): 7763-7773
Rauf, M.; Arif, M.; Fisahn, J.; Xue, G.-P.; Balazadeh, S.; Mueller-Roeber, B. 2013: NAC transcription factor speedy hyponastic growth regulates flooding-induced leaf movement in Arabidopsis. Plant Cell 25(12): 4941-4955
Lip, S.; Kurowska, M.; Szarejko, I. 2013: NAC transcription factors family and increased tolerance to water deficiency in plants. Postepy Biochemii 59(3): 295-304
Nakashima, K.; Takasaki, H.; Mizoi, J.; Shinozaki, K.; Yamaguchi-Shinozaki, K. 2012: NAC transcription factors in plant abiotic stress responses. Biochimica et Biophysica Acta 1819(2): 97-103
Monticone, M.; Taherian, R.; Stigliani, S.; Carra, E.; Monteghirfo, S.; Longo, L.; Daga, A.; Dono, M.; Zupo, S.; Giaretti, W.; Castagnola, P. 2014: NAC, tiron and trolox impair survival of cell cultures containing glioblastoma tumorigenic initiating cells by inhibition of cell cycle progression. Plos one 9(2): E90085
Zhang, Y.; Yang, J.W.; Ren, X.; Yang, J.-M. 2011: NAC1 and HMGB1 enter a partnership for manipulating autophagy. Autophagy 7(12): 1557-1558
Yap, K.L.; Fraley, S.I.; Thiaville, M.M.; Jinawath, N.; Nakayama, K.; Wang, J.; Wang, T.-L.; Wirtz, D.; Shih, I.-M. 2012: NAC1 is an actin-binding protein that is essential for effective cytokinesis in cancer cells. Cancer Research 72(16): 4085-4096
Korutla, L.; Furlong, H.A.; Mackler, S.A. 2014: NAC1, A POZ/BTB protein interacts with Parkin and may contribute to Parkinson's disease. Neuroscience 257: 86-95
Rahman, M.T.; Nakayama, K.; Ishikawa, M.; Rahman, M.; Katagiri, H.; Katagiri, A.; Ishibashi, T.; Iida, K.; Yamada, T.; Miyazaki, K. 2012: NAC1, a BTB/POZ protein overexpressed in uterine sarcomas. Anticancer Research 32(9): 3841-3845
Ishikawa, M.; Nakayama, K.; Yeasmin, S.; Katagiri, A.; Iida, K.; Nakayama, N.; Miyazaki, K. 2010: NAC1, a potential stem cell pluripotency factor expression in normal endometrium, endometrial hyperplasia and endometrial carcinoma. International Journal of Oncology 36(5): 1097-1103
Gupta, A.K.; Chan, G.M.; Greller, H.A.; Su, M.K. 2009: NAC: still the way to go. Critical Care 13(3): 411; Author Reply 411
Chuk, M. 2008: NACCHO helps local health departments adapt to the ever-changing field of environmental health. Journal of public health management and practice: JPHMP 14(6): 605-607
Leep, C.J.; Bhutta, C.Brickman. 2012: NACCHO monitors the financial health of local health departments: new tools make financial data more accessible to public health practitioners. Journal of public health management and practice: JPHMP 18(4): 393-395
Wood, S. 2010: NACCHO resources help local health departments fight obesity. Journal of public health management and practice: JPHMP 16(5): 472-473
Hofrichter, R. 2008: NACCHO's Health Equity Campaign: dialogue to action. Journal of public health management and practice: JPHMP 14(1): 80-81
Leep, C.J.; Shah, G.H. 2012: NACCHO's National Profile of Local Health Departments study: the premier source of data on local health departments for surveillance, research, and policymaking. Journal of public health management and practice: JPHMP 18(2): 186-189
Green, T.; Berktold, J. 2014: NACCHO's national community of practice support for local evidenced-based chronic disease self-management program. Journal of public health management and practice: JPHMP 20(5): 551-553
Richards, M. 2013: NACCHO's roots of health inequity curriculum encourages commitment to tackling social injustice. Journal of public health management and practice: JPHMP 19(5): 497-500
Gómez-Caravaca, A.M.ía.; Carrasco-Pancorbo, A.ía.; Segura-Carretero, A.; Fernández-Gutiérrez, A. 2009: NACE-ESI-TOF MS to reveal phenolic compounds from olive oil: introducing enriched olive oil directly inside capillary. Electrophoresis 30(17): 3099-3109
Warshawsky, B. 2014: NACI update on pertussis vaccination in pregnancy. Canadian Family Physician Medecin de Famille Canadien 60(6): 521
Weaver, K.L.; Alves-Guerra, M.-C.; Jin, K.; Wang, Z.; Han, X.; Ranganathan, P.; Zhu, X.; DaSilva, T.; Liu, W.; Ratti, F.; Demarest, R.M.; Tzimas, C.; Rice, M.; Vasquez-Del Carpio, R.; Dahmane, N.; Robbins, D.J.; Capobianco, A.J. 2014: NACK is an integral component of the Notch transcriptional activation complex and is critical for development and tumorigenesis. Cancer Research 74(17): 4741-4751
Manchester, C. 2013: NACNS newsletter: president's message. Clinical nurse specialist CNS 27(2): 55-58
Manchester, C. 2013: NACNS newsletter: president's message. Clinical nurse specialist CNS 27(6): 277-280
John, T.J. 2008: NACO and phony NGOs in India. Indian Journal of Medical Research 128(6): 778-779
Pace, D.G.; Bagasra, O. 2008: NACO must clean up phony NGOs in India. Indian Journal of Medical Research 128(1): 87-88
Muren, L.P.; Teräs, M.; Knuuti, J. 2014: NACP 2014 and the Turku PET symposium: the interaction between therapy and imaging. Acta Oncologica 53(8): 993-996
Lenz, B.; Sysk, C.; Thuerauf, N.; Clepce, M.; Reich, K.; Frieling, H.; Winterer, G.; Bleich, S.; Kornhuber, J. 2011: NACP-Rep1 relates to Beck Depression Inventory scores in healthy humans. Journal of Molecular Neuroscience: Mn 44(1): 41-47
Alekseeva, A.A.; Savin, S.S.; Tishkov, V.I. 2011: NAD (+) -dependent Formate Dehydrogenase from Plants. Acta Naturae 3(4): 38-54
Wang, J.; He, Z. 2009: NAD and axon degeneration: from the Wlds gene to neurochemistry. Cell Adhesion and Migration 3(1): 77-87
Pankiewicz, K.W. 2011: NAD and its role in biology and medicine. Current Medicinal Chemistry 18(13): 1890
Mei, S.-C.; Brenner, C. 2013: NAD as a genotype-specific drug target. Chemistry and Biology 20(11): 1307-1308
Wu, M.-F.; Yin, J.-H.; Hwang, C.-S.; Tang, C.-M.; Yang, D.-I. 2014: NAD attenuates oxidative DNA damages induced by amyloid beta-peptide in primary rat cortical neurons. Free Radical Research 48(7): 794-805
Lima, W.C.; Varani, A.M.; Menck, C.F.M. 2009: NAD biosynthesis evolution in bacteria: lateral gene transfer of kynurenine pathway in Xanthomonadales and Flavobacteriales. Molecular Biology and Evolution 26(2): 399-406
Zhuo, L.; Fu, B.; Bai, X.; Zhang, B.; Wu, L.; Cui, J.; Cui, S.; Wei, R.; Chen, X.; Cai, G. 2011: NAD blocks high glucose induced mesangial hypertrophy via activation of the sirtuins-AMPK-mTOR pathway. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 27(6): 681-690
Warszta, D.; Nebel, M.; Fliegert, R.; Guse, A.H. 2014: NAD derived second messengers: Role in spontaneous diastolic Ca(2+) transients in murine cardiac myocytes. Dna Repair 23: 69-78
Sorci, L.; Ruggieri, S.; Raffaelli, N. 2014: NAD homeostasis in the bacterial response to DNA/RNA damage. Dna Repair 23: 17-26
Benavente, C.A.; Jacobson, M.K.; Jacobson, E.L. 2009: NAD in skin: therapeutic approaches for niacin. Current Pharmaceutical Design 15(1): 29-38
Wang, J.; Yang, J.; Liu, P.; Bi, X.; Li, C.; Zhu, K. 2012: NAD induces astrocyte calcium flux and cell death by ART2 and P2X7 pathway. American Journal of Pathology 181(3): 746-752
Gray, J.P.; Alavian, K.N.; Jonas, E.A.; Heart, E.A. 2012: NAD kinase regulates the size of the NADPH pool and insulin secretion in pancreatic β-cells. American Journal of Physiology. Endocrinology and Metabolism 303(2): E191-E199
Di Stefano, G.; Manerba, M.; Vettraino, M. 2013: NAD metabolism and functions: a common therapeutic target for neoplastic, metabolic and neurodegenerative diseases. Current Topics in Medicinal Chemistry 13(23): 2918-2929
Micheli, V.; Jacomelli, G.; Di Marcello, F.; Notarantonio, L.; Sestini, S.; Cerboni, B.; Bertelli, M.; Pompucci, G.; Jinnah, H.A. 2009: NAD metabolism in HPRT-deficient mice. Metabolic Brain Disease 24(2): 311-319
Smiri, M.êz.; Chaoui, A.; Rouhier, N.; Gelhaye, E.; Jacquot, J.-P.; El Ferjani, E. 2010: NAD pattern and NADH oxidase activity in pea (Pisum sativum L.) under cadmium toxicity. Physiology and Molecular Biology of Plants: An International Journal of Functional Plant Biology 16(3): 305-315
Schemies, J.ör.; Uciechowska, U.; Sippl, W.; Jung, M. 2010: NAD(+) -dependent histone deacetylases (sirtuins) as novel therapeutic targets. Medicinal Research Reviews 30(6): 861-889
Kim, H.-J.; Oh, G.-S.; Choe, S.-K.; Kwak, T.H.; Park, R.; So, H.-S. 2014: NAD(+) Metabolism in Age-Related Hearing Loss. Aging and Disease 5(2): 150-159
Wang, B.; Ma, Y.; Kong, X.; Ding, X.; Gu, H.; Chu, T.; Ying, W. 2014: NAD(+) administration decreases doxorubicin-induced liver damage of mice by enhancing antioxidation capacity and decreasing DNA damage. Chemico-Biological Interactions 212: 65-71
Zheng, C.; Han, J.; Xia, W.; Shi, S.; Liu, J.; Ying, W. 2012: NAD(+) administration decreases ischemic brain damage partially by blocking autophagy in a mouse model of brain ischemia. Neuroscience Letters 512(2): 67-71
Sheng, C.; Chen, H.; Wang, B.; Liu, T.; Hong, Y.; Shao, J.; He, X.; Ma, Y.; Nie, H.; Liu, N.; Xia, W.; Ying, W. 2012: NAD(+) administration significantly attenuates synchrotron radiation X-ray-induced DNA damage and structural alterations of rodent testes. International Journal of Physiology Pathophysiology and Pharmacology 4(1): 1-9
Hipkiss, A.R. 2010: NAD(+) and metabolic regulation of age-related proteoxicity: a possible role for methylglyoxal?. Experimental Gerontology 45(6): 395-399
Gossmann, T.I.; Ziegler, M.; Puntervoll, P.ål.; de Figueiredo, L.F.; Schuster, S.; Heiland, I. 2012: NAD(+) biosynthesis and salvage--a phylogenetic perspective. Febs Journal 279(18): 3355-3363
Hong, Y.; Nie, H.; Wu, D.; Wei, X.; Ding, X.; Ying, W. 2014: NAD(+) treatment prevents rotenone-induced apoptosis and necrosis of differentiated PC12 cells. Neuroscience Letters 560: 46-50
Borradaile, N.M.; Pickering, J.G. 2009: NAD(+), sirtuins, and cardiovascular disease. Current Pharmaceutical Design 15(1): 110-117
Dwivedi, N.; Dube, D.; Pandey, J.; Singh, B.; Kukshal, V.; Ramachandran, R.; Tripathi, R.P. 2008: NAD(+)-dependent DNA ligase: a novel target waiting for the right inhibitor. Medicinal Research Reviews 28(4): 545-568
Cerutti, R.; Pirinen, E.; Lamperti, C.; Marchet, S.; Sauve, A.A.; Li, W.; Leoni, V.; Schon, E.A.; Dantzer, F.ço.; Auwerx, J.; Viscomi, C.; Zeviani, M. 2014: NAD(+)-dependent activation of Sirt1 corrects the phenotype in a mouse model of mitochondrial disease. Cell Metabolism 19(6): 1042-1049
Seiler, N.; Wagner, G. 1976: NAD(+)-dependent formation ofγ-aminobutyrate (GABA) from glutamate. Neurochemical Research 1(1): 113-131
Li, Y.; Liu, L.; Tian, P. 2014: NAD(+)-independent aldehyde oxidase catalyzes cofactor balanced 3-hydroxypropionic acid production in Klebsiella pneumoniae. Biotechnology Letters 36(11): 2215-2221
Kwak, M.-K.; Ku, M.; Kang, S.-O. 2014: NAD(+)-linked alcohol dehydrogenase 1 regulates methylglyoxal concentration in Candida albicans. Febs Letters 588(7): 1144-1153
Freeman, R.; Willner, I. 2009: NAD(+)/NADH-sensitive quantum dots: applications to probe NAD(+)-dependent enzymes and to sense the RDX explosive. Nano Letters 9(1): 322-326
Horch, M.; Lauterbach, L.; Lenz, O.; Hildebrandt, P.; Zebger, I. 2012: NAD(H)-coupled hydrogen cycling - structure-function relationships of bidirectional [NiFe] hydrogenases. Febs Letters 586(5): 545-556
Mukherjee, S.; Sen Santara, S.; Das, S.; Bose, M.; Roy, J.; Adak, S. 2012: NAD(P)H cytochrome b5 oxidoreductase deficiency in Leishmania major results in impaired linoleate synthesis followed by increased oxidative stress and cell death. Journal of Biological Chemistry 287(42): 34992-35003
Izzicupo, P.; Di Valerio, V.; D' Amico, M.A.; Di Mauro, M.; Pennelli, A.; Falone, S.; Alberti, G.; Amicarelli, F.; Miscia, S.; Gallina, S.; Di Baldassarre, A. 2010: NAD(P)H oxidase and pro-inflammatory response during maximal exercise: role of C242T polymorphism of the P22PHOX subunit. International Journal of Immunopathology and Pharmacology 23(1): 203-211
Maldonado, P.D.; Molina-Jijón, E.; Villeda-Hernández, J.; Galván-Arzate, S.; Santamaría, A.; Pedraza-Chaverrí, J. 2010: NAD(P)H oxidase contributes to neurotoxicity in an excitotoxic/prooxidant model of Huntington's disease in rats: protective role of apocynin. Journal of Neuroscience Research 88(3): 620-629
Maraldi, T.; Prata, C.; Vieceli Dalla Sega, F.; Caliceti, C.; Zambonin, L.; Fiorentini, D.; Hakim, G. 2009: NAD(P)H oxidase isoform Nox2 plays a prosurvival role in human leukaemia cells. Free Radical Research 43(11): 1111-1121
Bondi, C.D.; Manickam, N.; Lee, D.Y.; Block, K.; Gorin, Y.; Abboud, H.E.; Barnes, J.L. 2010: NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts. Journal of the American Society of Nephrology: Jasn 21(1): 93-102
Gallina, S.; Di Francescomarino, S.; Di Mauro, M.; Izzicupo, P.; D'Angelo, E.; D'Amico, M.A.; Pennelli, A.; Amicarelli, F.; Di Baldassarre, A. 2012: NAD(P)H oxidase p22(phox) polymorphism and cardiovascular function in amateur runners. Acta Physiologica 206(1): 20-28
Graciano, M.F.R.; Santos, L.R.B.; Curi, R.; Carpinelli, A.R. 2011: NAD(P)H oxidase participates in the palmitate-induced superoxide production and insulin secretion by rat pancreatic islets. Journal of Cellular Physiology 226(4): 1110-1117
Zhang, W.; Rojas, M.; Lilly, B.; Tsai, N.-T.; Lemtalsi, T.; Liou, G.I.; Caldwell, R.W.; Caldwell, R.B. 2009: NAD(P)H oxidase-dependent regulation of CCL2 production during retinal inflammation. Investigative Ophthalmology and Visual Science 50(6): 3033-3040
Zhou, X.; Bohlen, H.G.; Miller, S.J.; Unthank, J.L. 2008: NAD(P)H oxidase-derived peroxide mediates elevated basal and impaired flow-induced NO production in SHR mesenteric arteries in vivo. American Journal of Physiology. Heart and Circulatory Physiology 295(3): H1008-H1016
Trott, D.W.; Seawright, J.W.; Luttrell, M.J.; Woodman, C.R. 2011: NAD(P)H oxidase-derived reactive oxygen species contribute to age-related impairments of endothelium-dependent dilation in rat soleus feed arteries. Journal of Applied Physiology 110(5): 1171-1180
Zhu, D.; Hu, C.; Sheng, W.; Tan, K.S.; Haidekker, M.A.; Sun, A.Y.; Sun, G.Y.; Lee, J.C.-M. 2009: NAD(P)H oxidase-mediated reactive oxygen species production alters astrocyte membrane molecular order via phospholipase A2. Biochemical Journal 421(2): 201-210
Arora, S.; Vaishya, R.; Dabla, P.K.; Singh, B. 2010: NAD(P)H oxidases in coronary artery disease. Advances in Clinical Chemistry 50: 65-86
Yang, F.-Y.; Guan, Q.-K.; Cui, Y.-H.; Zhao, Z.-Q.; Rao, W.; Xi, Z. 2012: NAD(P)H quinone oxidoreductase 1 (NQO1) genetic C609T polymorphism is associated with the risk of digestive tract cancer: a meta-analysis based on 21 case-control studies. European Journal of Cancer Prevention: the Official Journal of the European Cancer Prevention Organisation 21(5): 432-441
Nakae, K.; Adachi, H.; Sawa, R.; Hosokawa, N.; Hatano, M.; Igarashi, M.; Nishimura, Y.; Akamatsu, Y.; Nomoto, A. 2013: NAD(P)H quinone oxidoreductase 1 (NQO1)-bioactivated pronqodine a regulates prostaglandin release from human synovial sarcoma cells. Journal of Natural Products 76(4): 510-515
Voynow, J.A.; Fischer, B.M.; Zheng, S.; Potts, E.N.; Grover, A.R.; Jaiswal, A.K.; Ghio, A.J.; Foster, W.M. 2009: NAD(P)H quinone oxidoreductase 1 is essential for ozone-induced oxidative stress in mice and humans. American Journal of Respiratory Cell and Molecular Biology 41(1): 107-113
Hershkovitz Rokah, O.; Shpilberg, O.; Granot, G. 2010: NAD(P)H quinone oxidoreductase protects TAp63gamma from proteasomal degradation and regulates TAp63gamma-dependent growth arrest. Plos one 5(6): E11401
Alard, A.; Fabre, B.; Anesia, R.; Marboeuf, C.; Pierre, P.; Susini, C.; Bousquet, C.; Pyronnet, Séphane. 2010: NAD(P)H quinone-oxydoreductase 1 protects eukaryotic translation initiation factor 4GI from degradation by the proteasome. Molecular and Cellular Biology 30(4): 1097-1105
Oliveira, H.C.; Saviani, E.E.; Salgado, I. 2009: NAD(P)H- and superoxide-dependent nitric oxide degradation by rat liver mitochondria. Febs Letters 583(13): 2276-2280
Petrovova, M.; Tkadlec, J.; Dvoracek, L.; Streitova, E.; Licha, I. 2014: NAD(P)H-hydrate dehydratase- a metabolic repair enzyme and its role in Bacillus subtilis stress adaptation. Plos one 9(11): E112590
Winkler, C.K.; Clay, D.; Entner, M.; Plank, M.; Faber, K. 2014: NAD(P)H-independent asymmetric C=C bond reduction catalyzed by ene reductases by using artificial co-substrates as the hydrogen donor. Chemistry 20(5): 1403-1409
Li, Y.-F.; Tseng, P.-J.; Lin, C.-C.; Hung, C.-L.; Lin, S.-C.; Su, W.-C.; Huang, Y.-L.; Sung, F.-C.; Tai, C.-K. 2009: NAD(P)H: Quinone oxidoreductase 1, glutathione S-transferase M1, environmental tobacco smoke exposure, and childhood asthma. Mutation Research 678(1): 53-58
Zhu, C-Lin.; Huang, Q.; Liu, C-Hai.; Lin, X-Sheng.; Xie, F.; Shao, F. 2013: NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T gene polymorphism association with digestive tract cancer: a meta-analysis. Asian Pacific journal of cancer prevention: APJCP 14(4): 2349-2354
Lee, J.; Kim, K.S.; Lee, M.H.; Kim, Y.S.; Lee, M.H.; Lee, S.E.; Kim, Y.K.; Ryu, M.J.; Kim, S.J.; Choi, M.J.; Jo, Y.S. 2013: NAD(P)H: quinone oxidoreductase 1 and NRH:quinone oxidoreductase 2 polymorphisms in papillary thyroid microcarcinoma: correlation with phenotype. Yonsei Medical Journal 54(5): 1158-1167
Zhu, H.; Li, Y. 2012: NAD(P)H: quinone oxidoreductase 1 and its potential protective role in cardiovascular diseases and related conditions. Cardiovascular Toxicology 12(1): 39-45
Das, A.; Dey, N.; Ghosh, A.; Das, T.; Chatterjee, I.B. 2011: NAD(P)H: quinone oxidoreductase 1 deficiency conjoint with marginal vitamin C deficiency causes cigarette smoke induced myelodysplastic syndromes. Plos one 6(5): E20590
Dinkova-Kostova, A.T.; Talalay, P. 2010: NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector. Archives of Biochemistry and Biophysics 501(1): 116-123
Bruge, F.; Virgili, S.; Cacciamani, T.; Principi, F.; Tiano, L.; Littarru, G.P. 2008: NAD(P)H:quinone oxidoreductase (NQO1) loss of function in Burkitt's lymphoma cell lines. Biofactors 32(1-4): 71-81
Stoehr, C.G.; Nolte, E.; Wach, S.; Wieland, W.F.; Hofstaedter, F.; Hartmann, A.; Stoehr, R. 2012: NAD(P)H:quinone oxidoreductase 1 (NQO1) P187S polymorphism and prostate cancer risk in Caucasians. International Journal of Molecular Sciences 13(9): 10959-10969
Sameer, A.S.; Shah, Z.A.; Syeed, N.; Rasool, R.; Afroze, D.; Siddiqi, M.A. 2010: NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population. Asian Pacific Journal of Cancer Prevention: Apjcp 11(1): 209-213
Xu, J.; Jaiswal, A.K. 2012: NAD(P)H:quinone oxidoreductase 1 (NQO1) competes with 20S proteasome for binding with C/EBPα leading to its stabilization and protection against radiation-induced myeloproliferative disease. Journal of Biological Chemistry 287(50): 41608-41618
Siegel, D.; Kepa, J.K.; Ross, D. 2012: NAD(P)H:quinone oxidoreductase 1 (NQO1) localizes to the mitotic spindle in human cells. Plos one 7(9): E44861
Singh, S.; Zahid, M.; Saeed, M.; Gaikwad, N.W.; Meza, J.L.; Cavalieri, E.L.; Rogan, E.G.; Chakravarti, D. 2009: NAD(P)H:quinone oxidoreductase 1 Arg139Trp and Pro187Ser polymorphisms imbalance estrogen metabolism towards DNA adduct formation in human mammary epithelial cells. Journal of Steroid Biochemistry and Molecular Biology 117(1-3): 56-66
Hubackova, M.; Vaclavikova, R.; Mrhalova, M.; Kubackova, K.; Kodet, R.; Gut, I.; Soucek, P. 2009: NAD(P)H:quinone oxidoreductase 1 Pro187Ser polymorphism and expression do not cosegregate with clinico-pathological characteristics of human mammary tumors. Pharmacogenetics and Genomics 19(7): 505-512
Kim, Y-Hoon.; Hwang, J.Hwan.; Kim, K-Shim.; Noh, J-Ran.; Gang, G-Tae.; Seo, Y.; Nam, K-Hoan.; Kwak, T.Hwan.; Lee, H.Gu.; Lee, C-Ho. 2015: NAD(P)H:quinone oxidoreductase 1 activation reduces blood pressure through regulation of endothelial nitric oxide synthase acetylation in spontaneously hypertensive rats. American Journal of Hypertension 28(1): 50-57
Morrissy, S.; Strom, J.; Purdom-Dickinson, S.; Chen, Q.M. 2012: NAD(P)H:quinone oxidoreductase 1 is induced by progesterone in cardiomyocytes. Cardiovascular Toxicology 12(2): 108-114
Patrick, B.A.; Das, A.; Jaiswal, A.K. 2012: NAD(P)H:quinone oxidoreductase 1 protects bladder epithelium against painful bladder syndrome in mice. Free Radical Biology and Medicine 53(10): 1886-1893
Potts-Kant, E.N.; Li, Z.; Tighe, R.M.; Lindsey, J.Y.; Frush, B.W.; Foster, W.Michael.; Hollingsworth, J.W. 2012: RETRACTED: NAD(P)H:quinone oxidoreductase 1 protects lungs from oxidant-induced emphysema in mice. Free Radical Biology and Medicine 52(3): 705-715
Zhou, H.; Dehn, D.; Kepa, J.K.; Siegel, D.; Scott, D.E.; Tan, W.; Ross, D. 2010: NAD(P)H:quinone oxidoreductase 1-compromised human bone marrow endothelial cells exhibit decreased adhesion molecule expression and CD34+ hematopoietic cell adhesion. Journal of Pharmacology and Experimental Therapeutics 334(1): 260-268
Levova, K.; Moserova, M.; Nebert, D.W.; Phillips, D.H.; Frei, E.; Schmeiser, H.H.; Arlt, V.M.; Stiborova, M. 2012: NAD(P)H:quinone oxidoreductase expression in Cyp1a-knockout and CYP1A-humanized mouse lines and its effect on bioactivation of the carcinogen aristolochic acid I. Toxicology and Applied Pharmacology 265(3): 360-367
Cui, X.; Jin, T.; Wang, X.; Jin, G.; Li, Z.; Lin, L. 2014: NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer. Oncology Reports 32(6): 2589-2595
Tamsett, T.J.; Picchione, K.E.; Bhattacharjee, A. 2009: NAD+ activates KNa channels in dorsal root ganglion neurons. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 29(16): 5127-5134
Magnifico, Sébastien.; Saias, L.; Deleglise, Bérangère.; Duplus, E.; Kilinc, D.; Miquel, M-Christine.; Viovy, J-Louis.; Brugg, B.; Peyrin, J-Michel. 2013: NAD+ acts on mitochondrial SirT3 to prevent axonal caspase activation and axonal degeneration. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 27(12): 4712-4722
Scheuplein, F.; Schwarz, N.; Adriouch, S.; Krebs, C.; Bannas, P.; Rissiek, B.ör.; Seman, M.; Haag, F.; Koch-Nolte, F. 2009: NAD+ and ATP released from injured cells induce P2X7-dependent shedding of CD62L and externalization of phosphatidylserine by murine T cells. Journal of Immunology 182(5): 2898-2908
Ying, W. 2008: NAD+ and NADH in ischemic brain injury. Frontiers in Bioscience: a Journal and Virtual Library 13: 1141-1151
Harkcom, W.T.; Ghosh, A.K.; Sung, M.S.; Matov, A.; Brown, K.D.; Giannakakou, P.; Jaffrey, S.R. 2014: NAD+ and SIRT3 control microtubule dynamics and reduce susceptibility to antimicrotubule agents. Proceedings of the National Academy of Sciences of the United States of America 111(24): E2443-E2452
Siegel, C.S.; McCullough, L.D. 2013: NAD+ and nicotinamide: sex differences in cerebral ischemia. Neuroscience 237: 223-231
Imai, S.-i.; Guarente, L. 2014: NAD+ and sirtuins in aging and disease. Trends in Cell Biology 24(8): 464-471
Cantó, C.; Auwerx, J. 2011: NAD+ as a signaling molecule modulating metabolism. Cold Spring Harbor Symposia on Quantitative Biology 76: 291-298
Vilchèze, C.; Weinrick, B.; Wong, K.-W.; Chen, B.; Jacobs, W.R. 2010: NAD+ auxotrophy is bacteriocidal for the tubercle bacilli. Molecular Microbiology 76(2): 365-377
Hipkiss, A.R. 2009: NAD+ availability and proteotoxicity. Neuromolecular Medicine 11(2): 97-100
Goody, M.F.; Kelly, M.W.; Reynolds, C.J.; Khalil, A.; Crawford, B.D.; Henry, C.A. 2012: NAD+ biosynthesis ameliorates a zebrafish model of muscular dystrophy. Plos Biology 10(10): E1001409
Wiley, C.; Campisi, J. 2014: NAD+ controls neural stem cell fate in the aging brain. EMBO Journal 33(12): 1289-1291
Prolla, T.A.; Denu, J.M. 2014: NAD+ deficiency in age-related mitochondrial dysfunction. Cell Metabolism 19(2): 178-180
Alano, C.C.; Garnier, P.; Ying, W.; Higashi, Y.; Kauppinen, T.M.; Swanson, R.A. 2010: NAD+ depletion is necessary and sufficient for poly(ADP-ribose) polymerase-1-mediated neuronal death. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 30(8): 2967-2978
Siegel, C.; McCullough, L.D. 2011: NAD+ depletion or PAR polymer formation: which plays the role of executioner in ischaemic cell death?. Acta Physiologica 203(1): 225-234
Magnone, M.; Bauer, I.; Poggi, A.; Mannino, E.; Sturla, L.; Brini, M.; Zocchi, E.; De Flora, A.; Nencioni, A.; Bruzzone, S. 2012: NAD+ levels control Ca2+ store replenishment and mitogen-induced increase of cytosolic Ca2+ by Cyclic ADP-ribose-dependent TRPM2 channel gating in human T lymphocytes. Journal of Biological Chemistry 287(25): 21067-21081
Massudi, H.; Grant, R.; Guillemin, G.J.; Braidy, N. 2012: NAD+ metabolism and oxidative stress: the golden nucleotide on a crown of thorns. Redox Report: Communications in Free Radical Research 17(1): 28-46
Ocampo, A.; Liu, J.; Barrientos, A. 2013: NAD+ salvage pathway proteins suppress proteotoxicity in yeast models of neurodegeneration by promoting the clearance of misfolded/oligomerized proteins. Human Molecular Genetics 22(9): 1699-1708
Zhao, C.; Hong, Y.; Han, J.; Ma, Y.; Chen, H.; Xia, W.; Ying, W. 2011: NAD+ treatment decreases tumor cell survival by inducing oxidative stress. Frontiers in Bioscience 3(2): 434-441
Salmina, A.B.; Inzhutova, A.I.; Morgun, A.V.; Okuneva, O.S.; Malinovskaia, N.A.; Lopatina, O.L.; Petrova, M.M.; Taranushenko, T.E.; Fursov, A.A.; Kuvacheva, N.V. 2012: NAD+-converting enzymes in neuronal and glial cells: CD38 as a novel target for neuroprotection. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 10: 29-37
Hughes, D.; Otani, T.; Yang, P.; Newman, R.A.; Yantiss, R.K.; Altorki, N.K.; Port, J.L.; Yan, M.; Markowitz, S.D.; Mazumdar, M.; Tai, H.-H.; Subbaramaiah, K.; Dannenberg, A.J. 2008: NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer. Cancer Prevention Research 1(4): 241-249
Liu, T.Fu.; Yoza, B.K.; El Gazzar, M.; Vachharajani, V.T.; McCall, C.E. 2011: NAD+-dependent SIRT1 deacetylase participates in epigenetic reprogramming during endotoxin tolerance. Journal of Biological Chemistry 286(11): 9856-9864
Yang, Y.; Cimen, H.; Han, M.-J.; Shi, T.; Deng, J.-H.; Koc, H.; Palacios, O.M.; Montier, L.; Bai, Y.; Tong, Q.; Koc, E.C. 2010: NAD+-dependent deacetylase SIRT3 regulates mitochondrial protein synthesis by deacetylation of the ribosomal protein MRPL10. Journal of Biological Chemistry 285(10): 7417-7429
Aguilera, L.; Giménez, R.; Badia, J.; Aguilar, J.; Baldoma, L. 2009: NAD+-dependent post-translational modification of Escherichia coli glyceraldehyde-3-phosphate dehydrogenase. International Microbiology: the Official Journal of the Spanish Society for Microbiology 12(3): 187-192
Liu, T.Fu.; Vachharajani, V.T.; Yoza, B.K.; McCall, C.E. 2012: NAD+-dependent sirtuin 1 and 6 proteins coordinate a switch from glucose to fatty acid oxidation during the acute inflammatory response. Journal of Biological Chemistry 287(31): 25758-25769
Ying, W. 2008: NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxidants and Redox Signaling 10(2): 179-206
Felczak, K.; Vince, R.; Pankiewicz, K.W. 2014: NAD-based inhibitors with anticancer potential. Bioorganic and Medicinal Chemistry Letters 24(1): 332-336
Picchianti, M.; Russo, C.; Castagnini, M.; Biagini, M.; Soldaini, E.; Balducci, E. 2015: NAD-dependent ADP-ribosylation of the human antimicrobial and immune-modulatory peptide LL-37 by ADP-ribosyltransferase-1. Innate Immunity 21(3): 314-321
Zhao, R.; Zheng, S.; Duan, C.; Liu, F.; Yang, L.; Huo, G. 2013: NAD-dependent lactate dehydrogenase catalyses the first step in respiratory utilization of lactate by Lactococcus lactis. Febs Open Bio 3: 379-386
Gao, C.; Jiang, T.; Dou, P.; Ma, C.; Li, L.; Kong, J.; Xu, P. 2012: NAD-independent L-lactate dehydrogenase is required for L-lactate utilization in Pseudomonas stutzeri SDM. Plos one 7(5): E36519
Tronconi, M.A.; Gerrard Wheeler, M.C.; Maurino, V.ón.G.; Drincovich, M.ía.F.; Andreo, C.S. 2010: NAD-malic enzymes of Arabidopsis thaliana display distinct kinetic mechanisms that support differences in physiological control. Biochemical Journal 430(2): 295-303
Ghosh, S.; George, S.; Roy, U.; Ramachandran, D.; Kolthur-Seetharam, U. 2010: NAD: a master regulator of transcription. Biochimica et Biophysica Acta 1799(10-12): 681-693
Pétriacq, P.; de Bont, L.; Tcherkez, G.; Gakière, B. 2013: NAD: not just a pawn on the board of plant-pathogen interactions. Plant Signaling and Behavior 8(1): E22477
Santiago, M.'e.B.; Vélez, M.M.; Borrero, S.; Díaz, A.ín.; Casillas, C.A.; Hofmann, C.; Guadalupe, A.R.; Colón, J.L. 2006: NADH Electrooxidation Using Bis(1,10-phenanthroline-5,6-dione) (2,2'-bipyridine)ruthenium(II)-Exchanged Zirconium Phosphate Modified Carbon Paste Electrodes. Electroanalysis 18(6): 559-572
Sasaki, Y.; Horiuchi, H.; Kawashima, H.; Mukai, T.; Yamamoto, Y. 2014: NADH Oxidase of Streptococcus thermophilus 1131 is Required for the Effective Yogurt Fermentation with Lactobacillus delbrueckii subsp. bulgaricus 2038. Bioscience of Microbiota Food and Health 33(1): 31-40
Tsvetkov, P.; Myers, N.; Eliav, R.; Adamovich, Y.; Hagai, T.; Adler, J.; Navon, A.; Shaul, Y. 2014: NADH binds and stabilizes the 26S proteasomes independent of ATP. Journal of Biological Chemistry 289(16): 11272-11281
Wengrowski, A.M.; Kuzmiak-Glancy, S.; Jaimes, R.; Kay, M.W. 2014: NADH changes during hypoxia, ischemia, and increased work differ between isolated heart preparations. American Journal of Physiology. Heart and Circulatory Physiology 306(4): H529-H537
Morgan, M.A.; Markus, B.; Hermkens, M.; Damm, F.; Reinhardt, D.; Zimmermann, M.; Thol, F.; Bunke, T.; Bogoeva, D.; Reuter, C.W.M.; de Haas, V.; van den Heuvel-Eibrink, M.M.; Zwaan, C.M.; Reinhardt, K. 2013: NADH dehydrogenase subunit 4 variant sequences in childhood acute myeloid leukaemia. British Journal of Haematology 161(6): 891-895
Kokaze, A.; Yoshida, M.; Ishikawa, M.; Matsunaga, N.; Karita, K.; Ohtsu, T.; Ochiai, H.; Shirasawa, T.; Nanri, H.; Baba, Y.; Hoshino, H.; Takashima, Y. 2014: NADH dehydrogenase subunit-2 237 Leu/Met polymorphism modifies effects of cigarette smoking on risk of elevated levels of serum liver enzyme in male Japanese health check-up examinees: a cross-sectional study. Tobacco Induced Diseases 12(1): 11
Kokaze, A.; Ishikawa, M.; Matsunaga, N.; Yoshida, M.; Satoh, M.; Teruya, K.; Masuda, Y.; Honmyo, R.; Uchida, Y.; Takashima, Y. 2007: NADH dehydrogenase subunit-2 237 Leu/Met polymorphism modifies the effects of alcohol consumption on risk for hypertension in middle-aged Japanese men. Hypertension Research: Official Journal of the Japanese Society of Hypertension 30(3): 213-218
Kokaze, A.; Ishikawa, M.; Matsunaga, N.; Karita, K.; Yoshida, M.; Ohtsu, T.; Shirasawa, T.; Sekii, H.; Ito, T.; Kawamoto, T.; Takashima, Y. 2009: NADH dehydrogenase subunit-2 237 Leu/Met polymorphism modulates the effects of coffee consumption on the risk of hypertension in middle-aged Japanese men. Journal of Epidemiology 19(5): 231-236
Gai, P.-P.; Zhao, C.-E.; Wang, Y.; Abdel-Halim, E.S.; Zhang, J.-R.; Zhu, J.-J. 2014: NADH dehydrogenase-like behavior of nitrogen-doped graphene and its application in NAD(+)-dependent dehydrogenase biosensing. Biosensors and Bioelectronics 62: 170-176
Wright, B.K.; Andrews, L.M.; Markham, J.; Jones, M.R.; Stringari, C.; Digman, M.A.; Gratton, E. 2012: NADH distribution in live progenitor stem cells by phasor-fluorescence lifetime image microscopy. Biophysical Journal 103(1): L7-L9
Su, G.-C.; Wei, Y.-H.; Wang, H.-W. 2011: NADH fluorescence as a photobiological metric in 5-aminolevlinic acid (ALA)-photodynamic therapy. Optics Express 19(22): 21145-21154
Asfour, H.; Wengrowski, A.M.; Jaimes, R.; Swift, L.M.; Kay, M.W. 2012: NADH fluorescence imaging of isolated biventricular working rabbit hearts. Journal of Visualized Experiments: Jove 2012(65)
Gonnella, T.P.; Leedahl, T.S.; Karlstad, J.P.; Picklo, M.J. 2011: NADH fluorescence lifetime analysis of the effect of magnesium ions on ALDH2. Chemico-Biological Interactions 191(1-3): 147-152
Srivastava, A.K.; Volesky, B. 1991: NADH fluorscence in a carbon-limited fermentation. Biotechnology and Bioengineering 38(2): 191-195
Lv, C.; Bai, Y.; Yang, S.; Zhao, G.; Chen, B. 2013: NADH induces iron release from pea seed ferritin: a model for interaction between coenzyme and protein components in foodstuffs. Food Chemistry 141(4): 3851-3858
Cortial, S.; Chaignon, P.; Iorga, B.I.; Aymerich, S.ép.; Truan, G.; Gueguen-Chaignon, V.; Meyer, P.; Moréra, S.; Ouazzani, J. 2010: NADH oxidase activity of Bacillus subtilis nitroreductase NfrA1: insight into its biological role. Febs Letters 584(18): 3916-3922
Muchnik, L.; Adawi, A.; Ohayon, A.; Dotan, S.; Malka, I.; Azriel, S.; Shagan, M.; Portnoi, M.; Kafka, D.; Nahmani, H.; Porgador, A.; Gershoni, J.M.; Gershoni, J.M.; Morrison, D.A.; Mitchell, A.; Tal, M.; Ellis, R.; Dagan, R.; Nebenzahl, Y.M. 2013: NADH oxidase functions as an adhesin in Streptococcus pneumoniae and elicits a protective immune response in mice. Plos one 8(4): E61128
Lin, P.-C.; Puhar, A.; Steuber, J. 2008: NADH oxidation drives respiratory Na+ transport in mitochondria from Yarrowia lipolytica. Archives of Microbiology 190(4): 471-480
Fu, J.; Wang, Z.; Chen, T.; Liu, W.; Shi, T.; Wang, G.; Tang, Y.-j.; Zhao, X. 2014: NADH plays the vital role for chiral pure D-(-)-2,3-butanediol production in Bacillus subtilis under limited oxygen conditions. Biotechnology and Bioengineering 111(10): 2126-2131
Percy, M.J.; Aslan, D. 2008: NADH-cytochrome b5 reductase in a Turkish family with recessive congenital methaemoglobinaemia type i. Journal of Clinical Pathology 61(10): 1122-1123
Knudsen, J.D.; Carlquist, M.; Gorwa-Grauslund, M. 2014: NADH-dependent biosensor in Saccharomyces cerevisiae: principle and validation at the single cell level. Amb Express 4: 81
Konishi, N.; Ishiyama, K.; Matsuoka, K.; Maru, I.; Hayakawa, T.; Yamaya, T.; Kojima, S. 2014: NADH-dependent glutamate synthase plays a crucial role in assimilating ammonium in the Arabidopsis root. Physiologia Plantarum 152(1): 138-151
Antosiewicz, J.; Spodnik, J.H.; Teranishi, M.; Herman-Antosiewicz, A.; Kurono, C.; Soji, T.; Woźniak, M.; Borkowska, A.; Wakabayashi, T. 2009: NADH-generating substrates reduce peroxyl radical toxicity in RL-34 cells. Folia Morphologica 68(4): 247-255
Vinogradov, A.D. 2008: NADH/NAD+ interaction with NADH: ubiquinone oxidoreductase (complex I). Biochimica et Biophysica Acta 1777(7-8): 729-734
Griendling, K.K.; Ushio-Fukai, M. 1997: NADH/NADPH Oxidase and Vascular Function. Trends in Cardiovascular Medicine 7(8): 301-307
Liu, J.; Yin, Y.; Song, Z.; Li, Y.; Jiang, S.; Shao, C.; Wang, Z. 2014: NADH: flavin oxidoreductase/NADH oxidase and ROS regulate microsclerotium development in Nomuraea rileyi. World Journal of Microbiology and Biotechnology 30(7): 1927-1935
Joro, R.; Dastidar, P.; Iivonen, V.; Ylänen, H.; Soimakallio, S. 2012: NADINE: new approaches to detecting breast cancer by sequential μm-wavelength imaging with the aid of novel frequency analysis techniques. Journal of Medical Engineering and Technology 36(5): 251-260
Firsanov, D.V.; Kropotov, A.V.; Mikhaĭlov, V.M. 2011: NADP increases the level of histone H2AX phosphorylation in mouse heart cells after ionizing radiation. Tsitologiia 53(4): 355-358
Shvets, V.N.; Davydov, V.V. 2007: NADP pool state and activity of NADP-dependent dehydrogenases in the heart tissue of adult and old rats during immobilization stress. Ukrains'kyi Biokhimichnyi Zhurnal 79(2): 50-54
Delorme, R.M.; Skorupska, H.T. 1993: NADP(+) glyceraldehyde-3-phosphate dehydrogenase in soybeans [Glycine max (L.) Merr.]: genetics and developmental expression. Tag. Theoretical and Applied Genetics. Theoretische und Angewandte Genetik 85(6-7): 851-856
Baldewpersad Tewarie, N.M.S.; Burgers, I.A.V.; Dawood, Y.; den Boon, H.C.; den Brok, M.G.H.E.; Klunder, J.H.; Koopmans, K.B.; Rademaker, E.; van den Broek, H.B.; van den Bersselaar, S.M.; Witjes, J.J.; Van Noorden, C.J.F.; Atai, N.A. 2013: NADP+ -dependent IDH1 R132 mutation and its relevance for glioma patient survival. Medical Hypotheses 80(6): 728-731
González, B.; Garrido, F.; Ortega, R.; Martínez-Júlvez, M.; Revilla-Guarinos, A.; Pérez-Pertejo, Y.; Velázquez-Campoy, A.án.; Sanz-Aparicio, J.; Pajares, M.ía.A. 2012: NADP+ binding to the regulatory subunit of methionine adenosyltransferase Ii increases intersubunit binding affinity in the hetero-trimer. Plos one 7(11): E50329
Wang, S.; Huang, H.; Moll, J.; Thauer, R.K. 2010: NADP+ reduction with reduced ferredoxin and NADP+ reduction with NADH are coupled via an electron-bifurcating enzyme complex in Clostridium kluyveri. Journal of Bacteriology 192(19): 5115-5123
Mayoral, J.G.; Nouzova, M.; Navare, A.; Noriega, F.G. 2009: NADP+-dependent farnesol dehydrogenase, a corpora allata enzyme involved in juvenile hormone synthesis. Proceedings of the National Academy of Sciences of the United States of America 106(50): 21091-21096
Jaaska, V. 1978: NADP-dependent aromatic alcohol dehydrogenase in polyploid wheats and their diploid relatives. on the origin and phylogeny of polyploid wheats. TAG. Theoretical and Applied Genetics. Theoretische und Angewandte Genetik 53(5): 209-217
Leterrier, M.; Barroso, J.B.; Valderrama, R.; Palma, Jé.M.; Corpas, F.J. 2012: NADP-dependent isocitrate dehydrogenase from Arabidopsis roots contributes in the mechanism of defence against the nitro-oxidative stress induced by salinity. Thescientificworldjournal 2012: 694740
De Angelis, M.; Calasso, M.; Di Cagno, R.; Siragusa, S.; Minervini, F.; Gobbetti, M. 2010: NADP-glutamate dehydrogenase activity in nonstarter lactic acid bacteria: effects of temperature, pH and NaCl on enzyme activity and expression. Journal of Applied Microbiology 109(5): 1763-1774
Wang, S.; Huang, H.; Kahnt, J.ör.; Mueller, A.P.; Köpke, M.; Thauer, R.K. 2013: NADP-specific electron-bifurcating [FeFe]-hydrogenase in a functional complex with formate dehydrogenase in Clostridium autoethanogenum grown on CO. Journal of Bacteriology 195(19): 4373-4386
Mustapha, N.M.; Tarr, J.M.; Kohner, E.M.; Chibber, R. 2010: NADPH Oxidase versus Mitochondria-Derived ROS in Glucose-Induced Apoptosis of Pericytes in Early Diabetic Retinopathy. Journal of Ophthalmology 2010: 746978
Dovhanj, J.; Kljaic, K.; Smolic, M.; Svagelj, D. 2010: NADPH and iron may have an important role in attenuated mucosal defense in Helicobacter pylori infection?. Mini Reviews in Medicinal Chemistry 10(14): 1309-1315
Skinner, J.R.; Ren, M.; Chan, K.K.; Stay, B. 2000: NADPH diaphorase and nitric oxide synthase in the corpus cardiacum-corpus allatum of the cockroach Diploptera punctata. Arthropod Structure and Development 29(1): 85-94
Kauny, J.; Sétif, P. 2014: NADPH fluorescence in the cyanobacterium Synechocystis sp. PCC 6803: a versatile probe for in vivo measurements of rates, yields and pools. Biochimica et Biophysica Acta 1837(6): 792-801
Zuris, J.A.; Ali, S.S.; Yeh, H.; Nguyen, T.A.; Nechushtai, R.; Paddock, M.L.; Jennings, P.A. 2012: NADPH inhibits [2Fe-2S] cluster protein transfer from diabetes drug target MitoNEET to an apo-acceptor protein. Journal of Biological Chemistry 287(15): 11649-11655
Jaquet, V.; Marcoux, J.; Forest, E.; Leidal, K.G.; McCormick, S.; Westermaier, Y.; Perozzo, R.; Plastre, O.; Fioraso-Cartier, L.; Diebold, B.; Scapozza, L.; Nauseef, W.M.; Fieschi, F.; Krause, K.-H.; Bedard, K. 2011: NADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action. British Journal of Pharmacology 164(2b): 507-520
Marrali, G.; Casale, F.; Salamone, P.; Fuda, G.; Caorsi, C.; Amoroso, A.; Brunetti, M.; Restagno, G.; Barberis, M.; Bertuzzo, D.; Canosa, A.; Moglia, C.; Calvo, A.; Chiò, A. 2014: NADPH oxidase (NOX2) activity is a modifier of survival in ALS. Journal of Neurology 261(11): 2178-2183
Fu, X.-J.; Peng, Y.-B.; Hu, Y.-P.; Shi, Y.-Z.; Yao, M.; Zhang, X. 2014: NADPH oxidase 1 and its derived reactive oxygen species mediated tissue injury and repair. Oxidative Medicine and Cellular Longevity 2014: 282854
Sadok, A.; Pierres, A.; Dahan, L.; Prévôt, C.; Lehmann, M.; Kovacic, H.é 2009: NADPH oxidase 1 controls the persistence of directed cell migration by a Rho-dependent switch of alpha2/alpha3 integrins. Molecular and Cellular Biology 29(14): 3915-3928
Basset, O.; Deffert, C.; Foti, M.; Bedard, K.; Jaquet, V.; Ogier-Denis, E.; Krause, K.-H. 2009: NADPH oxidase 1 deficiency alters caveolin phosphorylation and angiotensin II-receptor localization in vascular smooth muscle. Antioxidants and Redox Signaling 11(10): 2371-2384
Muzaffar, S.; Shukla, N.; Massey, Y.; Angelini, G.D.; Jeremy, J.Y. 2011: NADPH oxidase 1 mediates upregulation of thromboxane A2 synthase in human vascular smooth muscle cells: inhibition with iloprost. European Journal of Pharmacology 658(2-3): 187-192
Cristóvão, A.C.; Guhathakurta, S.; Bok, E.; Je, G.; Yoo, S.D.; Choi, D.-H.; Kim, Y.-S. 2012: NADPH oxidase 1 mediates α-synucleinopathy in Parkinson's disease. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 32(42): 14465-14477
Coant, N.; Ben Mkaddem, S.; Pedruzzi, E.; Guichard, C.éc.; Tréton, X.; Ducroc, R.; Freund, J.-N.; Cazals-Hatem, D.; Bouhnik, Y.; Woerther, P.-L.; Skurnik, D.; Grodet, A.; Fay, M.èl.; Biard, D.; Lesuffleur, T.éc.; Deffert, C.; Moreau, R.; Groyer, A.é; Krause, K.-H.; Daniel, F.; Ogier-Denis, E. 2010: NADPH oxidase 1 modulates WNT and NOTCH1 signaling to control the fate of proliferative progenitor cells in the colon. Molecular and Cellular Biology 30(11): 2636-2650
Choi, D.-H.; Lee, K.-H.; Kim, J.-H.; Seo, J.-H.; Kim, H.Y.; Shin, C.Y.; Han, J.-S.; Han, S.-H.; Kim, Y.-S.; Lee, J. 2014: NADPH oxidase 1, a novel molecular source of ROS in hippocampal neuronal death in vascular dementia. Antioxidants and Redox Signaling 21(4): 533-550
Choi, D.-H.; Cristóvão, A.C.; Guhathakurta, S.; Lee, J.; Joh, T.H.; Beal, M.F.; Kim, Y.-S. 2012: NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson's disease. Antioxidants and Redox Signaling 16(10): 1033-1045
Yang, C.-S.; Shin, D.-M.; Kim, K.-H.; Lee, Z.-W.; Lee, C.-H.; Park, S.G.; Bae, Y.S.; Jo, E.-K. 2009: NADPH oxidase 2 interaction with TLR2 is required for efficient innate immune responses to mycobacteria via cathelicidin expression. Journal of Immunology 182(6): 3696-3705
Wagner, S.; Dantz, C.; Flebbe, H.; Azizian, A.; Sag, C.M.; Engels, S.; Möllencamp, J.; Dybkova, N.; Islam, T.; Shah, A.M.; Maier, L.S. 2014: NADPH oxidase 2 mediates angiotensin II-dependent cellular arrhythmias via PKA and CaMKIi. Journal of Molecular and Cellular Cardiology 75: 206-215
Khan, S.A.; Nanduri, J.; Yuan, G.; Kinsman, B.; Kumar, G.K.; Joseph, J.; Kalyanaraman, B.; Prabhakar, N.R. 2011: NADPH oxidase 2 mediates intermittent hypoxia-induced mitochondrial complex I inhibition: relevance to blood pressure changes in rats. Antioxidants and Redox Signaling 14(4): 533-542
Jiao, J.; Dou, L.; Li, M.; Lu, Y.; Guo, H.-B.; Man, Y.; Wang, S.; Li, J. 2012: NADPH oxidase 2 plays a critical role in dysfunction and apoptosis of pancreatic β-cells induced by very low-density lipoprotein. Molecular and Cellular Biochemistry 370(1-2): 103-113
Li, M.; Dou, L.; Jiao, J.; Lu, Y.; Guo, H.-B.; Man, Y.; Wang, S.; Li, J. 2012: NADPH oxidase 2-derived reactive oxygen species are involved in dysfunction and apoptosis of pancreatic β-cells induced by low density lipoprotein. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 30(2): 439-449
Kim, D.; You, B.; Jo, E-Kyeong.; Han, S-Kyou.; Simon, M.I.; Lee, S.Joong. 2010: NADPH oxidase 2-derived reactive oxygen species in spinal cord microglia contribute to peripheral nerve injury-induced neuropathic pain. Proceedings of the National Academy of Sciences of the United States of America 107(33): 14851-14856
Yuan, H.; Zhang, X.; Huang, X.; Lu, Y.; Tang, W.; Man, Y.; Wang, S.; Xi, J.; Li, J. 2010: NADPH oxidase 2-derived reactive oxygen species mediate FFAs-induced dysfunction and apoptosis of β-cells via JNK, p38 MAPK and p53 pathways. Plos one 5(12): E15726
Lin, C-Chung.; Hsieh, H-Lung.; Shih, R-Horng.; Chi, P-Ling.; Cheng, S-Ei.; Chen, J-Chung.; Yang, C-Mao. 2012: NADPH oxidase 2-derived reactive oxygen species signal contributes to bradykinin-induced matrix metalloproteinase-9 expression and cell migration in brain astrocytes. Cell Communication and Signaling: Ccs 10(1): 35
Choi, S.; Kim, J.A.; Na, H.-Y.; Kim, J.-E.; Park, S.; Han, K.-H.; Kim, Y.J.; Suh, S.H. 2013: NADPH oxidase 2-derived superoxide downregulates endothelial KCa3.1 in preeclampsia. Free Radical Biology and Medicine 57: 10-21
Kuroda, J.; Ago, T.; Matsushima, S.; Zhai, P.; Schneider, M.D.; Sadoshima, J. 2010: NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proceedings of the National Academy of Sciences of the United States of America 107(35): 15565-15570
Yamaura, M.; Mitsushita, J.; Furuta, S.; Kiniwa, Y.; Ashida, A.; Goto, Y.; Shang, W.H.; Kubodera, M.; Kato, M.; Takata, M.; Saida, T.; Kamata, T. 2009: NADPH oxidase 4 contributes to transformation phenotype of melanoma cells by regulating G2-M cell cycle progression. Cancer Research 69(6): 2647-2654
Féraille, E.; Dizin, E.; Roth, I.; Derouette, J.-P.; Szanto, I.; Martin, P.-Y.; de Seigneux, S.; Hasler, U. 2014: NADPH oxidase 4 deficiency reduces aquaporin-2 mRNA expression in cultured renal collecting duct principal cells via increased PDE3 and PDE4 activity. Plos one 9(1): E87239
Zhang, Y.; Shimizu, H.; Siu, K.L.; Mahajan, A.; Chen, J.-N.; Cai, H. 2014: NADPH oxidase 4 induces cardiac arrhythmic phenotype in zebrafish. Journal of Biological Chemistry 289(33): 23200-23208
Graham, K.A.; Kulawiec, M.; Owens, K.M.; Li, X.; Desouki, M.M.; Chandra, D.; Singh, K.K. 2010: NADPH oxidase 4 is an oncoprotein localized to mitochondria. Cancer Biology and Therapy 10(3): 223-231
Barman, S.A.; Chen, F.; Su, Y.; Dimitropoulou, C.; Wang, Y.; Catravas, J.D.; Han, W.; Orfi, L.; Szantai-Kis, C.; Keri, G.; Szabadkai, I.; Barabutis, N.; Rafikova, O.; Rafikov, R.; Black, S.M.; Jonigk, D.; Giannis, A.; Asmis, R.; Stepp, D.W.; Ramesh, G.; Fulton, D.J.R. 2014: NADPH oxidase 4 is expressed in pulmonary artery adventitia and contributes to hypertensive vascular remodeling. Arteriosclerosis Thrombosis and Vascular Biology 34(8): 1704-1715
Ginnan, R.; Jourd'heuil, F.L.; Guikema, B.; Simons, M.; Singer, H.A.; Jourd'heuil, D. 2013: NADPH oxidase 4 is required for interleukin-1β-mediated activation of protein kinase Cδ and downstream activation of c-jun N-terminal kinase signaling in smooth muscle. Free Radical Biology and Medicine 54: 125-134
Goettsch, C.; Babelova, A.; Trummer, O.; Erben, R.G.; Rauner, M.; Rammelt, S.; Weissmann, N.; Weinberger, V.; Benkhoff, S.; Kampschulte, M.; Obermayer-Pietsch, B.; Hofbauer, L.C.; Brandes, R.P.; Schröder, K. 2013: NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis. Journal of Clinical Investigation 123(11): 4731-4738
Martin-Garrido, A.; Brown, D.I.; Lyle, A.N.; Dikalova, A.; Seidel-Rogol, B.; Lassègue, B.; San Martín, A.; Griendling, K.K. 2011: NADPH oxidase 4 mediates TGF-β-induced smooth muscle α-actin via p38MAPK and serum response factor. Free Radical Biology and Medicine 50(2): 354-362
Meng, D.; Mei, A.; Liu, J.; Kang, X.; Shi, X.; Qian, R.; Chen, S. 2012: NADPH oxidase 4 mediates insulin-stimulated HIF-1α and VEGF expression, and angiogenesis in vitro. Plos one 7(10): E48393
Zhuang, J.; Jiang, T.; Lu, D.; Luo, Y.; Zheng, C.; Feng, J.; Yang, D.; Chen, C.; Yan, X. 2010: NADPH oxidase 4 mediates reactive oxygen species induction of CD146 dimerization in VEGF signal transduction. Free Radical Biology and Medicine 49(2): 227-236
Muzaffar, S.; Jeremy, J.Y.; Angelini, G.D.; Shukla, N. 2012: NADPH oxidase 4 mediates upregulation of type 4 phosphodiesterases in human endothelial cells. Journal of Cellular Physiology 227(5): 1941-1950
Wang, J.; Hong, Z.; Zeng, C.; Yu, Q.; Wang, H. 2014: NADPH oxidase 4 promotes cardiac microvascular angiogenesis after hypoxia/reoxygenation in vitro. Free Radical Biology and Medicine 69: 278-288
Murray, T.V.A.; Smyrnias, I.; Shah, A.M.; Brewer, A.C. 2013: NADPH oxidase 4 regulates cardiomyocyte differentiation via redox activation of c-Jun protein and the cis-regulation of GATA-4 gene transcription. Journal of Biological Chemistry 288(22): 15745-15759
Miller, F.J. 2009: NADPH oxidase 4: walking the walk with Poldip2. Circulation Research 105(3): 209-210
Holterman, C.E.; Thibodeau, J.F.; Kennedy, C.R.J. 2015: NADPH oxidase 5 and renal disease. Current Opinion in Nephrology and Hypertension 24(1): 81-87
Ma, L.; Zhang, H.; Sun, L.; Jiao, Y.; Zhang, G.; Miao, C.; Hao, F. 2012: NADPH oxidase AtrbohD and AtrbohF function in ROS-dependent regulation of Na⁺/K⁺homeostasis in Arabidopsis under salt stress. Journal of Experimental Botany 63(1): 305-317
Sancho, P.; Fabregat, I. 2010: NADPH oxidase NOX1 controls autocrine growth of liver tumor cells through up-regulation of the epidermal growth factor receptor pathway. Journal of Biological Chemistry 285(32): 24815-24824
Moore, S.F.; MacKenzie, A.B. 2009: NADPH oxidase NOX2 mediates rapid cellular oxidation following ATP stimulation of endotoxin-primed macrophages. Journal of Immunology 183(5): 3302-3308
Sancho, P.; Mainez, J.ès.; Crosas-Molist, E.; Roncero, C.és.; Fernández-Rodriguez, C.M.; Pinedo, F.; Huber, H.; Eferl, R.; Mikulits, W.; Fabregat, I. 2012: NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development. Plos one 7(9): E45285
Gregg, J.L.; Turner, R.M.; Chang, G.; Joshi, D.; Zhan, Y.; Chen, L.; Maranchie, J.K. 2014: NADPH oxidase NOX4 supports renal tumorigenesis by promoting the expression and nuclear accumulation of HIF2α. Cancer Research 74(13): 3501-3511
Zhou, X.; Li, D.; Resnick, M.B.; Wands, J.; Cao, W. 2013: NADPH oxidase NOX5-S and nuclear factor κB1 mediate acid-induced microsomal prostaglandin e synthase-1 expression in Barrett's esophageal adenocarcinoma cells. Molecular Pharmacology 83(5): 978-990
Si, J.; Fu, X.; Behar, J.; Wands, J.; Beer, D.G.; Souza, R.F.; Spechler, S.J.; Lambeth, D.; Cao, W. 2007: NADPH oxidase NOX5-S mediates acid-induced cyclooxygenase-2 expression via activation of NF-kappaB in Barrett's esophageal adenocarcinoma cells. Journal of Biological Chemistry 282(22): 16244-16255
Kahles, T.; Kohnen, A.; Heumueller, S.; Rappert, A.; Bechmann, I.; Liebner, S.; Wittko, I.M.; Neumann-Haefelin, T.; Steinmetz, H.; Schroeder, K.; Brandes, R.P. 2010: NADPH oxidase Nox1 contributes to ischemic injury in experimental stroke in mice. Neurobiology of Disease 40(1): 185-192
Schröder, K.; Kohnen, A.; Aicher, A.; Liehn, E.A.; Büchse, T.; Stein, S.; Weber, C.; Dimmeler, S.; Brandes, R.P. 2009: NADPH oxidase Nox2 is required for hypoxia-induced mobilization of endothelial progenitor cells. Circulation Research 105(6): 537-544
Balteau, M.; Tajeddine, N.; de Meester, C.; Ginion, A.; Des Rosiers, C.; Brady, N.R.; Sommereyns, C.; Horman, S.; Vanoverschelde, J.-L.; Gailly, P.; Hue, L.; Bertrand, L.; Beauloye, C. 2011: NADPH oxidase activation by hyperglycaemia in cardiomyocytes is independent of glucose metabolism but requires SGLT1. Cardiovascular Research 92(2): 237-246
Edderkaoui, M.; Nitsche, C.; Zheng, L.; Pandol, S.J.; Gukovsky, I.; Gukovskaya, A.S. 2013: NADPH oxidase activation in pancreatic cancer cells is mediated through Akt-dependent up-regulation of p22phox. Journal of Biological Chemistry 288(51): 36259
Liu, K.; Liu, X.-S.; Xiao, L.; Shang, J.; Li, M.-C.; Xu, Y.-J.; Liu, H.-G. 2012: NADPH oxidase activation: a mechanism of erectile dysfunction in a rat model of sleep apnea. Journal of Andrology 33(6): 1186-1198
Jin, L.; Lagoda, G.; Leite, R.; Webb, R.C.; Burnett, A.L. 2008: NADPH oxidase activation: a mechanism of hypertension-associated erectile dysfunction. Journal of Sexual Medicine 5(3): 544-551
Durand, D.; Vivès, C.; Cannella, D.; Pérez, J.; Pebay-Peyroula, E.; Vachette, P.; Fieschi, F. 2010: NADPH oxidase activator p67(phox) behaves in solution as a multidomain protein with semi-flexible linkers. Journal of Structural Biology 169(1): 45-53
Rybicka, J.M.; Balce, D.R.; Khan, M.F.; Krohn, R.M.; Yates, R.M. 2010: NADPH oxidase activity controls phagosomal proteolysis in macrophages through modulation of the lumenal redox environment of phagosomes. Proceedings of the National Academy of Sciences of the United States of America 107(23): 10496-10501
Yuan, Z.-H.; Madamanchi, N.R.; Vendrov, A.E.; Niu, X.-L.; Li, J.-X.; Runge, M.S. 2008: NADPH oxidase activity does not affect cellular cholesterol loading in vascular smooth muscle cells. Sheng Li Xue Bao: 60(4): 511-519
Wang, X.-L.; Takai, T.; Kamijo, S.; Gunawan, H.; Ogawa, H.; Okumura, K. 2009: NADPH oxidase activity in allergenic pollen grains of different plant species. Biochemical and Biophysical Research Communications 387(3): 430-434
Goux, A.él.; Feillet-Coudray, C.; Jover, B.; Fouret, G.; Bargnoux, A.-S.; Cassan, C.éc.; Richard, S.; Badiou, S.ép.; Cristol, J.-P. 2011: NADPH oxidase activity is associated with cardiac osteopontin and pro-collagen type i expression in uremia. Free Radical Research 45(4): 454-460
Miller, A.A.; Drummond, G.R.; De Silva, T.M.; Mast, A.E.; Hickey, H.; Williams, J.P.; Broughton, B.R.S.; Sobey, C.G. 2009: NADPH oxidase activity is higher in cerebral versus systemic arteries of four animal species: role of Nox2. American Journal of Physiology. Heart and Circulatory Physiology 296(1): H220-H225
MacFarlane, P.M.; Satriotomo, I.; Windelborn, J.A.; Mitchell, G.S. 2009: NADPH oxidase activity is necessary for acute intermittent hypoxia-induced phrenic long-term facilitation. Journal of Physiology 587(Part 9): 1931-1942
Arruda, M.A.; Barja-Fidalgo, C. 2009: NADPH oxidase activity: in the crossroad of neutrophil life and death. Frontiers in Bioscience 14(12): 4546-4556
Souza, V.ón.; Escobar, M.D.C.; Bucio, L.; Hernández, E.; Gómez-Quiroz, L.E.; Gutiérrez Ruiz, M.C.ón. 2009: NADPH oxidase and ERK1/2 are involved in cadmium induced-STAT3 activation in HepG2 cells. Toxicology Letters 187(3): 180-186
Yang, J.; Pollock, J.S.; Carmines, P.K. 2012: NADPH oxidase and PKC contribute to increased Na transport by the thick ascending limb during type 1 diabetes. Hypertension 59(2): 431-436
Kuroda, J.; Sadoshima, J. 2010: NADPH oxidase and cardiac failure. Journal of Cardiovascular Translational Research 3(4): 314-320
Bartsch, C.; Bekhite, M.M.; Wolheim, A.; Richter, M.; Ruhe, C.; Wissuwa, B.; Marciniak, A.; Müller, J.ör.; Heller, R.; Figulla, H.-R.; Sauer, H.; Wartenberg, M. 2011: NADPH oxidase and eNOS control cardiomyogenesis in mouse embryonic stem cells on ascorbic acid treatment. Free Radical Biology and Medicine 51(2): 432-443
Espinosa, A.; García, A.; Härtel, S.; Hidalgo, C.; Jaimovich, E. 2009: NADPH oxidase and hydrogen peroxide mediate insulin-induced calcium increase in skeletal muscle cells. Journal of Biological Chemistry 284(4): 2568-2575
Eum, S.Yong.; Andras, I.; Hennig, B.; Toborek, M. 2009: NADPH oxidase and lipid raft-associated redox signaling are required for PCB153-induced upregulation of cell adhesion molecules in human brain endothelial cells. Toxicology and Applied Pharmacology 240(2): 299-305
Rao, K.; Liu, J.-H. 2009: NADPH oxidase and male erectile dysfunction. Zhonghua Nan Ke Xue 15(5): 455-458
Oates, J.C.; Mashmoushi, A.K.; Shaftman, S.R.; Gilkeson, G.S. 2013: NADPH oxidase and nitric oxide synthase-dependent superoxide production is increased in proliferative lupus nephritis. Lupus 22(13): 1361-1370
Qin, L.; Crews, F.T. 2012: NADPH oxidase and reactive oxygen species contribute to alcohol-induced microglial activation and neurodegeneration. Journal of Neuroinflammation 9: 5
Kim, M.; Han, C.-H.; Lee, M.-Y. 2014: NADPH oxidase and the cardiovascular toxicity associated with smoking. Toxicological Research 30(3): 149-157
Hernandes, M.S.; Café-Mendes, C.íl.C.; Britto, L.R.G. 2013: NADPH oxidase and the degeneration of dopaminergic neurons in parkinsonian mice. Oxidative Medicine and Cellular Longevity 2013: 157857
Czesnikiewicz-Guzik, M.; Lorkowska, B.; Zapala, J.; Czajka, M.; Szuta, M.; Loster, B.; Guzik, T.J.; Korbut, R. 2008: NADPH oxidase and uncoupled nitric oxide synthase are major sources of reactive oxygen species in oral squamous cell carcinoma. Potential implications for immune regulation in high oxidative stress conditions. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 59(1): 139-152
Joshi, S.; Peck, A.B.; Khan, S.R. 2013: NADPH oxidase as a therapeutic target for oxalate induced injury in kidneys. Oxidative Medicine and Cellular Longevity 2013: 462361
Block, M.L. 2008: NADPH oxidase as a therapeutic target in Alzheimer's disease. Bmc Neuroscience 9(Suppl 2): S8
Bevilacqua, E.; Gomes, S.Z.; Lorenzon, A.R.; Hoshida, M.S.; Amarante-Paffaro, A.M. 2012: NADPH oxidase as an important source of reactive oxygen species at the mouse maternal-fetal interface: putative biological roles. Reproductive Biomedicine Online 25(1): 31-43
Paletta-Silva, R.; Rocco-Machado, N.ál.; Meyer-Fernandes, J.é R. 2013: NADPH oxidase biology and the regulation of tyrosine kinase receptor signaling and cancer drug cytotoxicity. International Journal of Molecular Sciences 14(2): 3683-3704
Stanley, A.; Thompson, K.; Hynes, A.; Brakebusch, C.; Quondamatteo, F. 2014: NADPH oxidase complex-derived reactive oxygen species, the actin cytoskeleton, and Rho GTPases in cell migration. Antioxidants and Redox Signaling 20(13): 2026-2042
Wu, J.; Xu, H.; Yang, M.; Martin, C.M.; Kvietys, P.R.; Rui, T. 2009: NADPH oxidase contributes to conversion of cardiac myocytes to a proinflammatory phenotype in sepsis. Free Radical Biology and Medicine 46(10): 1338-1345
Tian, N.; Moore, R.S.; Phillips, W.E.; Lin, L.; Braddy, S.; Pryor, J.S.; Stockstill, R.L.; Hughson, M.D.; Manning, R.Davis. 2008: NADPH oxidase contributes to renal damage and dysfunction in Dahl salt-sensitive hypertension. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 295(6): R1858-R1865
Zhang, L.; Li, F.; Zhi, G.; Zhang, B.; Chen, Y-D. 2015: NADPH oxidase contributes to the left ventricular dysfunction induced by sinoaortic denervation in rats. Free Radical Research 49(1): 57-66
Tiurin-Kuz'min, P.A.; Agaronian, K.M.; Morozov, I.I.; Mishina, N.M.; Belousov, V.V.; Vorotnikov, A.V. 2010: NADPH oxidase controls EGF-induced proliferation via the ERK1/2-independent mechanism. Biofizika 55(6): 1048-1056
Mantegazza, A.R.; Savina, A.; Vermeulen, Mónica.; Pérez, L.; Geffner, J.; Hermine, O.; Rosenzweig, S.D.; Faure, F.; Amigorena, Sán. 2008: NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells. Blood 112(12): 4712-4722
Kigawa, Y.; Miyazaki, T.; Lei, X.-F.; Nakamachi, T.; Oguchi, T.; Kim-Kaneyama, J.-r.; Taniyama, M.; Tsunawaki, S.; Shioda, S.; Miyazaki, A. 2014: NADPH oxidase deficiency exacerbates angiotensin II-induced abdominal aortic aneurysms in mice. Arteriosclerosis Thrombosis and Vascular Biology 34(11): 2413-2420
Tse, H.M.; Thayer, T.C.; Steele, C.; Cuda, C.M.; Morel, L.; Piganelli, J.D.; Mathews, C.E. 2010: NADPH oxidase deficiency regulates Th lineage commitment and modulates autoimmunity. Journal of Immunology 185(9): 5247-5258
Felmy, B.; Songhet, P.; Slack, E.M.C.; Müller, A.J.; Kremer, M.; Van Maele, L.; Cayet, D.; Heikenwalder, M.; Sirard, J.-C.; Hardt, W.-D. 2013: NADPH oxidase deficient mice develop colitis and bacteremia upon infection with normally avirulent, TTSS-1- and TTSS-2-deficient Salmonella Typhimurium. Plos one 8(10): E77204
Gabelloni, M.ía.L.; Sabbione, F.; Jancic, C.; Fuxman Bass, J.; Keitelman, I.; Iula, L.; Oleastro, M.ía.; Geffner, J.R.; Trevani, A.ía.S. 2013: NADPH oxidase derived reactive oxygen species are involved in human neutrophil IL-1β secretion but not in inflammasome activation. European Journal of Immunology 43(12): 3324-3335
Turchan-Cholewo, J.; Dimayuga, V.M.; Gupta, S.; Gorospe, R.M.C.; Keller, J.N.; Bruce-Keller, A.J. 2009: NADPH oxidase drives cytokine and neurotoxin release from microglia and macrophages in response to HIV-Tat. Antioxidants and Redox Signaling 11(2): 193-204
Babalola, O.; Mamalis, A.; Lev-Tov, H.; Jagdeo, J. 2014: NADPH oxidase enzymes in skin fibrosis: molecular targets and therapeutic agents. Archives of Dermatological Research 306(4): 313-330
O'Brien, W.J.; Heimann, T.; Rizvi, F. 2009: NADPH oxidase expression and production of superoxide by human corneal stromal cells. Molecular Vision 15: 2535-2543
Fischer, M.T.; Sharma, R.; Lim, J.L.; Haider, L.; Frischer, J.M.; Drexhage, J.; Mahad, D.; Bradl, M.; van Horssen, J.; Lassmann, H. 2012: NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. Brain: a Journal of Neurology 135(Part 3): 886-899
Godbole, A.S.; Lu, X.; Guo, X.; Kassab, G.S. 2009: NADPH oxidase has a directional response to shear stress. American Journal of Physiology. Heart and Circulatory Physiology 296(1): H152-H158
Bechara, L.R.G.; Moreira, J.B.N.; Jannig, P.R.; Voltarelli, V.A.; Dourado, P.M.; Vasconcelos, A.R.; Scavone, C.; Ramires, P.R.; Brum, P.C. 2014: NADPH oxidase hyperactivity induces plantaris atrophy in heart failure rats. International Journal of Cardiology 175(3): 499-507
Yang, Z.; Sharma, A.K.; Marshall, M.; Kron, I.L.; Laubach, V.E. 2009: NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury. American Journal of Respiratory Cell and Molecular Biology 40(3): 375-381
Tang, X.N.; Cairns, B.; Kim, J.Y.; Yenari, M.A. 2012: NADPH oxidase in stroke and cerebrovascular disease. Neurological Research 34(4): 338-345
Gao, X.; Yang, T.; Liu, M.; Peleli, M.; Zollbrecht, C.; Weitzberg, E.; Lundberg, J.O.; Persson, A.Erik.G.; Carlström, M. 2015: NADPH oxidase in the renal microvasculature is a primary target for blood pressure-lowering effects by inorganic nitrate and nitrite. Hypertension 65(1): 161-170
Abe, J.-i.; Woo, C.-H. 2009: NADPH oxidase in vascular injury: a new insight about its regulation and role in T cells. Circulation Research 104(2): 147-149
Liu, Y.; Huang, H.; Xia, W.; Tang, Y.; Li, H.; Huang, C. 2010: NADPH oxidase inhibition ameliorates cardiac dysfunction in rabbits with heart failure. Molecular and Cellular Biochemistry 343(1-2): 143-153
Lu, X.-Y.; Wang, H.-D.; Xu, J.-G.; Ding, K.; Li, T. 2014: NADPH oxidase inhibition improves neurological outcome in experimental traumatic brain injury. Neurochemistry International 69: 14-19
Koulajian, K.; Desai, T.; Liu, G.C.; Ivovic, A.; Patterson, J.N.; Tang, C.; El-Benna, J.; Joseph, J.W.; Scholey, J.W.; Giacca, A. 2013: NADPH oxidase inhibition prevents beta cell dysfunction induced by prolonged elevation of oleate in rodents. Diabetologia 56(5): 1078-1087
Qian, L.; Gao, X.; Pei, Z.; Wu, X.; Block, M.; Wilson, B.; Hong, J.-S.; Flood, P.M. 2007: NADPH oxidase inhibitor DPi is neuroprotective at femtomolar concentrations through inhibition of microglia over-activation. Parkinsonism and Related Disorders 13(Suppl 3): S316-S320
Luo, X.-j.; Ji, S.-k.; Liu, B.; Zhang, H.-f.; Yang, Z.-b.; Ma, Q.-l. 2012: NADPH oxidase inhibitor apocynin attenuates ischemia/reperfusion induced myocardial injury in rats. Zhonghua Xin Xue Guan Bing Za Zhi 40(12): 991-996
Winiarska, K.; Focht, D.; Sierakowski, B.; Lewandowski, K.; Orlowska, M.; Usarek, M. 2014: NADPH oxidase inhibitor, apocynin, improves renal glutathione status in Zucker diabetic fatty rats: a comparison with melatonin. Chemico-Biological Interactions 218: 12-19
Kim, J.-A.; Neupane, G.P.; Lee, E.S.; Jeong, B.-S.; Park, B.C.; Thapa, P. 2011: NADPH oxidase inhibitors: a patent review. Expert Opinion on Therapeutic Patents 21(8): 1147-1158
Williams, H.C.; Griendling, K.K. 2007: NADPH oxidase inhibitors: new antihypertensive agents?. Journal of Cardiovascular Pharmacology 50(1): 9-16
Ejlerskov, P.; Christensen, D.P.; Beyaie, D.; Burritt, J.B.; Paclet, M.-H.; Gorlach, A.; van Deurs, B.; Vilhardt, F. 2012: NADPH oxidase is internalized by clathrin-coated pits and localizes to a Rab27A/B GTPase-regulated secretory compartment in activated macrophages. Journal of Biological Chemistry 287(7): 4835-4852
Lin, C.; Wang, H. 2012: NADPH oxidase is involved in H2O2-induced differentiation of human promyelocytic leukaemia HL-60 cells. Cell Biology International 36(4): 391-395
Nakagiri, A.; Sunamoto, M.; Murakami, M. 2007: NADPH oxidase is involved in ischaemia/reperfusion-induced damage in rat gastric mucosa via ROS production--role of NADPH oxidase in rat stomachs. Inflammopharmacology 15(6): 278-281
Chen, H.; Kim, G.S.; Okami, N.; Narasimhan, P.; Chan, P.H. 2011: NADPH oxidase is involved in post-ischemic brain inflammation. Neurobiology of Disease 42(3): 341-348
Jeon, S.M.; Lee, S.-J.; Kwon, T.K.; Kim, K.-J.; Bae, Y.-S. 2010: NADPH oxidase is involved in protein kinase CKIi down-regulation-mediated senescence through elevation of the level of reactive oxygen species in human colon cancer cells. Febs Letters 584(14): 3137-3142
Peng, Y.-J.; Nanduri, J.; Yuan, G.; Wang, N.; Deneris, E.; Pendyala, S.; Natarajan, V.; Kumar, G.K.; Prabhakar, N.R. 2009: NADPH oxidase is required for the sensory plasticity of the carotid body by chronic intermittent hypoxia. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 29(15): 4903-4910
Peshavariya, H.; Dusting, G.J.; Jiang, F.; Halmos, L.R.; Sobey, C.G.; Drummond, G.R.; Selemidis, S. 2009: NADPH oxidase isoform selective regulation of endothelial cell proliferation and survival. Naunyn-Schmiedeberg's Archives of Pharmacology 380(2): 193-204
Cui, W.; Matsuno, K.; Iwata, K.; Ibi, M.; Katsuyama, M.; Kakehi, T.; Sasaki, M.; Ikami, K.; Zhu, K.; Yabe-Nishimura, C. 2009: NADPH oxidase isoforms and anti-hypertensive effects of atorvastatin demonstrated in two animal models. Journal of Pharmacological Sciences 111(3): 260-268
Segal, B.H.; Han, W.; Bushey, J.J.; Joo, M.; Bhatti, Z.; Feminella, J.; Dennis, C.G.; Vethanayagam, R.R.; Yull, F.E.; Capitano, M.; Wallace, P.K.; Minderman, H.; Christman, J.W.; Sporn, M.B.; Chan, J.; Vinh, D.C.; Holland, S.M.; Romani, L.R.; Gaffen, S.L.; Freeman, M.L.; Blackwell, T.S. 2010: NADPH oxidase limits innate immune responses in the lungs in mice. Plos one 5(3): E9631
Han, W.; Li, H.; Cai, J.; Gleaves, L.A.; Polosukhin, V.V.; Segal, B.H.; Yull, F.E.; Blackwell, T.S. 2013: NADPH oxidase limits lipopolysaccharide-induced lung inflammation and injury in mice through reduction-oxidation regulation of NF-κB activity. Journal of Immunology 190(9): 4786-4794
Li, G.; Scull, C.; Ozcan, L.; Tabas, I. 2010: NADPH oxidase links endoplasmic reticulum stress, oxidative stress, and PKR activation to induce apoptosis. Journal of Cell Biology 191(6): 1113-1125
Paik, Y.H.; Brenner, D.A. 2011: NADPH oxidase mediated oxidative stress in hepatic fibrogenesis. Korean Journal of Hepatology 17(4): 251-257
Abdullah, Z.; Bayraktutan, U. 2014: NADPH oxidase mediates TNF-α-evoked in vitro brain barrier dysfunction: roles of apoptosis and time. Molecular and Cellular Neurosciences 61: 72-84
Serrano, F.; Chang, A.; Hernandez, C.; Pautler, R.G.; Sweatt, J.D.; Klann, E. 2009: NADPH oxidase mediates beta-amyloid peptide-induced activation of ERK in hippocampal organotypic cultures. Molecular Brain 2: 31
Seo, J.-S.; Park, J.-Y.; Choi, J.; Kim, T.-K.; Shin, J.-H.; Lee, J.-K.; Han, P.-L. 2012: NADPH oxidase mediates depressive behavior induced by chronic stress in mice. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 32(28): 9690-9699
McCarty, M.F.; Barroso-Aranda, J.; Contreras, F. 2010: NADPH oxidase mediates glucolipotoxicity-induced beta cell dysfunction--clinical implications. Medical Hypotheses 74(3): 596-600
Collins-Underwood, J.R.; Zhao, W.; Sharpe, J.G.; Robbins, M.E. 2008: NADPH oxidase mediates radiation-induced oxidative stress in rat brain microvascular endothelial cells. Free Radical Biology and Medicine 45(6): 929-938
Sharma, A.K.; Mulloy, D.P.; Le, L.T.; Laubach, V.E. 2014: NADPH oxidase mediates synergistic effects of IL-17 and TNF-α on CXCL1 expression by epithelial cells after lung ischemia-reperfusion. American Journal of Physiology. Lung Cellular and Molecular Physiology 306(1): L69-L79
Tang, X.; Zhong, W.; Tu, Q.; Ding, B. 2014: NADPH oxidase mediates the expression of MMP-9 in cerebral tissue after ischemia-reperfusion damage. Neurological Research 36(2): 118-125
Allan, E.R.O.; Tailor, P.; Balce, D.R.; Pirzadeh, P.; McKenna, N.T.; Renaux, B.; Warren, A.L.; Jirik, F.R.; Yates, R.M. 2014: NADPH oxidase modifies patterns of MHC class II-restricted epitopic repertoires through redox control of antigen processing. Journal of Immunology 192(11): 4989-5001
Wang, R.; Dashwood, W.-M.; Nian, H.; Löhr, C.V.; Fischer, K.A.; Tsuchiya, N.; Nakagama, H.; Ashktorab, H.; Dashwood, R.H. 2011: NADPH oxidase overexpression in human colon cancers and rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). International Journal of Cancer 128(11): 2581-2590
Izquierdo-Vega, J.A.; Sánchez-Gutiérrez, M.; Del Razo, L.M.ía. 2011: NADPH oxidase participates in the oxidative damage caused by fluoride in rat spermatozoa. Protective role of α-tocopherol. Journal of Applied Toxicology: Jat 31(6): 579-588
Usui, S.; Oveson, B.C.; Lee, S.Y.; Jo, Y.-J.; Yoshida, T.; Miki, A.; Miki, K.; Iwase, T.; Lu, L.; Campochiaro, P.A. 2009: NADPH oxidase plays a central role in cone cell death in retinitis pigmentosa. Journal of Neurochemistry 110(3): 1028-1037
Khan, U.; Bevan, S.; Markus, H.S. 2007: NADPH oxidase polymorphisms in cerebral small vessel disease. Cerebrovascular Diseases 24(1): 135-138
Röhm, M.; Grimm, M.J.; D'Auria, A.C.; Almyroudis, N.G.; Segal, B.H.; Urban, C.F. 2014: NADPH oxidase promotes neutrophil extracellular trap formation in pulmonary aspergillosis. Infection and Immunity 82(5): 1766-1777
Deepe, G.S. 2012: NADPH oxidase regulates efficacy of vaccination in aspergillosis. Journal of Clinical Investigation 122(5): 1608-1611
Hsieh, C.-H.; Wu, C.-P.; Lee, H.-T.; Liang, J.-A.; Yu, C.-Y.; Lin, Y.-J. 2012: NADPH oxidase subunit 4 mediates cycling hypoxia-promoted radiation resistance in glioblastoma multiforme. Free Radical Biology and Medicine 53(4): 649-658
Hsieh, C-Hung.; Shyu, W-Cherng.; Chiang, C-Yi.; Kuo, J-Wen.; Shen, W-Chung.; Liu, R-Shyan. 2011: NADPH oxidase subunit 4-mediated reactive oxygen species contribute to cycling hypoxia-promoted tumor progression in glioblastoma multiforme. Plos one 6(9): E23945
Li, Q.; Fu, G-Bo.; Zheng, J-Tai.; He, J.; Niu, X-Bing.; Chen, Q-Dan.; Yin, Y.; Qian, X.; Xu, Q.; Wang, M.; Sun, A-Fang.; Shu, Y.; Rui, H.; Liu, L-Zhi.; Jiang, B-Hua. 2013: NADPH oxidase subunit p22(phox)-mediated reactive oxygen species contribute to angiogenesis and tumor growth through AKT and ERK1/2 signaling pathways in prostate cancer. Biochimica et Biophysica Acta 1833(12): 3375-3385
Calò, L.A.; Davis, P.A. 2007: NADPH oxidase subunits (NOX-1, p22phox, Rac-1) and tacrolimus-induced nephrotoxicity in a rat renal transplant model. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 22(8): 2402; Author Reply 2403
Wilkinson-Berka, J.L.; Deliyanti, D.; Rana, I.; Miller, A.G.; Agrotis, A.; Armani, R.; Szyndralewiez, C.éd.; Wingler, K.; Touyz, R.M.; Cooper, M.E.; Jandeleit-Dahm, K.A.; Schmidt, H.H.H.W. 2014: NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy. Antioxidants and Redox Signaling 20(17): 2726-2740
Bordt, E.A.; Polster, B.M. 2014: NADPH oxidase- and mitochondria-derived reactive oxygen species in proinflammatory microglial activation: a bipartisan affair?. Free Radical Biology and Medicine 76: 34-46
Carnesecchi, S.ép.; Deffert, C.; Pagano, A.; Garrido-Urbani, S.; Métrailler-Ruchonnet, I.; Schäppi, M.; Donati, Y.; Matthay, M.A.; Krause, K.-H.; Barazzone Argiroffo, C. 2009: NADPH oxidase-1 plays a crucial role in hyperoxia-induced acute lung injury in mice. American Journal of Respiratory and Critical Care Medicine 180(10): 972-981
Jendrysik, M.A.; Vasilevsky, S.; Yi, L.; Wood, A.; Zhu, N.; Zhao, Y.; Koontz, S.M.; Jackson, S.H. 2011: NADPH oxidase-2 derived ROS dictates murine DC cytokine-mediated cell fate decisions during CD4 T helper-cell commitment. Plos one 6(12): E28198
Gonzalez, D.R.; Treuer, A.V.; Lamirault, G.; Mayo, V.; Cao, Y.; Dulce, R.A.; Hare, J.M. 2014: NADPH oxidase-2 inhibition restores contractility and intracellular calcium handling and reduces arrhythmogenicity in dystrophic cardiomyopathy. American Journal of Physiology. Heart and Circulatory Physiology 307(5): H710-H721
Zhang, G.-Y.; Wu, L.-C.; Dai, T.; Chen, S.-Y.; Wang, A.-Y.; Lin, K.; Lin, D.-M.; Yang, J.-Q.; Cheng, B.; Zhang, L.; Gao, W.-Y.; Li, Z.-J. 2014: NADPH oxidase-2 is a key regulator of human dermal fibroblasts: a potential therapeutic strategy for the treatment of skin fibrosis. Experimental Dermatology 23(9): 639-644
Brennan-Minnella, A.M.; Won, S.J.; Swanson, R.A. 2015: NADPH oxidase-2: linking glucose, acidosis, and excitotoxicity in stroke. Antioxidants and Redox Signaling 22(2): 161-174
Kallenborn-Gerhardt, W.; Schröder, K.; Del Turco, D.; Lu, R.; Kynast, K.; Kosowski, J.; Niederberger, E.; Shah, A.M.; Brandes, R.P.; Geisslinger, G.; Schmidtko, A. 2012: NADPH oxidase-4 maintains neuropathic pain after peripheral nerve injury. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 32(30): 10136-10145
Zhang, M.; Brewer, A.C.; Schröder, K.; Santos, C.X.C.; Grieve, D.J.; Wang, M.; Anilkumar, N.; Yu, B.; Dong, X.; Walker, S.J.; Brandes, R.P.; Shah, A.M. 2010: NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proceedings of the National Academy of Sciences of the United States of America 107(42): 18121-18126
Gatto, G.J.; Ao, Z.; Kearse, M.G.; Zhou, M.; Morales, C.R.; Daniels, E.; Bradley, B.T.; Goserud, M.T.; Goodman, K.B.; Douglas, S.A.; Harpel, M.R.; Johns, D.G. 2013: NADPH oxidase-dependent and -independent mechanisms of reported inhibitors of reactive oxygen generation. Journal of Enzyme Inhibition and Medicinal Chemistry 28(1): 95-104
Chang, J.; Jiang, Z.; Zhang, H.; Zhu, H.; Zhou, S-Feng.; Yu, X. 2011: NADPH oxidase-dependent formation of reactive oxygen species contributes to angiotensin II-induced epithelial-mesenchymal transition in rat peritoneal mesothelial cells. International Journal of Molecular Medicine 28(3): 405-412
Liu, X-xian.; Zhou, H-juan.; Cai, L.; Zhang, W.; Ma, J-lin.; Tao, X-juan.; Yu, J-ning. 2014: NADPH oxidase-dependent formation of reactive oxygen species contributes to transforming growth factor β1-induced epithelial-mesenchymal transition in rat peritoneal mesothelial cells, and the role of astragalus intervention. Chinese Journal of Integrative Medicine 20(9): 667-674
Frasch, S.C.; Berry, K.Z.; Fernandez-Boyanapalli, R.; Jin, H.-S.; Leslie, C.; Henson, P.M.; Murphy, R.C.; Bratton, D.L. 2008: NADPH oxidase-dependent generation of lysophosphatidylserine enhances clearance of activated and dying neutrophils via G2A. Journal of Biological Chemistry 283(48): 33736-33749
Kong, X.; Thimmulappa, R.; Kombairaju, P.; Biswal, S. 2010: NADPH oxidase-dependent reactive oxygen species mediate amplified TLR4 signaling and sepsis-induced mortality in Nrf2-deficient mice. Journal of Immunology 185(1): 569-577
Jiang, F.; Liu, G.-S.; Dusting, G.J.; Chan, E.C. 2014: NADPH oxidase-dependent redox signaling in TGF-β-mediated fibrotic responses. Redox Biology 2: 267-272
Souvannakitti, D.; Nanduri, J.; Yuan, G.; Kumar, G.K.; Fox, A.P.; Prabhakar, N.R. 2010: NADPH oxidase-dependent regulation of T-type Ca2+ channels and ryanodine receptors mediate the augmented exocytosis of catecholamines from intermittent hypoxia-treated neonatal rat chromaffin cells. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 30(32): 10763-10772
Frey, R.S.; Ushio-Fukai, M.; Malik, A.B. 2009: NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology. Antioxidants and Redox Signaling 11(4): 791-810
Rajamohan, S.B.; Raghuraman, G.; Prabhakar, N.R.; Kumar, G.K. 2012: NADPH oxidase-derived H(2)O(2) contributes to angiotensin II-induced aldosterone synthesis in human and rat adrenal cortical cells. Antioxidants and Redox Signaling 17(3): 445-459
Wang, Z.; Wei, X.; Zhang, Y.; Ma, X.; Li, B.; Zhang, S.; Du, P.; Zhang, X.; Yi, F. 2009: NADPH oxidase-derived ROS contributes to upregulation of TRPC6 expression in puromycin aminonucleoside-induced podocyte injury. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 24(5-6): 619-626
Sasaki, H.; Yamamoto, H.; Tominaga, K.; Masuda, K.; Kawai, T.; Teshima-Kondo, S.; Rokutan, K. 2009: NADPH oxidase-derived reactive oxygen species are essential for differentiation of a mouse macrophage cell line (RAW264.7) into osteoclasts. Journal of Medical Investigation: Jmi 56(1-2): 33-41
Chen, H.; Zhang, B.; Yao, Y.; Chen, N.; Chen, X.; Tian, H.; Wang, Z.; Zheng, Q. 2012: NADPH oxidase-derived reactive oxygen species are involved in the HL-60 cell monocytic differentiation induced by isoliquiritigenin. Molecules 17(11): 13424-13438
DuPont, J.J.; Ramick, M.G.; Farquhar, W.B.; Townsend, R.R.; Edwards, D.G. 2014: NADPH oxidase-derived reactive oxygen species contribute to impaired cutaneous microvascular function in chronic kidney disease. American Journal of Physiology. Renal Physiology 306(12): F1499-F1506
Wang, H-Jun.; Pan, Y-Xia.; Wang, W-Zhong.; Zucker, I.H.; Wang, W. 2009: NADPH oxidase-derived reactive oxygen species in skeletal muscle modulates the exercise pressor reflex. Journal of Applied Physiology 107(2): 450-459
Han, C.Y.; Umemoto, T.; Omer, M.; Den Hartigh, L.J.; Chiba, T.; LeBoeuf, R.; Buller, C.L.; Sweet, I.R.; Pennathur, S.; Abel, E.D.; Chait, A. 2012: NADPH oxidase-derived reactive oxygen species increases expression of monocyte chemotactic factor genes in cultured adipocytes. Journal of Biological Chemistry 287(13): 10379-10393
Chen, Y.; Zhang, A.-h.; Huang, S.-m.; Ding, G.-x.; Zhang, W.-z.; Bao, H.-y.; Wu, H.-m.; Chen, R.-h. 2009: NADPH oxidase-derived reactive oxygen species involved in angiotensin II-induced monocyte chemoattractant protein-1 expression in mesangial cells. Zhonghua Bing Li Xue Za Zhi 38(7): 456-461
Al-Sabbagh, M.; Fusi, L.; Higham, J.; Lee, Y.; Lei, K.; Hanyaloglu, A.C.; Lam, E.W.-F.; Christian, M.; Brosens, J.J. 2011: NADPH oxidase-derived reactive oxygen species mediate decidualization of human endometrial stromal cells in response to cyclic AMP signaling. Endocrinology 152(2): 730-740
Manea, A. 2010: NADPH oxidase-derived reactive oxygen species: involvement in vascular physiology and pathology. Cell and Tissue Research 342(3): 325-339
Li, Y-Long.; Gao, L.; Zucker, I.H.; Schultz, H.D. 2007: NADPH oxidase-derived superoxide anion mediates angiotensin II-enhanced carotid body chemoreceptor sensitivity in heart failure rabbits. Cardiovascular Research 75(3): 546-554
Tsai, K.-H.; Wang, W.-J.; Lin, C.-W.; Pai, P.; Lai, T.-Y.; Tsai, C.-Y.; Kuo, W.-W. 2012: NADPH oxidase-derived superoxide anion-induced apoptosis is mediated via the JNK-dependent activation of NF-κB in cardiomyocytes exposed to high glucose. Journal of Cellular Physiology 227(4): 1347-1357
Al Ghouleh, I.; Magder, S. 2012: NADPH oxidase-derived superoxide destabilizes lipopolysaccharide-induced interleukin 8 mRNA via p38, extracellular signal-regulated kinase mitogen-activated protein kinase, and the destabilizing factor tristetraprolin. Shock 37(4): 433-440
Rueckschloss, U.; Villmow, M.; Klöckner, U. 2010: NADPH oxidase-derived superoxide impairs calcium transients and contraction in aged murine ventricular myocytes. Experimental Gerontology 45(10): 788-796
Brothers, K.M.; Gratacap, R.L.; Barker, S.E.; Newman, Z.R.; Norum, A.; Wheeler, R.T. 2013: NADPH oxidase-driven phagocyte recruitment controls Candida albicans filamentous growth and prevents mortality. Plos Pathogens 9(10): E1003634
Pi, X.; Xie, L.; Portbury, A.L.; Kumar, S.; Lockyer, P.; Li, X.; Patterson, C. 2014: NADPH oxidase-generated reactive oxygen species are required for stromal cell-derived factor-1α-stimulated angiogenesis. Arteriosclerosis Thrombosis and Vascular Biology 34(9): 2023-2032
Morshed, M.; Hlushchuk, R.; Simon, D.; Walls, A.F.; Obata-Ninomiya, K.; Karasuyama, H.; Djonov, V.; Eggel, A.; Kaufmann, T.; Simon, H.-U.; Yousefi, S. 2014: NADPH oxidase-independent formation of extracellular DNA traps by basophils. Journal of Immunology 192(11): 5314-5323
Murotomi, K.; Takagi, N.; Takeo, S.; Tanonaka, K. 2011: NADPH oxidase-mediated oxidative damage to proteins in the postsynaptic density after transient cerebral ischemia and reperfusion. Molecular and Cellular Neurosciences 46(3): 681-688
Moon, E.J.; Sonveaux, P.; Porporato, P.E.; Danhier, P.; Gallez, B.; Batinic-Haberle, I.; Nien, Y.-C.; Schroeder, T.; Dewhirst, M.W. 2010: NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment. Proceedings of the National Academy of Sciences of the United States of America 107(47): 20477-20482
Lherminier, J.; Elmayan, T.; Fromentin, J.ér.ôm.; Elaraqui, K.T.; Vesa, S.; Morel, J.; Verrier, J.-L.; Cailleteau, B.; Blein, J.-P.; Simon-Plas, F.ço. 2009: NADPH oxidase-mediated reactive oxygen species production: subcellular localization and reassessment of its role in plant defense. Molecular Plant-Microbe Interactions: Mpmi 22(7): 868-881
Hsieh, H-Lung.; Lin, C-Chung.; Shih, R-Horng.; Hsiao, L-Der.; Yang, C-Mao. 2012: NADPH oxidase-mediated redox signal contributes to lipoteichoic acid-induced MMP-9 upregulation in brain astrocytes. Journal of Neuroinflammation 9: 110
Jiang, F.; Zhang, Y.; Dusting, G.J. 2011: NADPH oxidase-mediated redox signaling: roles in cellular stress response, stress tolerance, and tissue repair. Pharmacological Reviews 63(1): 218-242
Abais, J.M.; Zhang, C.; Xia, M.; Liu, Q.; Gehr, T.W.B.; Boini, K.M.; Li, P.-L. 2013: NADPH oxidase-mediated triggering of inflammasome activation in mouse podocytes and glomeruli during hyperhomocysteinemia. Antioxidants and Redox Signaling 18(13): 1537-1548
Yan, Q.; Gao, K.; Chi, Y.; Li, K.; Zhu, Y.; Wan, Y.; Sun, W.; Matsue, H.; Kitamura, M.; Yao, J. 2012: NADPH oxidase-mediated upregulation of connexin43 contributes to podocyte injury. Free Radical Biology and Medicine 53(6): 1286-1297
Li, Y.-N.; Xi, M.-M.; Guo, Y.; Hai, C.-X.; Yang, W.-L.; Qin, X.-J. 2014: NADPH oxidase-mitochondria axis-derived ROS mediate arsenite-induced HIF-1α stabilization by inhibiting prolyl hydroxylases activity. Toxicology Letters 224(2): 165-174
Yang, C-Mao.; Lee, I-Ta.; Hsu, R-Chun.; Chi, P-Ling.; Hsiao, L-Der. 2013: NADPH oxidase/ROS-dependent PYK2 activation is involved in TNF-α-induced matrix metalloproteinase-9 expression in rat heart-derived H9c2 cells. Toxicology and Applied Pharmacology 272(2): 431-442
Dong, J.; Chen, P.; Wang, R.; Yu, D.; Zhang, Y.; Xiao, W. 2011: NADPH oxidase: a target for the modulation of the excessive oxidase damage induced by overtraining in rat neutrophils. International Journal of Biological Sciences 7(6): 881-891
Wood, M.J. 2011: NADPH oxidase: short-term foe, long-term friend. Journal of Applied Physiology 111(5): 1231-1232
Schilder, Y.D.C.; Heiss, E.H.; Schachner, D.; Ziegler, J.ür.; Reznicek, G.; Sorescu, D.; Dirsch, V.M. 2009: NADPH oxidases 1 and 4 mediate cellular senescence induced by resveratrol in human endothelial cells. Free Radical Biology and Medicine 46(12): 1598-1606
Cano-Domínguez, N.; Alvarez-Delfín, K.; Hansberg, W.; Aguirre, J.ús. 2008: NADPH oxidases NOX-1 and NOX-2 require the regulatory subunit NOR-1 to control cell differentiation and growth in Neurospora crassa. Eukaryotic Cell 7(8): 1352-1361
Garrido, A.M.; Griendling, K.K. 2009: NADPH oxidases and angiotensin Ii receptor signaling. Molecular and Cellular Endocrinology 302(2): 148-158
Madamanchi, N.R.; Runge, M.S. 2010: NADPH oxidases and atherosclerosis: unraveling the details. American Journal of Physiology. Heart and Circulatory Physiology 298(1): H1-H2
Nabeebaccus, A.; Zhang, M.; Shah, A.M. 2011: NADPH oxidases and cardiac remodelling. Heart Failure Reviews 16(1): 5-12
Dennis, K.E.; Aschner, J.L.; Milatovic, D.; Schmidt, J.W.; Aschner, M.; Kaplowitz, M.R.; Zhang, Y.; Fike, C.D. 2009: NADPH oxidases and reactive oxygen species at different stages of chronic hypoxia-induced pulmonary hypertension in newborn piglets. American Journal of Physiology. Lung Cellular and Molecular Physiology 297(4): L596-L607
Tong, X.; Schröder, K. 2009: NADPH oxidases are responsible for the failure of nitric oxide to inhibit migration of smooth muscle cells exposed to high glucose. Free Radical Biology and Medicine 47(11): 1578-1583
Vlahos, R.; Selemidis, S. 2014: NADPH oxidases as novel pharmacologic targets against influenza a virus infection. Molecular Pharmacology 86(6): 747-759
Coso, S.; Harrison, I.; Harrison, C.B.; Vinh, A.; Sobey, C.G.; Drummond, G.R.; Williams, E.D.; Selemidis, S. 2012: NADPH oxidases as regulators of tumor angiogenesis: current and emerging concepts. Antioxidants and Redox Signaling 16(11): 1229-1247
Sánchez-Sánchez, B.; Gutiérrez-Herrero, S.; López-Ruano, G.; Prieto-Bermejo, R.; Romo-González, M.; Llanillo, M.; Pandiella, A.; Guerrero, C.; Miguel, J.ús.F.S.; Sánchez-Guijo, F.ín.; Del Cañizo, C.; Hernández-Hernández, A. 2014: NADPH oxidases as therapeutic targets in chronic myelogenous leukemia. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 20(15): 4014-4025
Huang, J.; Brumell, J.H. 2009: NADPH oxidases contribute to autophagy regulation. Autophagy 5(6): 887-889
Schröder, K. 2015: NADPH oxidases in bone homeostasis and osteoporosis. Cellular and Molecular Life Sciences: Cmls 72(1): 25-38
Brandes, R.P.; Weissmann, N.; Schröder, K. 2010: NADPH oxidases in cardiovascular disease. Free Radical Biology and Medicine 49(5): 687-706
Zhang, M.; Perino, A.; Ghigo, A.; Hirsch, E.; Shah, A.M. 2013: NADPH oxidases in heart failure: poachers or gamekeepers?. Antioxidants and Redox Signaling 18(9): 1024-1041
Bokoch, G.M. 2009: NADPH oxidases in innate immunity. Journal of Innate Immunity 1(6): 507-508
Bernard, K.; Hecker, L.; Luckhardt, T.R.; Cheng, G.; Thannickal, V.J. 2014: NADPH oxidases in lung health and disease. Antioxidants and Redox Signaling 20(17): 2838-2853
Schröder, K. 2014: NADPH oxidases in redox regulation of cell adhesion and migration. Antioxidants and Redox Signaling 20(13): 2043-2058
Selemidis, S.; Sobey, C.G.; Wingler, K.; Schmidt, H.H.H.W.; Drummond, G.R. 2008: NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition. Pharmacology and Therapeutics 120(3): 254-291
Konior, A.; Schramm, A.; Czesnikiewicz-Guzik, M.; Guzik, T.J. 2014: NADPH oxidases in vascular pathology. Antioxidants and Redox Signaling 20(17): 2794-2814
Wang, H.-X.; Yang, H.; Han, Q.-Y.; Li, N.; Jiang, X.; Tian, C.; Du, J.; Li, H.-H. 2013: NADPH oxidases mediate a cellular "memory" of angiotensin Ii stress in hypertensive cardiac hypertrophy. Free Radical Biology and Medicine 65: 897-907
Gilleron, M.èn.; Marechal, X.; Montaigne, D.; Franczak, J.; Neviere, R.; Lancel, S. 2009: NADPH oxidases participate to doxorubicin-induced cardiac myocyte apoptosis. Biochemical and Biophysical Research Communications 388(4): 727-731
Vendrov, A.E.; Madamanchi, N.R.; Niu, X.-L.; Molnar, K.C.; Runge, M.; Szyndralewiez, C.éd.; Page, P.; Runge, M.S. 2010: NADPH oxidases regulate CD44 and hyaluronic acid expression in thrombin-treated vascular smooth muscle cells and in atherosclerosis. Journal of Biological Chemistry 285(34): 26545-26557
Ryder, L.S.; Dagdas, Y.F.; Mentlak, T.A.; Kershaw, M.J.; Thornton, C.R.; Schuster, M.; Chen, J.; Wang, Z.; Talbot, N.J. 2013: NADPH oxidases regulate septin-mediated cytoskeletal remodeling during plant infection by the rice blast fungus. Proceedings of the National Academy of Sciences of the United States of America 110(8): 3179-3184
Paravicini, T.M.; Touyz, R.M. 2008: NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 31(Suppl 2): S170-S180
Sedeek, M.; Nasrallah, R.; Touyz, R.M.; Hébert, R.L. 2013: NADPH oxidases, reactive oxygen species, and the kidney: friend and foe. Journal of the American Society of Nephrology: Jasn 24(10): 1512-1518
Meitzler, J.L.; Antony, S.; Wu, Y.; Juhasz, A.; Liu, H.; Jiang, G.; Lu, J.; Roy, K.; Doroshow, J.H. 2014: NADPH oxidases: a perspective on reactive oxygen species production in tumor biology. Antioxidants and Redox Signaling 20(17): 2873-2889
Lassègue, B.; Griendling, K.K. 2010: NADPH oxidases: functions and pathologies in the vasculature. Arteriosclerosis Thrombosis and Vascular Biology 30(4): 653-661
Guzik, T.J.; Griendling, K.K. 2009: NADPH oxidases: molecular understanding finally reaching the clinical level?. Antioxidants and Redox Signaling 11(10): 2365-2370
Vanden Berghe, T.; Declercq, W.; Vandenabeele, P. 2007: NADPH oxidases: new players in TNF-induced necrotic cell death. Molecular Cell 26(6): 769-771
San Martin, A.; Griendling, K.K. 2014: NADPH oxidases: progress and opportunities. Antioxidants and Redox Signaling 20(17): 2692-2694
Chen, L.-Y.; Wu, Y.-Q.; Zhang, Z.-H. 2012: NADPH oxidation-reduction reaction platform and its regulatory role in Ang II-mediated ROS signaling pathway. Sheng Li Ke Xue Jin Zhan 43(6): 439-444
Santiago, H.C.; Gonzalez Lombana, C.Z.; Macedo, J.P.; Utsch, L.; Tafuri, W.L.; Campagnole-Santos, M.J.é; Alves, R.O.; Alves-Filho, J.é C.F.; Romanha, A.J.; Cunha, F.Q.; Teixeira, M.M.; Radi, R.; Vieira, L.Q. 2012: NADPH phagocyte oxidase knockout mice control Trypanosoma cruzi proliferation, but develop circulatory collapse and succumb to infection. Plos Neglected Tropical Diseases 6(2): E1492
Ohashi, K.; Kawai, S.; Koshimizu, M.; Murata, K. 2011: NADPH regulates human NAD kinase, a NADP⁺-biosynthetic enzyme. Molecular and Cellular Biochemistry 355(1-2): 57-64
Pérez-Ruiz, J.M.; Guinea, M.; Puerto-Galán, L.; Cejudo, F.J. 2014: NADPH thioredoxin reductase C is involved in redox regulation of the Mg-chelatase i subunit in Arabidopsis thaliana chloroplasts. Molecular Plant 7(7): 1252-1255
Kirchsteiger, K.; Ferrández, J.; Pascual, M.ía.B.én.; González, M.; Cejudo, F.J. 2012: NADPH thioredoxin reductase C is localized in plastids of photosynthetic and nonphotosynthetic tissues and is involved in lateral root formation in Arabidopsis. Plant Cell 24(4): 1534-1548
Ma, Y.; Chen, H.; Zhao, C.; Xia, W.; Ying, W. 2011: NADPH treatment decreases C6 glioma cell survival by increasing oxidative stress. Frontiers in Bioscience 3(4): 1221-1228
Milczarek, R.; Sokołowska, E.; Hallmann, A.; Kaletha, K.; Klimek, J. 2008: NADPH- and iron-dependent lipid peroxidation inhibit aromatase activity in human placental microsomes. Journal of Steroid Biochemistry and Molecular Biology 110(3-5): 230-235
Pow, D.V. 1992: NADPH-Diaphorase (Nitric Oxide Synthase) Staining in the Rat Supraoptic Nucleus is Activity-Dependent: Possible Functional Implications. Journal of Neuroendocrinology 4(4): 377-380
Zhou, X.; Li, M.; Sheng, C.; Qiu, X. 2011: NADPH-cytochrome P450 oxidoreductase from the chicken (Gallus gallus): sequence characterization, functional expression and kinetic study. Comparative Biochemistry and Physiology. Toxicology and Pharmacology: Cbp 153(1): 53-59